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ABSTRACT 
Regulation of the acto-myosin interaction is mediated by the Ca2+ -induced changes in 
the properties of the thin filament proteins tropomyosin and troponin. Two major 
tropomyosin isoforms, a and 13, are expressed in striated muscle with larger amounts of 
13 expressed in slow-contracting skeletal muscle and slower beating hearts of big 
mammals. The regulatory properties of a and 13 tropomyosin were defined in terms of 
the three-state model of regulation. The Ca2+-dependent regulation of the thin filament 
was identical for a and 13 in the presence of skeletal troponin proteins. However, 
13 tropomyosin-containing thin filaments were more Ca2+ sensitive in the presence of 
cardiac troponin. The thermal stability of the two isoforms was also examined using 
Differential Scanning Calorimetry. 13 tropomyosin was significantly less thermostable 
than a tropomyosin as it is partially unfolded at 37°C when free in solution. In the 
presence of actin, both u and 13 tropomyosin stability is increased. However, 13 
tropomyosin unfolding starts at 40°C, a temperature the body can reach. These 
findings provide an explanation for the low level of 13 tropomyosin expression in the 
heart and the fact that it is predominantly found associated with a tropomyosin as a 
heterodimer. 
Familial Hypertrophy Cardiomyopathy (FHC) is an autosomal dominant disease, which 
causes sudden death of young and healthy individuals. The effect of FHC mutations 
expressed in tropomyosin and troponin proteins on the regulatory process was 
investigated. Two mutations in u tropomyosin (D175N and EI80G), and three 
mutations in trponin (G203S and K206Q in TnI, L29E in TnC) were examined. Both 
D175N and E180G increased the Ca2+ sensitivity of the system when associated with 
cardiac troponin Also, both mutations decreased the local stability of tropomyosin 
when free in solution In the presence of actin, D 17 5N tropomyosin thermal stability 
was indistinguishable from wild type. No detectable changes in the regulatory function 
of the thin filament were observed with troponin mutations G203S in troponin I and 
L29E in troponin C. However, K206Q mutation in troponin I caused an increase in the 
Ca2+ sensitivity interestingly only when troponin I was phosphorylated. 
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Chapter 1 Introduction 
Motility is an indispensable feature in living organisms. It occurs in all eukaryotic cells 
and ultimately results in active transport through membranes, cell division, the beating 
of flagella and cilia and the contraction of muscles. Muscle is the most understood 
motility system Over the decades, a combination of functional and structural studies 
provided insights into the molecular mechanisms controlling muscle contraction and its 
regulation. Understanding these processes will have implications in not only 
understanding muscle function in health and disease but also energy transduction for 
force and motion production in both muscle and non-muscle cells. 
The importance of studying the proteins which regulate muscle contraction is reflected 
by the potential development of therapeutic target drugs that can alter the contractile 
properties of the heart in a desired way. The characterisation of these proteins has also 
allowed their use as biochemical markers for the diagnosis of several heart injuries. 
The results presented in this thesis have been obtained using both skeletal and cardiac 
proteins, the structure and function of which are described in this chapter. 
1 Muscle structure and proteins 
1.1 General structure of striated muscle 
Both skeletal and cardiac muscles have a striated appearance when viewed under the 
light microscope. Skeletal muscle consists of a bundle of long muscle fibres (also 
referred to as muscle cells) each consisting of a number of myofibrils (Figure 1.1 a). 
The fibre striations arise from the presence of repeating units named sarcomeres which 
can be seen on an electron micrograph of longitudinal section of a myofibril 
(Figure I.2a). Figure 1.2b is a schematic representation of a sarcomere structure. It 
consists of alternating dark and light bands, the A and I bands respectively. The A 
band makes up the thick filament (150 A in thickness) whereas the I band makes up the 
thin filament (90 A in thickness), the proteins that constitute these two filaments will be 
discussed in details in section 1.2. A cross-section through a muscle fibre reveals the 
hexagonal arrangement of the two filaments with one thick filament being surrounded 
by six thin filaments (Figure 1.1 b). At the centre of each I band is found a Z line. Two 
1 
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successive Z lines form the bOlmdaries of one sarcomere unit. The region of the A 
band where there is no overlap with the I band is named the H zone. 
The cardiac and skeletal sarcomeric structures are very similar except for the existence 
of different protein isoforms. However, the general anatomy and the nature of the 
stimulation signal for contraction are different between the two types of muscle. 
Cardiac muscle cells are smaller in diameter and length as compared to their skeletal 
counterparts. Also, skeletal muscle cells are innervated whereas the action potential 









Bundle of muscle fibres 
Nucleus 
Figure 1.la: Anatomy of skeletal muscle. Skeletal muscle is a bundle of fibres. 
Each fibre or muscle cell is made up of a bundle of myofibrils consisting of 
repeating sarcomere units (Mathews et ai, 2000). 
Figure 1.lb: Transverse section througb 
nlament lattice. The cross section shown 
was performed where the thick and thin 
filaments overlap. One thick filament is 
surrounded by six thin filaments (Stryer, 
1996). 
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(bl Myosin filaments 
r~--------~A~--------__ ~
Actin filaments Actin filaments 
A. A r \ r 
• 
Z disk ~Io(---~>I I '""<----~>I Z disk 
AI Zone A I Zone 
- I band~)It<-< ---- A band------:l)*'I<E-1 band-
,---------.. ---------) - y
Sarcomere 
Figure 1.2: The sarcomere structure. (a) Electron micrograph of a 
myofibril showing the different bands which give the muscle its striated 
appearance. (b) Schematic representation of the sarcomere showing the 
thick (blue) and thin (red) filaments, the Z-lines which determine the 
sarcomere boundaries and the A and I bands (Lodish et ai, 2001). 
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The sarcomere is the basic contractile unit. The thick and thin filaments slide over each 
other leading to shortening of the sarcomere length and resulting in muscle contraction 
The sliding theory was first put forward by Huxley and Hanson (1954) as well as 
Huxley and Niedergerke (1954) when they demonstrated that the length of both thin 
and thick filaments remained constant during muscle contraction (Figure 1.3). The 
interaction between the two filaments is aided by heads projecting from the thick 
filament and named cross-bridges. Cross-bridges are regularly spaced and helically 
arranged along the thick filament. Details of how cross-bridges drive muscle 







1"-< I-b-a-nd--=*~----- A band -------=~~(~I-ba-n-d~)1 
+ATP, Ca2-t-
Contracted 
~~----- A band ----~~ 
Figure 1.3: Sarcomere shortening by rdarnent sliding. In the presence 
of both Ca2+ and A TP, the sarcomere undergoes contraction as a result of 
the sliding of the think and thick filaments past each other. The length of 
the two filaments remains unchanged. Actin is a polarised filament and 
both its barbed (+) and pointed (-) ends are shown in this figure (Lodish 
et ai, 2001). 
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1.2 Muscle proteins 
1.2.1 Myosin 
Introduction 
The major protein component of the thick filament is myosin Myosin is expressed in 
almost every vertebrate cell and to date 18 different classes have been reported in the 
literature (Sellers, 2000). Muscle myosin or myosin type II is made up of six 
polypeptide chains: two identical heavy chains (MHC) with a molecular weight of 
220 kDa each and two pairs of light chains (about 20 kDa each) named the essential 
and regulatory light chains (ELC and RLC respectively). The C-terminal half of each 
myosin II heavy chain forms a long a-helical tail which associates with the a-helical 
tail of the second heavy chain, giving rise to a coiled coil rod-like tail structure. The N-
terminal end of the molecule forms a globular head structure. A neck region, 
associated with the two light chains, links the two structural domains (Figure l.4a). 
Under physiological conditions the myosin II molecules aggregate and the coiled coil 
tails become packed together constituting the core of the thick filament structure. The 
globular myosin heads previously described as cross-bridges project out of the thick 
filament (see Figure 1.3). 
Different muscle types express different myosin isoforms suited for their function. It is 
now clear that the MHC is the m~or determinant of the mechanical properties of the 
fibre (Schiaffino and Reggiani, 1996) and currently 8 MHC are known to be expressed 
in mammalian sarcomeric muscles (Weiss et ai, 1999). Two MHC isoforms are 
expressed in the heart, MHC-a and MHC-J3/slow while in the adult skeletal muscle 4 
isoforms exist: slow MHC-I and fast MHC-llA, nx and 1m. The slow skeletal MHC-I 
has identical properties to the cardiac MHC-J3/s10w. The three remaining MHC 
proteins are developmental isoforms. 
The myosm II molecule is susceptible to proteolytic digestion. At high salt 
concentration, chymotrypsin treatment cleaves the molecule into two segments 1) light 
meromyosin (LMM) which consists of a long coiled coil tail 2) heavy meromyosin 
(HMM) which consists of a coiled coil tail and the two globular myosin heads. A 
further digestion of the HMM molecule with papain yields two identical sub fragment 1 
6 
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molecules (S 1) and a rod-like shaped subfragment 2 (S2) (Lowey et ai, 1969) (Figure 
l.4b). S 1 is a 130 kDa fragment made up of 95 kDa heavy chain and one of each light 
chain molecule. Sl exhibits all the enzymatic activity of the myosin molecule (ATPase 
activity) and retains the ability to bind the thin filament. At low salt concentration, 
myosin molecules aggregate to form a filament. In this case only the neck region of the 
myosin molecule is accessible to proteolysis. Chymotrypsin treatment under these 
conditions yields Sl with only one light chain (the ELC chain) and a long coiled coil 
tail (see chapter 2, section 1.2.11). 
The first Sl X-ray crystal structure from chicken was resolved by Rayment et al 
(l993a) (Figure 1.5). The myosin head region or the motor domain can be subdivided 
into three subdomains: 25K (N-termina1), 50K (middle) and 20K (C-terminal) domains 
which can be proteolytically separated. The 50K domain is further subdivided by a 
cleft into upper and lower 50K and comprises the actin-binding domain of the motor 
protein. The ATP binding pocket of the motor is located where the three subdomains 
come together (see structure). The 20K domain at the C-terminal end of S 1 is a long (1-
helix that extends from the actin-binding site, binds the light chains and would 
normally be connected to the coiled coil tail of myosin. The RLC binds at the extreme 
C-terminal end of the 20K helix, whereas the ELC is found in the middle region of the 
helix. The two light chains share sequence and structural homology with the 
calmodulin protein. However, unlike calmodulin which contains four Ca2+ -binding 
motifs, RLC contains only one and ELC none. 
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a) head neck tail 
~~ r----------~----------~ 
130nm 
N-terminus ____________ C-terminus 
Regulatory light chains (RLC) 






Figure 1.4: (a) Schematic representation of Myosin II structure. The protein 
is a dimer made up of two globular heads which comprise the ATPase active site 
functionning as a motor, a neck region where the light chains bind and long tail 
characterised by its coiled coil structure. (b) Enzymatic cleavage of Myosin II. 
Myosin IT subfragments are produced by treatment with chymotrypsin to yield 
HMM (Heavy Meromyosin) and LMM (Light Meromyosin) and then with papain 
to yield S 1 and S2 (myosin Subfragment 1 and 2). Both HMM and S 1 retain the 
full ATPase activity of the molecule (Lodish et aI, 2001). 
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Upper SOK Domain 
Regulatory Light Chain 
Actin Binding Domain 
Essential Light Chain 
Figure 1.5: Myosin n 81 crystal structure from chicken skeletal muscle (Rayment 
et al, 1993a). The S 1 head domain consists of both ~-sheets and a-helices. The head 
domain are colour coded: the upper 50K domain in red and the lower 50K domain in 
grey, the 20K domain in blue and the 25K domain in green. The neck region, a long 
a-helix which extends from the head domain, binds two-calmodulin-like light chains: 
the regulatory light chain (RLC) in magenta and the essential light chain (ELC) in 
yellow (Geeves and Holmes, 1999) 
9 
Chapter 1 Introduction 
1.2.2 Thin filament proteins 
The thin filament is made up primarily of three types of proteins: ac~ tropomyosin 
(Tm) and troponin (Tn) proteins (Figure 1.6). 
1.2.2.1 Actin 
Actin is a ubiquitous protein found in abundant amounts in eukaryotic cells. Different 
isoforms are expressed in different specialised tissue cells or even within the same cell 
type. These are encoded by different genes and are believed to provide functional 
diversity. a.-Actin is the vertebrate muscle isoform and the major constituent of muscle 
thin filaments. The monomeric form of actin (43 kDa) has a globular structure called 
G-actin which is bound to one ATP molecule. Under physiological conditions, G-actin 
polymerises to form a filament known as F -actin. This polymerisation process is driven 
by ATP hydrolysis and the polymerised actin is tightly bound to ADP (Carlier, 1990). 
During its preparation, actin is kept unpolymerised at low salt concentrations and in the 
presence of Ca2+ ions. Under these conditions actin has a high critical concentration 
(the concentration at which polymerisation takes place), which in this case is about 
0.1 mM. Polymerisation is achieved by increasing the salt concentration and by adding 
Mi+ ions to displace the bound Ca2+ ions (Spudich and Watt, 1971). Under these 
conditions, the actin critical concentration goes down to about 0.1 J,1M. The rate at 
which actin polymerisation takes place is considerably faster than the rate at which 
ATP hydrolysis occurs. Also, the rate at which actin monomers are added at the barbed 
end of the filament is significantly higher than the rate at which they are added at the 
pointed end of the filament (F -actin is a polar molecule as all its monomeric units point 
in the same direction with respect to the filament axis (Figure 1.8». On the other hand, 
the A TP hydrolysis rate is higher at the pointed end compared to the barbed end. 
Consequently, the pointed end of the filament will contain ADP-bound actin monomers 
whereas the barbed end will have ATP or ADP-Pi-bound actin monomers. The 
opposite is true for the disassembly of the filament. This process is known as 
treadmilling and is very dynamic in the case of cytoplasmic actin as compared to 
muscle actin (reviewed in Carlier, 1991 and Sheterline et ai, 1995). 
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When using low actin concentrations (less than 1 JlM), it is necessary to stabilise the 
filament with phalloidin, a fungal cyclic peptide that binds to polymerised actin and 
reduces the critical concentration by two orders of magnitude (Cooper, 1987). 
The first X-ray structure of G-actin was determined by Kabsch et al (1990) 
(Figure 1. 7). Actin could be crystallised in the monomeric G-form, which is suitable 
for X-ray studies, because it can bind to pancreatic DNase I (Deoxyribonuclease n in a 
1: 1 complex overcoming the problems arising from its tendency to polymerise. This 
structure was followed by the publication of other G-actin structures in complex with 
profilin (Schutt et ai, 1993) and gelsolin (McLaughlin et ai, 1993). The most recent 
structure of G-actin bound to a probe that prevents its polymerisation was resolved by 
Graceffa and Dominguez (2003). All the G-actin atomic structures revealed the 
presence of two major domains of approximately the same size though referred to as 
small and large domains separated by a cleft where both the nucleotide and cation 
(Mg2+ or Ca2l reversibly bind. These two domains are further subdivided into two 
subdomains 1 and 2 located in the small domain, 3 and 4 located in the large domain. 
Both N and C termini of G-actin lie in subdomain 1 also where the most reactive 
Cys 374 is located. 
A model for the actin polymer structure based on the detailed structure of the actin 
monomer combined with actin filament images obtained with electron microscopy and 
X-ray diffraction was put forward by Schroder et ai, (1990); Lorenz et ai, (1995). In 
this structure, the filament is shown as a long helix consisting of two linear strands of 
F -actin wrapped around each other (Figure 1.6). In the double-stranded actin filament 
the monomers are oriented in the same direction relative to the filament axis as seen 
with SI-decorated actin filaments which show and arrowhead-like appearance 
confirming the actin polarity (Flicker et ai, 1991) (Figure 1.8). This is because opposite 
ends of the actin monomer are found at each end of the filament while the same actin 
monomer subdomains are exposed to the outside (subdomains 1 and 2 are exposed to 









Figure 1.6: Schematic representation of the thin filament 
structure. The thin filament is made up of a double stranded actin 
filament to which binds tropomyosin (Tm) and the troponin (Tn) 
complex. Tm is an extended coiled-coil structure which wraps itself 
around the actin backbone. The Tn complex is made up of three 
subunits: the inhibitory subunit (TnI), the Ca2+ -binding subunit (TnC) 
and finally the Tm-binding subunit (TnT). The C-terminal end of one 
Tm overlap with the N-terminal end of the neighbouring Tm molecule. 
One Tm. Tn complex binds every seven actins (Gordon et ai, 2000). 
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2 
0288 
Figure 1.7: G-actin crystal structure. Monomeric actin is divided up into 
two major domains by a cleft where cation and nucleotide bind. Each 
domain is further divided into subdomains 1 and 2 (on the right), 3 and 4 
(on the left). Both N- and C-termini are located in subdomain 1 (Kabsch et 
ai, 1990) 
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Barbed (+) end 
Pointed (-) end 
Figure 1.8: Schematic representation of the F -actin double helix. 
The F-actin is a polarised filament as shown by the pattern of myosin 
molecule (blue) binding forming an arrowhead-like appearance. The 
monomers are oriented such as all subdomains 1 and 3 point towards 
the barbed (+) end of the filament whereas all sub domains 2 and 4 
point towards the pointed (-) end of the filament. Subdomain 1 and 2 
always face the outside of the filament. Myosin binding site is mainly 
at subdomain 1 and at the interface between subdomains 1 and 3. Note 
that the myosin head and the actin monomers are not drawn to scale. 
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1.2.2.2 Tropomyosin 
Tropomyosin (Tm) is present in most eukaryotic cell types associated with actin. It is 
an extended molecule made up of two a-helical chains which interact with each other 
giving rise to a coiled-coil structure (Philips et ai, 1986) (Figure 1.9). This is made 
possible because of the characteristic repeating pattern of the heptad motif in which 
successive groups of seven amino acids (a-b-c-d-e-j-g) have hydrophobic residues in 
the first and fourth positions (a and d residues). These hydrophobic residues form a 
long hydrophobic strip along the sequence of each Tm helix stabilising the core of the 
coiled-coil structure. In the coiled-coil, residues a and d are non-polar and interact with 
one another. These hydrophobic residues are highly conserved in all Tm isoforms 
found in all types of eukaryotic cells. Residues e and g on the other hand tend to be 
either acidic or basic and can form either inter- or intra-chain salt bridges, further 
stabilising the coiled-coil (Figure 1.10) (Tobacman, 1996; Gordon et ai, 2000; Perry, 
2001). However, unlike most coiled-coils, Tm is characterised by the presence of 
alanine clusters in its sequence (Brown et ai, 2001). These alanines are believed to 
bend the molecule and provide some sort of flexibility necessary for Tm to wrap around 
actin. Flexibility of Tm is also essential for its function as a key player in the C~+­
mediated regulation of muscle contraction in both skeletal and cardiac muscles. This 
aspect is discussed in great detail in section 3. Tm is also found in the cytoskeleton of 
non-muscle cells associated with actin involved in cell trafficking. However, the exact 
biological function of non-muscle Tm is not clear. 
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Figure 1.9: Tropomyosin structure. Tm is made up of two a-helices 
which interact with each other giving rise to a coiled-coil structure 
Figure 1.10: Cross-section of an a-helical coiled coil. The amino acids 
in the heptad sequence are marked A-B-C-D-E-F and G. Residues A and D 
are non-polar and form the hydrophobic core of the coiled coil structure. 
Residues E and G tend to be charged and can form ionic interaction 
stabilising the structure. The remaining residues tend to vary. 
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The mammalian Tm family comprises a large number of isoforms, so far 20 have been 
identified. Different isoforms are located in different cell types or are associated with 
different filaments within the same cell. These isoforms arise from the expression of 
four different genes TPM1, 2, 3 and 4 with alternative promoter and RNA processing 
(Lees-Miller and Helfman, 1991; Helfman 1994). TPM1 and TPM2 encode for the 
skeletal and smooth muscle a and 13 isoforms respectively (Figure 1.11). TPM1 gene 
has 15 exons, whereas TPM2 has only 13. In both genes exons 3, 4, 5, 7 and 8 are 
expressed in all a- and 13-Tm isoforms. The different isoforms encoded by these two 
genes arise from the alternative splicing of the remaining exons (la1b, 2a1b 6a1b, 9 
aIb/c/d in TPM1 giving rise to at least nine isoforms and 1a, 2b, 6a1b, 9aJd in TPM2 
giving rise to at least three isoforms). For instance, the main difference between 
skeletal and smooth a-Tm is in the alternative splicing of exons 2 and 9 whereas the 
main difference between skeletal and smooth 13-Tm is in the alternative splicing of 
exons 6 and 9. The alternatively spliced exon 6a1b and 9aJb encode for the skeletal Tm 
domain responsible for binding the TnT head and tail domains respectively. 
Alternative exons in different isoforms provide sequence differences. For example, 
exons 9a and 9d of TPM1 both encode for 27 amino acids with only 4 identical 
residues. However, sequences of the same exons are highly conserved within different 
specIes. 
Some parts of the Tm molecule are more conserved than others. The N-terminal end of 
Tm is highly conserved between isoforms with 18 out of 20 residues conserved in all 
vertebrate Tm. This N-terminal sequence along with the C-terminal sequence (encoded 
by exons 1 and 9 respectively) are responsible for the head-to-tail polymerisation of the 
Tm molecule giving rise to the filamentous structure ofTm (Perry, 2001). 
Polymerisation of Tm dimers into a long filament involves the overlap of 8-9 amino 
acids at the C- and N-terminal ends of two molecules (McLachlan and Stewart, 1975). 
It is believed that the interaction between the side chains of these residues are of an 
ionic nature explaining the depolymerising effect high salt conditions have on Tm 
filaments. This head-tail arrangement also explains the reduction in the length of Tm in 
the filament (406 ± 1.4 A) as compared to that ofnon-polymerised Tm (423 A) (Philips 
et ai, 1986). 
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The expression of the two major striated muscle Tm components a and (3 is dependent 
on both the tissue-type and the stage of development (Amphlett et ai, 1976; Bronson 
and Schachat, 1982; Muthuchamy et ai, 1993). Generally, in skeletal muscle the a-Tm 
isoform is more associated with fast-contracting fibres (Cummins and Perry, 1974; 
Heeley et ai, 1983). In the heart muscle, the a-TID, whose sequence is identical to that 
of skeletal 0.-Tm (Lewis and Smillie, 1980), is the predominant isoform with the (3-Tm 
amount increasing in the slower beating hearts of bigger mammals (Perry, 2001). 
Amino acid sequence analyses of the a and (3 sequences revealed that differences 
between the two isoforms occur at the C-terminal end of the protein, the site for 
troponin complex binding. The cysteine content is also different as 0.-Tm contains one 
Cys residue at position 190 whereas (3-Tm contains two Cys residues at position 36 and 
190 (Mak et ai, 1979; Mak et ai, 1980). The two major forms present in muscle are 0.(3 
and 0.0.. The (3(3 form has been reported to exist but in very small amounts in the cell. 
This is due to preferential heterodimer over homodimer formation (Lehrer and Qian, 
1990; Lehrer et ai, 1989). The significance of having two skeletal Tm isoforms and the 
biological properties of the different dimers is still not established. It has however been 
reported that in smooth muscle, heterodimers have stronger end-to-end interaction and 
stronger actin binding properties than homodimers (Lehrer et ai, 1997). 
All Tm isoforms have the same characteristic structure described above. In vertebrate 
cells, Tm molecules are either a 6 or 7 -actin binding proteins with an amino acid 
sequence of 248 (fibroblast Tm) and 284 ·(muscle Tm) respectively. Both a and (3 Tm 
have 284 amino acids and span seven actin monomers or one actin structural unit. This 
can be demonstrated by co-sedimentation experiments where saturation of actin by Tm 
is achieved at a 7: 1 ratio respectively under physiological conditions. Binding of Tm to 
actin has a cooperative nature and the binding affinity is strengthened by the presence 
of either Tn (Hill et ai, 1992) or myosin (Cassel and Tobacman, 1996). In the same 
way, myosin affinity for actin is increased in the presence of Tm (Williams and Greene, 
1983; Maytum et ai, 1999; Tobacman and Butters, 2000). Tropomyosin is also found 
to stabilise the actin filament (increasing the filament stiffuess) and to induce actin 
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Figure 1.11: The coding sequence of the a- and (i-Tm genes responsible for 
the expression of Tm in both skeletal and smooth muscles. Exons are 
represented by boxes and introns by lines. Exons expressed in both skeletal and 
smooth Tm isoforms are filled with black. Isoform diversity arises from the 
alternative expression of the remaining exons. The gene organisation represented 
above is that of chicken. Exons marked with dotted lines and stars have been 
detected in chicken but not in rat. This figure is taken from the review by Perry 
(2001) and is adapted from Lees-Miller and Helfman, 1991). Exon 6b represented 
as shaded in skeletal muscle J3 Tm should be clear. 
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1.2.2.3 Troponin proteins 
The troponin (Tn) complex of proteins is composed of three subunits; the Ca2+ -binding 
subunit (TnC), the inhibitory subunit (TnI) and the tropomyosin binding subunit (TnT). 
Tn complex binds actin with a stoichiometry of 1:7 Tn:actin and with a periodicity of 
38.5 nm along the thin filament. The structure and function of each subunit is 
discussed in details below. 
1.2.2.3.1 Troponin C 
TnC (18 kDa) is the protein responsible for binding Ca2+ in both skeletal and cardiac 
thin filaments. TnC protein is the only Tn subunit whose entire structure was resolved 
in solution both in the presence (Houdusse et la, 1997) and absence (Hezberg and 
James, 1985) of Ca2+ (Figure 1.12). TnC consists of two globular domains found at the 
N and C termini of the sequence separated by a long central helix. Each globular 
domain contains two cation-binding sites of the EF hand, helix-loop-helix type. The 
two sites at the N-terminal end are named site I and II, they bind Ca2+ with an affinity 
of about 105 M-1 and have a preferential binding for Ca2+ over Mi+ (Potter and 
Gergely, 1974). The two sites at the C-terminal end are named sites ill and N. These 
have a higher Ca2+ affinity of about 107 M"l and a high Mg2+ affinity (103 M-1) resulting 
in their saturation with Mi+ when the muscle is relaxed (under conditions where Ca
2
+ 
concentration is about 0.1 JlM or less and the Mg2+ is at the millimolar level) (Zot and 
Potter, 1982). When muscle contraction is triggered, the Ca2+ levels rise in the cell to 
reach about 10 fJM. Under these conditions, the Mi+ in sites ill and N is exchanged 
by Ca2+ and sites I and II become also saturated. In this case muscle contraction is 
triggered as reflected by an increase in acto. myosin ATPase activity and force 
generation. The cardiac TnC isoform contains a single Ca
2
+ -binding site at the N-
terminal domain of the protein This is due to the substitution of three aspartic acids by 
a leucine, alanine and cysteine in site I (Van Eerd and Takahashi, 1976). 
1.2.2.3.2 Troponin I 
TnI is the inhibitory subunit of Tn. In the absence of Ca
2
+, it binds tightly to the 
myosin-binding region on actin and inhibits muscle contraction. So far, three TnI 
isoforms are reported to be expressed in the mammalian muscle cell. These are the 
skeletal slow and fast isoforms and the cardiac isoform, with each one being the 
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product of a separate gene (Syska et ai, 1974). There is about 60% homology between 
the three isoforms and about 80 % homology between the same isoform across different 
species. Skeletal TnI isoforms are a single 181 amino acid chain with a molecular 
weight of about 21 lilla. The cardiac TnI has a characteristic 30-amino acid extension 
at the N-terminal end of the molecule increasing its molecular weight to 24 kDa 
(Wilkinson and Grand, 1978). The cardiac extension is highly conserved and contains 
important phosphorylation sites. The protein is phosphorylated by protein kinase A 
(PKA) as a response to adrenaline stimulation (England, 1975~ Solaro et ai, 1976). 
PKA phosphorylates two adjacent serine residues (22 and 23 in human sequence) 
(Mittmann et ai, 1992). Cardiac TnI phosphorylation has been reported to cause a 
decrease in the Ca2+ sensitivity of the system and will be further discussed in chapter 6 
(for review on TnI properties and functions see Perry, 1999). 
1.2.2.3.3 Troponin T 
TnT is the Tn protein that holds the Tn complex and actin. Tm together. Therefore 
fulfilling an important structural role. In addition to that, it is required for the normal 
Ca2+-sensitive acto.myosin ATPase activity in the presence of TnC-TnI (potter et ai, 
1995) and it is believed to affect the Ca2+ sensitivity of the system. It has also been 
shown to alter the cooperative activation of the thin filament (Schaertl et ai, 1995). 
TnT is an extended molecule of about 185 ± 25 A long and 20 A wide as revealed 
under the electron microscope (Flicker et ai, 1982). It has a molecular weight that 
varies between 31 and 36 kDa depending on the isoform. It is an asymmetric protein as 
it consists of an extended a-helical tail at the N-terminal end termed TnTI and a 
globular domain at the C-termina1 end termed TnT2. The two distinctive TnT domains 
can be obtained by chymotryptic digestion. TnT shows an antiparallel arrangement 
relative to Tm. The TnTI region lies at the C-terminal domain of Tm including at the 
overlap region between two neighbouring Tm and extends towards the centre of the Tm 
molecule. This makes TnT influence Tm affinity for actin as well as Tm flexibility 
and cooperative effect (Section 3.3). Interestingly, the hypervariable region of the 
molecule is located at the part of TnT which interacts with Tm overlap region The 
TnT2 domain lies one third of the way down from the Tm C-terminal end and interacts 
with both TnC an TnI as well as Tm. The binding of Tm to actin is enhanced by the 
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both TnT1 in a Ca2+ -insensitive manner and by TnT2 in a Ca2+ -sensitive manner 
(Pearlstone and Smillie, 1982; Heeley et ai, 1987, Schaert1 et ai, 1995). The binding 
affinity of Tm to actin is reported to be more significantly affected by Ca2+ in the 
skeletal system i.e. six-fold decrease (Rosenfeld and Taylor, 1985) compared to the 
cardiac system where little change was observed (Dahiya et ai, 1994). Hence, through 
its interactions with the other components of the thin filament, TnT controls the 
position of Tm on actin and determines the cooperativity of the filament, two aspects of 
a crucial importance in muscle regulation (for review on TnT see Perry, 1998). 
1.2.3 Other muscle proteins 
In addition to actin, myosin and the regulatory complex of proteins, muscle sarcomeres 
require other proteins that ensure normal assembly, structural integrity and normal 
function of the muscle cell. These include: Cl-actinin believed to be responsible for F-
actin anchoring to the Z-disc, nebulin is implicated in the actin polymerisation process 
and is responsible for determining the length ofF-actin during sarcomere assembly and 
titin the elastic element in muscle which acts as a spring (Squire, 1997 for review and 
refs therein). Additional thick filament proteins include protein-C, H and X all reported 
to be essential for thick filament assembly (Winegrad, 1999). 
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Figure 1.12: Toe crystal structure in tbe bolo and apo states. On 
the left hand side is a ribbon representation of a Ca
2
+ -free skeletal 
turkey TnC molecule (Herzberg and James, 1985). The C-terminal 
Ca2+ -binding sites (ill and IV) exhibit a high Ca
2
+ affinity and are 
always occupied under physiological conditions. On the right hand 
side is a ribbon representation of a rabbit fast skeletal TnC with Ca
2
+ 
bound at both C and N termini (Houdusse et aI, 1997). (Ca
2
+is 
represented by solid circles). Helices are colour coded and indicated 




1.2.4 Calcium-dependent interactions of the thin filament proteins 
The mechanism underlying regulation of muscle contraction is explained by a 
switching in the affinity of TnI for actin and for TnC as a function of Ca2+. In the 
absence of Ca
2
+, TnI is reported to have a high affinity for actin sterically inhibiting 
myosin heads binding. When Ca2+ binds TnC, the inhibitory effect of TnI is reversed 
as its affinity for TnC is increased weakening its interaction with actin. This is 
reflected by the co-migration of TnI and TnC as a single band on electrophoresis gel in 
the presence of Ca2+ (Head and Perry, 1974). The enhanced affinity ofTnI for TnC can 
be explained at the molecular level by comparing the X-ray structures ofTnC with and 
without Ca
2
+ bound (holo and apo states respectively) (Figure 1.12) (Hezberg and 
James, 1985; Houdusse et ai, 1997). The structure revealed the presence of five helices 
in the N-domain designated N, A, B, C and D. The C-domain contains helices E, F, G, 
and H. Parts of helices D and E make up the interdomain helical linker. The Ca2+ 
binding sites (helix-loop-helix EF hands) are made up of helix A-loop-helix B (site I), 
helix C-Ioop-helix D (site n), helix E-Ioop-helix F (site ill) and helix G-Ioop-helix H 
(site IV). Comparison between the two structures (with and without Ca2l revealed that 
the main differences arise in the interhelical angles at the N-domain of the molecule. In 
the Ca2+-bound state, the helices A and B, C and D are perpendicular to each other. In 
the apo state however, the helices are almost parallel to each other with helices B and C 
folded down along the central helix. In the latter case, the N-domain of TnC is seen as 
a closed structure. Binding of Ca2+ therefore produces the conformational change 
required to move helices B and C away from the hydrophobic stretch of amino acid in 
the central helix. The change in helices orientation opens up the structure and allows 
TnI to interact with the TnC hydrophobic sequence, switching the site of interaction 
from actin to TnC. These structural changes indicated that the N-terminallobe of Tne 
plays a regulatory role. Therefore, site I and n are referred to as the regulatory sites. 
The C-terminal lobe on the other hand plays a structural role as it binds to the N-
terminal domain of TnI and anchors the TnC to the rest of troponin (Vassylyev et ai, 
1998). For this reason, sites ill and IV are referred to as structural sites. 
When the structure of the cardiac TnC in the presence of bound Ca2+ was resolved, it 
unexpectedly resembled the apo structure described above (Sia et ai, 1997). This 
suggested that the C~+ -induced changes observed in the skeletal system were less 
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favourable in the cardiac system. To explain the mechanism by which TnC and TnI 
interactions take place, McKay et al (1999) suggested that Tn! binding to TnC forced 
the N-terminal structure of TnC to open. This difference between the skeletal and 
cardiac systems could be at the heart of major differences in the Ca2+ -regulation of 
muscle contraction. 
Understanding the nature of Tn! interactions with the other thin filament proteins, in 
particular with TnC and actin required the identification of the TnI sequences which 
take part in such interactions. Tn! sequence comprises two highly conserved regions 
important for its function. These have been identified as residues 17-23 and 97-121 in 
the rabbit skeletal isoform (Syska et aI, 1976; Van Eyk et ai, 1993). The latter 
comprises the inhibitory peptide, the Tn! sequence that binds strongly to actin in the 
absence of Ca2+ (Figure 13). In fact, TnI interacts with every protein in the thin 
filament highlighting its key role in regulation. It therefore needs to adopt different 
conformations to fulfil its function. 
Structural data on isolated Tn! is not available, being a highly basic protein it tends to 
aggregate in solution. However, information about Tn! interaction with TnC has been 
obtained using short Tn! fragments in either NMR or X-ray crystallography studies 
(Campbell et aI, 1991; Campbell et aI, 1992; Farah et aI, 1994; Krudy et aI, 1994; 
Vassylyev et aI, 1998). Tn! fragments were produced by cyanogen bromide digestion 
and those selected for structural studies (peptides 1-21, 1-47 and 96-116) are not only 
highly conserved but they also bound to a TnC affinity column (Syska et aI, 1976). 
The structural studies revealed the antiparallel orientation of the two proteins. The N-
terminal end of Tn! (residues 1-47) was found to interact with the C-terminal end of 
TnC (sites III and IV) in the presence of either Ca2+ or Mi+ in what is referred to as the 
structural interaction, as it permits TnC to be anchored to the thin filament 
(Figure 1.13). Even though residues at the C-terminal end of TnI are strongly 
conserved between species, there was no evidence of that part of TnI binding to TnC 
from affinity chromatography experiments. NMR studies backed up by cross-linking 
experiments do however support an interaction of the C-domain of Tn! (residues 115-
131 in rabbit skeletal isoform corresponding to residues 148-164 in the human cardiac 
isoform) with the regulatory N-domain of TnC. 
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Actin is another key interaction partner ofTnl As with TnC, the TnI-actin interactions 
are complex and are at the heart of the regulatory process. The inhibitory region 
(residues 97-116) is not the only part of Tn! that establishes contact with actin. This 
was clearly demonstrated by the fact that it is only 50 % efficient at inhibiting the 
actomyosin ATPase activity as compared to the full-length native Tn!, suggesting the 
presence of additional actin-binding sites in TnI required for full inhibitory activity. 
Removal of residues 140-180 in rabbit skeletal Tn! reduces its inhibitory action (Tripet 
et ai, 1997) whereas removal of the inhibitory region results in complete loss of 
inhibition (Farah et ai, 1994). This implies that the inhibitory function of residues 140-
148 is complementary to that of inhibitory region and cannot take place in the absence 
of the latter. 
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Figure 1.13: Model explaining the Ca2+ -dependent interactions of TnI with 
actin and Tne. The amino acid numbering corresponds to that of rabbit fast 
skeletal Tn!. The corresponding sequence of rat cardiac TnI would be 32-73, 
130-149, 149-165, 165-174 and 174-182. The regions implicated in establishing 
interactions are indicated by black arrows in the case where ci+ is bound to the 
N-domain of Tne and by orange arrows in the case where Ca2+ is absent. In 
absence of Ca2+, residues 1-40 of TnI interact with TnC structural sites located at 
the C-domain. This interaction is believed to allow the anchoring on TnC to the 
thin filament. Residues 96-115 corresponding to the inhibitory region of TnI as 
well as residues 140-148 both interact with actin These interactions sterically 
block the formation of an ATPase active acto.myosin complex. In the presence 
of Ca2+, the inhibitory region switches sites of interaction to bind the TnC-C 
domain. Residues 115-131 on the other hand bind to TnC N-domain, more 
specifically the hydrophobic stretch of residues which becomes exposed upon 
Ca2+ binding to TnC (Adapted from Tripet et ai, 1997) 
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1.2.5 The atomic structure of the human cardiac tropooin complex 
The core domain of human cardiac Tn, which consists of the TnC (residues 1-161), TnI 
(residues 31-210) and TnT2 (residues 183-288), in the Ca2+-staurated fo~ was 
resolved at high resolution using X-ray crystallography by Maeda and co-workers 
(Takeda et aI, 2003). This allowed for the first time the visualisation of how 
polypeptide chains of the three subunits are folded around each other in the troponin 
complex (Figure 1.14). 
As already shown in the TnC-TnI binary complex published by Vassylyev et al (1998), 
the N-terminal portion of TnI (residues 43-79) corresponding to helix HI (I) interacts 
with the TnC C-Iobe via its amphiphilic portion (residues 43-65) to form the first site of 
TnI-TnC binding. TnI residues 90-135 form a long a-helix (H2(I)) that interacts with 
TnT a-helix (H2(T2)) spanning residues 226-271 and giving rise to a parallel coiled-
coil arm. This coiled-coil structure arises because of the presence of heptad repeats 
made up of residues highly conserved between species. At the C-terminal end of this 
coiled coil, TnT interacts with the C-Iobe of TnC at the region where all three Tn 
subunits come together. The interaction of these three proteins is stabilised by the 
permanent presence of cations (Ca2+ or Mi+) at sites ill and IV in the C-Iobe of TnC. 
TnT residues 272-288, reported to interact with tropomysin, are not well defined in this 
structure. However, it is through that part of TnT that the TnC-TnI complex is 
integrated into the Tmactin complex. TnT residues 204-220 of the C-domain form 
another a-helix (Hl(T2)), positioned at 600 relative to the TnI-TnT coiled coil arm 
(Figure 1.14). This part of TnT extends into the TnTI portion (N-terminal end) of the 
molecule (not present in the structure) which represents the second site for Tn 
anchoring to Tm and actin. 
The TnI inhibitory region (cardiac sequence 137-148) is an extended a-helix followed 
up by another amphiphilic a-helix H3(I) (residues 150-159). The latter interacts with 
the conserved hydrophobic patch at the N-domain of TnC when it is Ca2+-saturated 
(second TnI-TnC binding site). The C-terminal domain ofTnI, previously identified as 
an actin-binding site (Tripet et aI, 1997), was not defined in this structure apart from 
resides 164-188 which form the H4(I) helix that does not seem to interact with the rest 
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of the Tn molecule. The ampbiphilic a-helix H3(1) is therefore positioned between two 
TnI actin-binding sites (the inhibitory peptide (residues 137-148) and the C-terminal 
helix (residues 164-210)) both required for full actomyosin ATPase inhibition by TnI in 
the absence of Ca2+ (Farah et ai, 1994). Therefore, as previously speculated, the 
ampbipbilic a-helix is the Ca+2 -dependent molecular switch whose binding to TnC in 
the presence of Ca2+ triggers the detachment of the two TnI inhibitory peptides from 
actin. The opposite happens when Ca2+ is removed from the system. The rigid TnI-
TnT arm is also thought to play an important role in releasing inhibition and 
determining tropomyosin location on actin. It is positioned between the TnT1 portion 
of TnT and the mobile C-domain ofTnI (two point of Tn attachment to Tm). The Ca2+-
dependent movement ofTnI can thus cause the TnI-TnT arm to rotate (Figure 1.15). 
The Tn core domain can therefore be divided into a number of subdomains namely the 
regulatory head domain, the TnI-TnT arm domain, the TnT1 domain, the TnT and TnI 
C-terminal domains. These subdomains are linked by flexible loops which would 
provide the whole molecule with the flexibility required for its function. 
The Maeda structure despite describing the overall architecture of the Tn core complex 
does lack description of many of the potential actin and Tm sites on TnI and TnT. This 
was due to a poor definition of the electron map at those sites. 
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Figure 1.14: Crystal structure of human troponin core domain. 
TnC, TnT and TnI are coloured red, yellow and blue respectively. Tn! 
helices that bind to TnC are coloured dark blue. The three Ca
2
+ ions 
bound to TnC are represented with filled black circles (Takeda et ai, 
2003) 
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Figure 1.15: A proposed mechanism for the interaction of 
troponin with the other components of the thin filament. The 
parts of Tn not defined in the crystal structure are schematically 
represented by ellipsoids. These are the N- and C-terrninal portions 
of TnT (yellow), the C-terminal end of Tn! and the inhibitory 
region IR (dark blue). Sites of interaction with actin.Tm are 
indicated with black arrows (Takeda et aI, 2003). 
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2 The molecular basis of muscle contraction 
Though many details remain to be answered, the general mechanism underlying muscle 
contraction has been elucidated for many years. First, Huxley and Hanson as well as 
Huxley and Niedergerke (1954) explained the observation of sarcomere length 
shortening without filament length shortening by suggesting that muscle contraction 
resulted from the sliding of the thick and thin filaments past each other. Later on, a 
biochemical model was put forward by Lymn and Taylor (1971). This model was the 
first to give an account for the role of ATP hydrolysis by the myosin head in the cross-
bridge cycle (Figure 1. 16). It was found that when ATP was bound to myosin, the 
affinity of the latter for actin was significantly reduced, causing the dissociation of the 
acto. myosin complex. However, since the presence of actin accelerated the myosin-
catalysed ATP reaction, it was suggested that rebinding to actin took place and helped 
the release of the hydrolysis products. Indeed, the myosin head bound to ADP.Pi can 
bind actin and this helps accelerate the release of the hydrolysis products, giving rise to 
the nucleotide-free, strongly-bound acto. myosin complex (rigor complex). Binding of 
an ATP molecule to myosin starts the cycle again In this model, the power stroke or 
the conformational change in the myosin head which produces motility is coupled with 
the hydrolysis products release step. As successive cycles take place, myosin heads 
will appear to be rowing on the actin surface, producing the sliding effect. 
The Lymn and Taylor model of the cross-bridge cycle, though giving an overall idea of 
the process, is an over simplified picture. The model is constantly refined as more 
information is obtained from both biochemical and structural work. 
The movement of the myosin along the actin filament is the result of a change in the 
myosin affinity for actin combined with the tilting movement of the a-helical neck 
region of myosin (the lever arm) (Holmes, 1997). This is made possible through 
complex communications between the nucleotide-binding site, the actin-binding site 
and the converter region which is linked to the lever arm (it can be seen in the myosin 
head structure shown in Figure 1.5 that the nucleotide binding site is located where all 
the head domains come together). The affinity of the myosin head for actin depends 
on the type of nucleotide bound to myosin and vice versa A cleft region extends from 
the nucleotide binding site into the actin-binding site of the 50K domain which it 
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divides into upper and lower SDK domains. The SDK domain also comprises two loops 
termed switch I (SWI) (upper domain) and switch II (SWII) (lower domain). SWI 
binds to the nucleotide and communicates with the actin-binding site. SWII interacts 
with the y-Pi and communicates with the converter domain. It is these two switches 
which transmit conformational changes from one domain to the other during the cross-
bridge cycle ultimately causing a 60° rotation of the converter region and resulting in 
the movement of the lever arm (about 10 nm) (see Geeves and Holmes, 1999 for 
review). 
In 1980, Eisenberg and Greene proposed that myosin has two binding states to actin, a 
weak binding state when bound to ATP or ADP.Pi and a strong binding state when 
nucleotide-free or ADP bound. Goody and Holmes (1983) suggested that tighter 
binding of the nucleotide to myosin resulted in a weaker binding of myosin to actin and 
VIce versa When myosin is weakly attached to actin (A-state), it can reversibly 
isomerise to the strongly bound rigor complex (R-state) resulting in the reduction in the 
nucleotide affinity and its release. These changes in nucleotide affinities and actin 
binding affinities are coupled to the opening and closing of the switches as well as the 
cleft region A tight binding to actin is linked to the closure of the cleft and happens 
when SWI is open. A weak binding to actin is linked to the opening of the cleft and 
happens when SWI is closed. SWI is open either when no nucleotide is bound or when 
a hydrolysis product is to be released and is closed once A TP is bound and is to be 
hydrolysed. The opening and closing of SWII will determine the conformation of the 
lever arm in either the pre- (closed SWll) or post-power stroke (open SWll) 
conformation and will result eventually in the movement of the lever arm (Smith and 
Rayment, 1996; Dominguez et ai, 1998). 
A description of the sequence of changes taking place is as follows. A nucleotide-free 
myosin binds actin tightly forming a rigor complex (A.M). In this case, both SWI and 
SWll are open and the SDK cleft is closed. Binding to ATP happens in two steps, first 
forming a weak complex with myosin which remains strongly bound to actin (A.M-
ATP) and then weakening the acto.myosin interaction (A-M.ATP). The transition 
between these two states results from the closing of SWI and the opening of the SDK 
cleft. Up to this stage the lever arm is in the post-power stroke conformation. It is only 
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when a conformational change at the level of the nucleotide-binding site takes place to 
bring all residues required for the ATPase around the ATP molecu1e that the tail adopts 
the pre-power stroke conformation. Hydrolysis of ATP (which requires both SWI and 
SWII to be closed) into ADP and Pi will result in the rebinding of the myosin to actin. 
This will open SWI (weakening Pi binding to allow its release) and is followed by the 
closing of the 50K cleft subsequently resulting in an increase in the myosin affinity for 
actin. The release of Pi will result in the opening of SWII achieving the post-power 
stroke conformation. ADP, whose affinity is also weakened, is released and the cycle 

















Figure 1.16: The Lymn and Taylor model of the crossbridge cycle. In the 
nucleotide-free state, the mysoin head (M) is strongly attached to actin (A) 
forming a rigor complex (1). Binding of A TP decreases the affinity of myosin 
to actin and subsequent dissociation takes place (2). ATP hydrolysis yields the 
M.ADP.Pi complex and results in a conformational change (3). Reassociation 
with actin takes place (4). Actin accelerates hydrolysis product release resulting 
in a second conformational change (the power stroke), the reverse of the first 
one (4-1 transition). This cyclic change of S 1 conformation and affinity results 
in the sliding of the two filaments over each other producing muscle contraction 
(Lymn and Taylor, 1971). 
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3 Regulation of muscle contraction 
The force-generating cyclic interaction of myosin heads with actin has to be tightly 
controlled. This is achieved by the action of the thin filament regulatory proteins, 
which respond according to the level of Ca2+ concentrations in the muscle cell The 
mechanisms of regulation of muscle contraction have been extensively investigated. 
Below is a description of the working models put forward to try to understand the 
complexity of the system 
3.1 The McKillop and Geeves three-state model of regulation 
Muscle contraction is triggered by an increase in the intracellular Ca2+ concentrations 
(Ebashi et aI, 1969). This is reflected experimentally by the dependence of muscle 
tension production on pCa (pCa=-log[Ca2+]). However full activation of muscle 
contraction is not just dependent on ci+ binding to TnC. The rigor binding of myosin 
heads to actin is also required as suggested by both biochemical (McKillop and Geeves, 
1993) and structural (Vibert et ai, 1997 ; Wakabayashi, 2001; Craig and Lehman, 2001) 
evidence. Based on the biochemical evidence obtained from a combination of kinetic 
and equilibrium binding studies, McKillop and Geeves put forward the three-state 
model to account for the process of muscle regulation Their model was a modification 
of the two-step steric-blocking model (Parry and Squire, 1973; Wakabayashi et ai, 
1975) as it takes into consideration the influence of myosin heads. The steric model 
described the binding of Ca2+ to TnC as being the only trigger for muscle contraction 
Binding of Ca2+ ions to TnC causes a series of conformational changes within the thin 
filament leading ultimately the relocation of TID, exposing the myosin-binding sites on 
actin. In the three-state model (Figure 1.17) the filament is believed to exist in a 
dynamic equilibrium between three myosin binding states namely Blocked (B-state), 
closed (C-state or the Ca2+-induced state) and open (M-state or myosin-induced state). 
In the three-state model the ATPase activity is OFF when the filament is in the B- and 
C- states and it is turned ON when the filament is in the M -state. The three states are 
characterised by different Tm positions on actin In the absence of ci+, the filament is 
predominantly in the B-state as tropomyosin occupies the potential myosin-binding 
sites on actin preventing the formation of the acto-myosin complex. When Ca
2
+ binds 
to TnC, Tm moves away towards the inner region of actin allowing the formation of a 
weakly bound acto-myosin complex which does not exhibit an ATPase activity. The 
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binding of myosin heads shifts the position of Tm further switching the equilibrium into 
the M-state. Subsequently, the isomerisation from weakly to strongly-bound (rigor) 
myosin heads (A- to R-state transition) takes place. It is only in the R-state that the 
acto-myosin complex is ATPase active leading to force production. Thus, the full 
activation of muscle contraction is only achieved when both Ca2+ binds to TnC and 
when myosin binds actin in the rigor state. 
3.1.1 The biochemical evidence for the three-state model of regulation 
The existence of three states of the filament was deduced from S 1 binding to actin as 
defined by both equilibrium and kinetic measurements. The binding of S 1 to actin 
under equilibrium conditions (see chapter 3, section 3) follows a simple binding 
reflected by a hyperbolic curve. This suggested the non-cooperative nature of the 
binding, with actin monomers behaving as independent entities. In the presence of Tm 
or Tm. Tn complex, the binding curve is sigmoid which is indicative of the cooperative 
switching between two states of the filament induced by S 1 binding. In the presence of 
the regulatory complex (Tm.Tn complex) and Ca2+, 20% of the filament is found to be 
in the ON state. On Ca2+ removal, the figure goes down to 5%. 
Evidence for a third state came from kinetic studies of the rate of S 1 binding to actin 
using stopped-flow experiments under pseudo-first order conditions (either actin or S1 
in a large excess over the other; see chapter 3, section 2). The results indicated that the 
rate of S 1 binding to either actin, actin. Tm or actin Tm. Tn complex in the presence of 
Ca2+ was similar. In the absence of Ca2+ and under the conditions where only few actin 
sites become occupied by S1 (i.e. actin in excess over S1) the rate of S1 binding to actin 
is a factor of 3 lower. The change in the rate of S 1 binding to actin was explained in 
terms of a change in the fraction of actin sites available for binding. This meant that all 
the actin sites are available for S1 binding in the presence ofCa
2
+ (more than 95%) and 
only one third was available in the absence of Ca2+ (about 30%). The kinetic results 
therefore conflicted with the previously described equilibrium binding results. The 
most plausible explanation was that the two experiments described two different 
populations of the ON and OFF states. The three-state model could account for these 
differences. The distribution between the blocked, closed and open states is dependent 
on the proteins bound to actin and on the presence or absence of Ca
2
+. When only Tm is 
bound to actin, the filament is mainly in the closed (80%) and open (20%) states, with 
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the blocked state not substantially populated (less than 5%). A similar distribution of 
the three states is reported when the Tm Tn complex is bound to actin in the presence of 
Ca2+. In the absence of Ca2+, the filament is predominantly in the blocked (75%) and 
closed (25%) states with less than 5% in the open state. Ks and KT, the equilibrium 
constants between blocked/closed and closed/open states respectively are Ca2+-
dependent, with a lesser effect of Ca2+ on KT. The type of nucleotide bound to S 1 will 




S1 binds to form A state 
Isomeristation to R s1ate only 
possible for open filament 
Figure 1.17: The three-state model for thin rdarnent regulation. The thin 
filament is believed to exist in a dynamic equilibrium between three states namely: 
blocked, closed and open depending on Tm position on the filament. Ks defines the 
equilibrium constant between the blocked and the closed states, and KT defines the 
equilibrium constant between the closed and open states. Kl ~d ~2 represent the 
equilibrium constant of Sl binding to form an A state (weak bmding) and R state 
(strong binding) respectively (McKillop and Geeves, 1993). 
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3.1.2 The structural evidence for the three-state model of regulation 
The validity of the three-state model was confirmed later on by EM studies carried out 
on reconstituted thin filaments (Figure 1.18) (Vibert et ai, 1997; Craig and Lehman, 
2001). These images show clearly Tm occupying three different locations on the actin 
filament, both Ca2+ and S I-induced. These structural changes were in a good 
agreement with the biochemically defined blocked, closed and open states of the 
filament. The EM images show Tm interacting with the myosin-binding sites on actin 
in the absence of Ca2+. The addition of ci+ shifts Tm to a position that allows the 
formation of acto-myosin complex but the isomerisation to the rigor complex is still 
sterically prevented. It is only in the presence of both Ca2+ and strongly-bound myosin 
heads that the Tm is moved further away allowing the formation of the ATPase active, 
rigor acto.myosin complex. The reconstruction of these high-resolution images 
required the use of helical averaging of a number of collected images. As a result of 
that, this technique, though allowing the localisation of the long helical molecule of 
TID, did not give much information about the localisation and contribution of Tn which 
binds once every seven actins. To overcome this problem, the group of Wakabayashi 
(2001) applied single particle analysis to reconstruct the three-dimensional image of the 
thin filament. Their images where Tn could be visualised confirmed that full activation 
could not be achieved by ci+ only and the binding of myosin heads was also required. 
Crossbridge and tropomyosin positions on actin 
It is widely accepted that there are two states of myosin crossbridge binding to actin: 
weakly-bound state (attachment A-state) and strongly-bound (rigor R-state) (Eisenberg 
and Greene, 1980; McKillop and Geeves, 1993; Geeves and Conibear, 1995) with the 
transition between the two involving the force-generating conformational change or 
power stroke of the ATPase cycle. Structural data (Rayment et ai, 1993b) supported by 
mutational analyses (see Sheterline et ai, 1995 for review and refs therein) concluded 
that formation of an acto.myosin complex involved three types of interactions. The 
formation of a disordered (non-stereospecific) complex involving ionic interactions 
mainly between lysine residues located on the 50K to 20K junction loop of myosin and 
negatively charged acidic residues at the N-terminal end of actin subdomain 1. A 
stereospecific interaction arises as a result of hydrophobic interactions between the two 
helices at the lower 50K domain of the myosin head (Figure 1.5) and a number of 
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hydrophobic residues located at the interface between subdomains 1 and 3 of actin 
The strengthening of this interaction involves the recruitment of additional loops from 
the upper 50K domain with interactions predominantly ionic in nature. These 
interactions are believed to extend to the adjacent actin monomer, making one myosin 
head bind two actin subunits and accounting for the myosin-induced polymerisation of 
actin. 
The data obtained by Vibert et al (1997) is in good agreement with the proposed pattern 
of interactions described above. In the absence of Ca2+ (when the A-state formation is 
prohibited (blocked state)), the position ofTm as revealed by electron microscopy does 
not block the electrostatic binding site of myosin on the periphery of actin. The 
presence of Ca2+ shifts Tm position towards the inner region of the filament uncovering 
the strong binding sites of myosin (allowing the A-state formation) but still blocking 
the formation of the strong rigor complex as access to the all the residues required for 
the hydrophobic interaction is still sterically prevented. The conclusion was that in the 
absence of Ca2+, there is the possibility for the formation of a non-stereospecific 
acto.myosin complex which precedes the formation of the A-state myosin crossbridge. 
This initial non-specific binding is thought to allow the myosin cross bridge to be in the 
vicinity of the stereospecific attachment site on actin (docking process). 
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Figure 1.18: Structural evidence for the three-state model of thin 
filament regulation. The images are 3·D reconstructions of thin 
filaments under different experimental conditions a) relaxed filament 
in the absence of Ca2+ b) activated filament in the presence of Ca2+ c) 
in the presence of bound myosin heads (not shown on this figure). A 
shift of 25° in Tm position is observed as Ca2+ is added uncovering 
actin binding sites and allowing the formation of a weakly bound 
acto. myosin complex (image b). Binding myosin heads to the 
filament in the presence of Ca2+ causes a further shift of 10° in Tm 
position uncovering the sites required for the formation of a rigor 
acto. myosin complex (image c). The three Tm positions on actin are 
superimposed in image d. These three structural states of the thin 
filament are believed to correspond to the biochemically identified 
blocked, closed and open states (Craig and Lehman, 2001) 
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3.2 Cooperative binding reactions 
Proteins with more than one ligand-binding site may display sigmoidal binding curves 
instead of hyperbolic ones, which is indicative of a cooperative binding of the ligand. 
3.2.1 The Monod Wyman and Changeux (MWC) model 
The Monod, Wyman and Changeux (MWC) cooperative model (1965) (Figure 1.19) 
was established by studying the binding of oxygen to haemoglobin. The multi-subunit 
protein is assumed to exist in equilibrium between two states or conformations; a low 
ligand- affinity and a high ligand-affinity state. When none of the sites are occupied, 
the low affinity conformation of the protein is predominant. As more sites become 
occupied the equilibrium is shifted toward the high affinity state each time by a given 
factor corresponding to the ratio between the two affinities. This mechanism of 
cooperative binding therefore allows a several fold increase in the equilibrium constant 
between the two states of the protein as a result of the binding of few ligand molecules. 
This way, the protein can switch between the two states over a small range of ligand 
concentration 
Most proteins that exhibit this sort of behaviour have been reported to be enzymes 
subject to feedback activation or inhibition. This explains the need for cooperativity, as 
it provides a more efficient and rapid means for the switching between the two states of 
the protein. 
3.2.2 The Koshland-Nementhy Filmer (KNF) model 
In the KNF model (1966), it is assumed that the switching between the two 
conformations of the enzyme happens in a sequential manner, as the conformation of 
each subunit changes upon ligand binding (Figure 1.20). In other words, in the absence 
of ligand only one conformation exists (low affinity state) and binding of the first 
ligand will induce a conformational change in the subunit (high affinity conformation) 
which is subsequently transmitted to the neighbouring site. It is only when all the sites 
become occupied that complete switching into the second conformation takes place 
(ON state). 
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Combining both the MWC and the KNF models would give rise to a scheme where all 
the possible sub states are described. This sort of model is very complex as it contains 
too many binding parameters and protein conformations. Therefore, to simplify the 
analysis, experimental results are interpreted either in terms ofMWC or KNF model. 
3.3 Cooperativity in the muscle thin filament 
The muscle thin filament is a complex structure made up of repeating units each 
comprising an assembled complex of at least 5 proteins (Figure 1.6). The nature of 
interactions between these proteins is very complex and is highly allosteric/cooperative 
(see chapter 3 section 3.2.3) both within and between the thin filament structural units 
(reviewed by Lehrer and Geeves, 1998). 
Ca
2
+ binding to TnC is cooperative. The cooperativity is believed to occur between the 
two Ca2+ binding sites (I and II) ofTnC (as revealed from ci+ binding to isolated TnC) 
(Potter and Gergely, 1975; Grabarek et ai, 1983) and potentially over a long range as 
reflected by the large Hill coefficient value (> 2) obtained using fibre measurements 
(Brandt et ai, 1980). This cooperativity is confirmed as the Hill value for Ca2+ binding 
to cardiac TnC, which has only one effective Ca2+ -binding site as compared to two sites 
in skeletal TnC, is lower. The affinity of Ca2+ for TnC is dependent on whether TnC is 
free or bound to TnI with Ca2+ affinity being higher when TnC is tightly bound to TnI. 
Similarly, the affinity of TnI for actin is dependent on whether TnC is Ca2+ -bound or 
free, as TnI binding to actin is tighter in the absence ofCa2+ (Potter and Gergely, 1974; 
Grabarek et ai, 1983; Ingraham and Swenson, 1984). So as postulated by Geeves and 
Lehrer (2002) TnI can be regarded as an allosteric effector for Ca2+ binding to TnC, and 
in the same way Ca2+ can be regarded as allosteric effector of the thin filament 
conformation changes. 
Myosin binding to the thin filament is also cooperative as indicated by the sigmoid 
equilibrium binding curves (Greene and Eisenberg, 1980; Hill et ai, 1980; Geeves and 
Halsall, 1987; Maytum et ai, 1999). The cooperative unit size switching between the 
B- and C-states (i.e. the number of actin monomers that switch between the two 
transition upon myosin binding and as a response to Ca2+ activation) was found to be no 
smaller than 7 (the size of a structural unit) (Head et ai, 1995). The cooperative unit 
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size for the C- to M-state transition is found to be around 7 in the absence of Ca2+ and 
almost twice that in the presence of Ca2+ (Maytum et aI, 1999). TnTl influences the 
cooperative unit size of the filament (Schaertl et aI, 1995). Owing to its location at the 
overlap region, it strengthens the head to tail interaction of two neighbouring Tm and 
therefore stiffens the Tm filament allowing an easier propagation of the signal (Maytum 
et aI, 1999). This explanation is consistent with the results obtained with smooth Tm 
known to have stronger Tm-Tm contacts and a cooperative unit size of 12 (Lehrer et ai, 
1997). The cooperative unit size is independent of the length of Tm as fibroblast Tm 
(which binds 6 actins) has a similar cooperative size as the smooth Tm (which binds 7 
actins) (Maytum et aI, 2001). In the absence of Ca2+, the cooperative unit size is no 
larger than the structural unit size as under these conditions the TnI is strongly bound to 
every seven actins producing a pinning effect and preventing a long range 
cooperauVlty. These findings led to the suggestion of the continuous flexible model for 
Tm by Maytum et al (1999). Tm is believed to form a continuous, dynamic cable along 
the actin filament with Tm stiffuess being the determinant of the cooperative unit size 
(Figure 1.21). 
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E Kc E* -E ~ 
Kb ~ xKc ~ xKb 
E ln < > * E In 
Kb ~ x2 Kc ~ xKb 
~n * -E > E 2n 
Kb ~ ~ xKb x3 Kc 
* ~n < > E 3n 
Kb t t xKb x4Kc 
E4n -E > * E 4n 
Figure 1.19: A scheme for the MWC cooperative model. 
The ligand (n) binds to the enzyme (E) which contains 4 
ligand-binding sites. The ~e is in equilibrium between 
two conformations E and E defined by the constant Kc. 
Binding of the ligand to the E conformation of the enzyme is 
defined by the equilibrium Kb which is increased by a factor x 
when the enzyme is in the E* conformation As more sites 
become occupied by the ligand the Kc equilibrium is 
increased by the factor x allowing a rapid switching between 
the two states of the enzyme. It is assumed that the different 
enzyme subunits are identical in each state. The ligand 
affinity for the enzyme should therefore remain unchanged as 
more sites become occupied. 
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E8< >EE < >ffi< >ffi< >ffi 
Figure 1.20: Schematic representation of the KNF model. The full switching 
between the low and high affinity conformations of the protein is only achieved 
once all the ligand-binding sites become occupied. Intermediate sub states arise 
as the binding of a ligand to a vacant site changes its conformation and influences 
the conformation of the neighbouring site at the interface. 
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3.4 Other muscle regulation models 
3.4.1 The Hill model 
Introduction 
The McKillop and Geeves model is a refinement of the Hill et al (1980) model. In the 
Hill model, the filament is considered as a linear array of repeating structural units 
(seven actins, one Tm and one Tn complex) with each unit being in either the ON 
(ATPase active) or OFF (ATPase inactive) state. SI binds each state with a different 
affinity. Hill et al included an extra cooperative parameter to take into consideration 
the influence of interaction between two adjacent units (Figure 1.21). 
3.4.2 The Tobacman model 
The Tobacman model tries to address the mechanism by which the C- to M-state 
transition occurs by assigning a role to actin in the process of regulation (Tobacman 
and Butters, 2000). It has been established by many groups that the affinity of myosin 
for actin is enhanced in the presence of tropomyosin (Williams and Greene, 1983; 
Maytum et aI, 1999; Tobacman and Butters, 2000) and that the affinity of tropomyosin 
for actin is enhanced in the presence of myosin bound to actin (Cassel and Tobacman 
1996; Maytum et aI, 2001). Tobacman explains this mutual effect of myosin and Tm 
by an indirect interaction promoted by a conformational change in actin In other 
words, there would be an allosteric effect from actin promoting the myosin-Tm 
interaction. The actin conformational change would happen upon myosin binding to 
actin and would subsequently strengthen the binding of Tm to the inner domain of 
actin. The same changes to actin would be promoted when Tm is bound to its inner 
region. To date, there is no structural evidence to back up the Tobacman hypothesis as 
no structural changes have so far been detected in actin. 
47 
Chapter 1 Introduction 
1) Discontinuous Tm model 
tID 111111, IIIII " 111111, IIIII " IIIIIII ~ III ~ I' 111111, 11111 1m ~ 
2) Continuous Oexible Tm model 
H IIII ~IIIIIII' IIIII ~IIIIII r II ft B IIIII~ III ~ IPIIIIIII~ IIIIII1III t ~ 
3) TnI pinning 
Figure 1.21: Discontinuous cooperative and continuous flexible models of Tm. 
Actin is shown with three potential Tm binding sites corresponding to the blocked (B), 
closed (C) and open (M) states of the filament. On the left is shown the filament in the 
absence of S 1 and on the right is the filament bound to one S 1 head. Panels 1 and 2 
correspond to the state of the filament when it is either bound to Ca2+ or in the absence 
of Tn. In this case the Tm switches between the closed and open positions when S 1 is 
bound. Modell was described by Hill et al (1980) and describes Tm as a rigid filament 
with only one unit switching between states but with an increased likelihood for the 
adjacent unit to also switch states. Panel 2 represents the Maytum et al model where 
Tm is shown as a dynamic flexible filament whose stiflhess determines the extent of the 
cooperativity of the system Panel C represents the effect of TnI (grey oval) on the 
extent of cooperativity when Ca2+ is absent. The strongly bound TnI to actin prevents 
the propagation of the signal between units as it pins the Tm down every seven actins. 
It also constrains Tm to the blocked and closed states (Maytum et ai, 1999). 
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4 Hypertrophic cardiomyopathy mutations 
Familial Hypertrophic Cardiomyopathy (FHC) is an autosomal dominant disease. It 
affects 1 in 500 individuals and is characterised by left ventricular hypertrophy and 
cellular disarray. FHC mutations are believed to be the cause of sudden death in young 
and healthy individuals (for reviews see Maron et aI, 1995; Bonne et aI, 1998; 
Redwood et aI, 1999; Marian and Roberts, 2001). So far, the mutations that cause FHC 
have been found to arise in sarcomeric proteins namely myosin heavy and light chains 
(Watkins et aI, 1993, Flavigny et aI, 1998), actin (Mogensen et aI, 1999) TnT and TnI 
(Thierfelder et aI, 1994; Kimura et aI, 1997), a-tropomyosin (Watkins et aI, 1995) and 
myosin binding protein-C (Bonne et aI, 1995). The severity of FHC mutations is 
variable and probably linked to the degree of structural and functional disruption 
caused by different mutations. 
More details about FHC mutations in tropomyosin and troponin are discussed in 
chapters 5 and 6. 
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5 Project aims 
So far most of the work on the three state model of regulation has been accomplished 
with skeletal muscle proteins. The aim of this study was to extend the initial studies to 
the cardiac system and to define all the parameters of the model in the presence of 
cardiac thin filament proteins. This would lead on to the investigation of the effects of 
cardiomyopathy mutations on the regulatory process and the definition of the subtle 
changes that can arise from these mild mutations. The kinetic methods used to define 
the three state model of regulation would be used to interpret the effect of 
phosphorylation of cardiac Tn on the Ca2+ sensitivity of the thin filament. The in vitro 
assay system in which reconstituted proteins are used offers a big advantage over the in 
vivo fibre measurements as factors which affect the Ca2+ sensitivity of the system, such 
as the level of Tn phosphorylation and the isoform type present in the Tn complex, can 
be defined and controlled. 
Establishing a Tm expression system and the validation of the use of recombinant 
proteins would ultimately allow the expression of different Tm isoforms as well as Tm 
carrying FHC mutations in large quantities. A number of approaches would then be 
used to characterise these molecules. These would include both the kinetic and 
equilibrium techniques previously applied to define the three state model parameters, 
actin binding assays as well as a calorimetry technique to investigate protein thermal 
stability. This would be followed by the development of a procedure for the production 
and characterisation of the aJ3 Tm heterodimer. 
The effect of cardiac TnI phosphorylation on the Ca2+ -dependent regulation of muscle 
contraction will be investigated for both the WT and FHC-carrying Tn complexes. The 
alterations brought about by phosphorylation and dephosphorylation can be accounted 
for by measuring specific rates and equilibrium constants within the model. 
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Chapter 2 
1 Protein biochemistry materials and methods 
1.1 Materials 
1.1.1 Chemicals 
Materials and Methods 
Unless otherwise stated, all the chemicals used in the preparations were purchased 
either from Sigma-Aldritch, Fisher, BOH or Melford. N-(I-pyrenyl)iodoacetamide was 
purchased from Molecular Probes. 
1.2 Methods 
1.2.1 Sodium Dodecyl Sulphate Polyacrylamide Gel Elecrophoresis (SDS-PAGE) 
Protein purity was checked on SOS-PAGE gels made of 12.5 % resolving gel (6.25 ml 
of 30 % acrylamide, 5.55 ml of dH20, 3 ml resolving gel buffer (see section below), 
150 ~l ofl0 % SOS, 10 ~l TEMEO (N,N,N',N'-Tetramethylethylenediamine) 100 ~l of 
10 % APS (Ammonium Persulphate) and 4.8 % stacking gel (0.8 m1 of 30 % 
acrylamide, 3.6 ml dH20, 0.5 ml stacking gel buffer (see section below), 50 ~l of 10 % 
SOS, 10 ~l TEMEO, 34 ~ of 10 % APS). All protein samples had sample buffer added 
to them and were heated up to 100°C for 3 minutes before loading. The gels were run 
in the running buffer (see section below) at 30 rnA for 50 minutes. The gels were 
incubated with the staining solution until protein bands started to appear. The 
destaining was carried out until most of the background staining was removed. 
SDS-PAGE standard buffers and solutions 
Acrylamide solution 30 % Acrylamide 
0.8 % N, N-methylenbisacrylamide 
SOS solution 10%SOS 
Resolving gel buffer 23 g TRIS I HCI pH 8.8 in 100 ml total volume 
Stacking gel buffer 7.56 g TRIS IHCI pH 6.8 in 50 ml total volume 









5.8 nU Glycerol 
5 mg Bromophenol blue 
Materials and Methods 
dH20 added up to afmal volume of 50 nU 
7.2 g rl Glycine 
1.52 g rl TRIS 
0.5 grl SDS 
5 g Coomassie G250 
0.5 g Coounassie R250 
solved in 50 m1 unethanol 
dH20 added up to a fmal volume of 1 1 
1 g Coomassie R 
40 % unethanol 
10 % Acetic acid 
50 % water 
7 % Acetic acid 
25 % Methanol 
1.2.2 Estimation of protein concentration 
All protein concentrations were determined by photometric absorbance at 280 run. The 
concentration of the protein-containing solution was calculated using the Beer-Lambert 
law where A = &. c. I (A: the solution absorbance, &: the molar extinction coefficient 
(1 morl em-I), 1: length of the light path (em), c: protein concentration (unol rl)) 
1.2.3 Native muscle protein preparations 
All steps of protein preparations were carried out at 4 °C unless otherwise stated. The 
purity of proteins produced in each preparation was verified by SDS gel electrophoresis. 
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Acetone powder, myosin and S 1 preparations were all performed by our technician Ms 
Nancy Adamek. 
The following muscle proteins were prepared from freshly killed white New Zealand 
rabbits. The back and leg muscles were minced and transferred into 3 I of Guba-Straub 
buffer (0.3 M KCI, 0.1 M KH2P04, 0.05 M K2HP04, pH 6.6). The mixture was stirred 
for 15 minutes and then centrifuged at 4, 500 g for 30 minutes. The resulting pellet was 
used for actin and regulatory control protein preparations, whereas the supernatant was 
used for myosin preparation. 
1.2.4 Actin preparation 
1.2.4.1 Acetone powder preparation 
The pellet from rabbit muscle mixture (section 1.2.3) was transferred into 5 I of 
extraction buffer (4% NaHC03, 0.1 mM CaCh) and stirred for 30 minutes. This was 
followed by filtration through a double layer of muslin. The residue was transferred into 
1 I of buffer containing 10 mM NaHCDJ, 10 mM Na2C03 and 0.1 mM CaCho 10 1 of 
distilled water (20°C) were added and the mixture was filtered again through a double 
layer of muslin. The residue was transferred into 2.5 I acetone, incubated for 20 
minutes, and then filtered through a double layer of muslin. The latter was repeated four 
times. The residue from the final wash was dried on Whatman paper in a fume 
cupboard for 2 days. The powder was sifted through a mesh to remove unwanted tissue 
residues and was kept at -20°C for several months. 
1.2.4.2 F -actin preparation 
The preparation ofF-actin was based on a method previously described by Spudich and 
Watt (1971). 1-2 g of acetone powder was added to pre-chilled 10 mM TRIS, 0.5 mM 
ATP, 0.2 mM CaCh, 1 mM DTT pH 8.0 buffer and stirred for 30 minutes. The mix was 
then filtered under vacuum through a double layer of cheesecloth. The filtrate was used 
for the F-actin preparation and the solid residue was used for thin filament regulatory 
protein (Tm Tn complex also referred to as control proteins CPs) preparation (see 
section 1.2.7). 
The filtrate was centrifuged at 100, 000 g for 1 hour and the pellet was discarded. KCI 
and MgCh were added to the supernatant to a final concentration of 100 mM and 2 mM 
respectively. The resulting solution was stirred for 1 hour at room temperature to 
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achieve actin polymerisation. The polymerised actin was collected by centrifugation at 
100,000 g for 3 hours. The actin pellet was resuspended in depolymerising buffer 
(5 mM TRIS, 0.2 mM CaCh, 1 mM NaN3 pH 7.5) using a homogeniser and dialysed 
overnight against the same buffer. The depolymerised actin was centrifuged at 
100,000 g for 1 hour and the concentration of actin present in the supernatant was 
measured by absorbance at 280 nm. The actin concentration was diluted to 1 mg ml-1 
using depolymerising buffer and actin was then polymerised as previously described. 
Unlabelled actin was obtained by centrifugation at 100,000 g for 3 hours. The pellet 
was redissolved in and dialysed against the appropriate experimental buffer (20 mM 
MOPS, 100 mM KCI, 5mM MgCh, 1 mM NaN3 pH 7.0). The unlabelled actin was 
stored up to two weeks at 4°C. The concentration of actin prepared following this 
protocol usually ranged between 100 and 200 IlM (actin's extinction coefficient 
a = 1.104 mg-1 ml cm-l and its molecular weight is 42,000 Da). 
1.2.5 Pyrene labelled F-actin Preparation 
The labelling of F -actin with the N-(l-pyrenyl)iodoacetamide (pyrene fluorophore) was 
based on a procedure by Criddle et al (1985). Pyrene (5mg ml-1 solved in DMF) was 
added to the stirred 1 mg ml- l repolymerised actin solution (as described in section 
1.2.4.2) very slowly to reach a final concentration of 0.8 % w/w (pyrenelactin). The 
pyrene labelling of actin was carried out by stirring the two components together over 
an 18 hour period in the dark at room temperature. The labelled actin was centrifuged 
at 7, 800 g for 1 hour to remove residual pyrene and denatured protein. The supernatant 
was then centrifuged at 100, 000 g for 3 hours. The pellet was resuspended in the 
appropriate experimental buffer (20 mM MOPS, 100 mM KCI, 5 mM MgCh, 1 mM 
NaN3 pH 7.0) using a homogeniser, and dialysed overnight. In order to discard any 
precipitated pyrene-actin, the actin was spun in an Eppendorf centrifuge at maximum 
speed for 5-10 minutes. The concentration of the supernatant and the percentage of 
labelling were assessed by UV spectroscopy. These varied between 100-200 IlM and 
80-100% respectively. The pyrene label has an absorbance peak at both 280 nm (E = 
1.059 X 104 M-1 cm-l) and 344 nm (a = 2.33 x 104 Ml em-l). By calculating the 
concentration of pyrene from the 344 nm absorbance peak, its absorbance at 280 nm can 
be subtracted and the actin concentration can be deduced at that wavelength. The 
pyrene-actin was stored at 4 °c for up to two weeks. 
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1.2.6 Phalloidin-stabilised F -actin preparation 
Actin critical concentration (see chapter 1, section l.2. 2.1) is 0.1-1 J.1M depending on 
the buffer conditions. Therefore when low actin concentrations were used in an 
experiment, the fungal toxin phalloidin was added in a 1: 1 molar ratio with actin. An 
overnight incubation allowed the stabilisation of the filamentous form of actin (Cooper, 
1987; Kurzawa and Geeves, 1996). 
1.2.7 Control proteins (CPs) preparation 
Control proteins are made up of both the troponin complex (Tn) and tropomyosin (Tm) 
proteins. These are prepared as follows. The solid residue from the cheesecloth 
filtration in the F-actin preparation (section l.2.4.2) was added to 10 mM TRIS, 2 mM 
DTT, 1 mM NaN3 pH 8.0 buffer and stirred for 5 hours at room temperature. The 
resulting solution was filtered through a double layer of cheesecloth. The filtrate was 
subjected to a 40 % ammonium sulphate cut (0.24 g ml-1) and stirred for 20 minutes in 
order to precipitate the actin. After a centrifugation step at 9, 800 g for 30 minutes, the 
supernatant was taken through a second ammonium sulphate cut (0.13 g ml-1) reaching 
60 % saturation and resulting in CPs precipitation. The proteins were recovered by 
centrifugation at 9, 800 g for 30 minutes. They were then resuspended in 5 mM TRIS, 
0.5 mM DTT pH 8.0 buffer, against which they were dialysed 3-4 times. The 
concentration, which normally varied between 20-30 J.IM, was measured by absorbance 
at 280 nm (E = 0.385 mg- l ml cm-l , Mwt = 136, 000 Da). CPs were stored for up to two 
weeks at 4°C. 
1.2.8 Skeletal tropomyosin and skeletal troponin preparation 
In order to separate CP components, the following procedure was followed. CPs were 
dialysed overnight against 50 mM KCI, 10 mM TRIS, 0.5 mM DIT pH 8. O. The CP 
concentration was then diluted to 1 mg ml- l using the same buffer. This was followed 
by 3-4 pH cuts where the pH was dropped slowly to 4.6, the isoelectric point for Tm. 
The Tm was collected in a pellet after each pH cut by centrifugation at 27, 000 g for 
15 minutes, leaving the Tn in the supernatant. The supernatant of each pH cut had its 
pH readjusted to 8.0 and some DTT added to it. The Tm pellet from the final pH cut 
was redissolved in 250 mM KCI, 5 mM TRIS, 0.2 mM EDTA, 0.2 mM DIT pH 7.5 to 
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give a protein concentration of 1 mg ml- l . The solution was spun at 17,500 g for 30 
minutes and this was followed by a 53 % ammonium sulphate cut (0.32 g ml-I ) and by 
20 min stirring which allowed the precipitation of any remaining Tn in the pellet. The 
Tm-containing supernatant was heat precipitated at 30°C for 30 minutes and the 
solution was centrifuged at 17, 500 g for 30 minutes. The pellet was then resuspended 
in storage buffer (10 mM KCI, 10 mM MOPS, 1 mM EDTA, 0.2 mM DIT, 1 % 
sucrose pH 7.5). The Tn-containing supernatants were pooled together and taken 
through a 70 % ammonium sulphate cut (0.47 mg ml- l ) in order to precipitate the Tn 
proteins. This was followed by a centrifugation step at 12, 000 g for 30 minutes. The 
pellet was then dissolved in storage buffer. Both protein concentrations were measured 
by UV spectroscopy (skTm's extinction coefficient e = 0.276 mg-1 ml cm-l and 
Mwt dimer = 66,000 Da. SkTn's extinction coefficient, e = 0.45 mg -I m1 em-I, and 
Mwt =70, 000 Da). Both proteins were stored at -20 °C. 
1.2.9 a -tropomyosin preparation 
The preparation was based on a method described by Smillie (1982) with modifications. 
Control proteins from preparation 2.4.2 were dialysed against the following urea buffer 
(6 M urea, 50 mM TRIS, 1 mM EDTA, 5 mM DIT pH 6.5). The protein solution was 
then loaded on an anion-exchange chromatography column (Pharmacia Resource Q 
6ml) and the proteins were eluted using a 0-300 mM NaCI gradient (Figure 2.1). The 
fractions from the a Tm-containing peak were pooled together and the protein was 
concentrated by a pH cut to 4.6. This was followed by a centrifugation step at 27, 000 g 
for 15 minutes. The pellet was then resuspended and dialysed against storage buffer 
(10 mM KCI, 10 mM MOPS, 0.2 mM EDTA, 0.2 mM DIT, 1 % sucrose pH 7.5). This 
preparation gave a protein yield of 15-20 mg (e = 0.276 mg-
1 
ml cm-t, and 
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Figure 2.1: a) Protein elution protUe from a-Tm preparation. The 
different peaks represent the 280 nm absorbance of different proteins as they 
elute from the column The salt gradient is shown in green. b) SDS-gel of the 
different protein peaks. The different peaks were identified by running a 
12 % SDS-Page gel. The different peaks are (A) a-T~ (B) mixed 0.- and p-
Tm, (C) TnT and finally (D) mixed a- and p-Tm 
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1.2.10 Myosin preparation 
Based on the method described by Margossian and Lowey (1982) the myosin was 
prepared as follows. The supernatant from the rabbit muscle mixture (section 2.4) was 
filtered through a 1 cm layer of Whatman paper and then transferred into 30 1 of cold 
distilled water causing myosin precipitation The precipitate was allowed to settle 
overnight and most of the water was removed carefully. The excess water was removed 
by centrifugation at 4 500 g for 45 min. The myosin pellet was redissolved into 1 lof 
0.5 M KCI. Further purification steps were undertaken by precipitation into distilled 
water. The final pellet was redissolved in 500 ml of 0.5 M KCI, 10 mM KPi, 1 mM 
DTI pH 6.5 buffer. Long term storage at -20°C was possible when the myosin 
solution was mixed with an equal volume of glycerol. 
1.2.11 Skeletal myosin subfragment (SI) preparation 
About 10-20 g of myosin was dissolved in II of digestion buffer (125 mM KCI, 10 mM 
KPi, 2 mM EDTA, 2 mM DTI pH 6.5). Addition of chymotrypsin to a final 
concentration of 0.1 mg ml-1 was followed by a 20 minute incubation at room 
temperature under a constant stirring. The digestion reaction was stopped by the 
addition of 0.5 roM PMSF (500 mM stock solution in ethanol) and the mixture was 
dialysed overnight against 10 I of 5 mM KPi pH 6.5 buffer. The undigested myosin was 
removed by centrifugation at 15, 000 g for 1 hour. The yield of the digestion was on 
average around 100-200 mg of SI per 1 g of myosin. The SI preparation was further 
purified by anion-exchange chromatography using a DEAE-Sephacel column (500 ml 
gel bed volume) equilibrated in 50 roM imidazol pH 7.0. The elution of the protein was 
achieved using a 0-250 mM KCI gradient and the presence of S 1 was confirmed by the 
presence of absorbance peaks at 280 nm. The S I-containing fractions were pooled and 
dialysed against 10 I of10 mM KPi pH 7.5. Sl was freeze-dried after the addition of an 
equal amount (w/w) of sucrose. For experimental uses, SI was dissolved and dialysed 
against 20 mM MOPS, 30 mM KCI, 5 mM MgCh pH 7.0. The concentration ofSl was 
determined using UV spectroscopy (E = 0.79 mg-1 ml cm-t, Mwt = 115, 000 Da). The 
S 1 solution was stable at 4 °C for a couple of weeks. 
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2 Molecular biology materials and methods 
2.1 Materials 
2.1.1 Chemicals, enzymes, and kits 
Materials and Methods 
All chemicals were purchased from Sigma-Aldritc~ Fisher, BDH or Melford. 
Molecular biology enzymes (restriction endonuclease, Taq polymerase and T4 DNA 
ligase enzymes) and their buffers were purchased from Roche. The purification kits (gel 
cleanup, plasmid purification, mini and midi prep kits) were purchased from Eppendorf 
2.1.2 Oligonucleotide primers 
Primers were synthesised by MWG-Biotech. They were designed to create an NdeI site 
at the start codon and a BamHI site directly downstream of the stop codon to enable the 
cloning into the pJC20 vector. The 5' end of the f3-Tm gene (see appendix for 
sequence) had a dipeptide extension (Ala (GCG) and Ser (AGe)) inserted into its 








~ Tm sequence 
2.1.3 pJC20 vector 
pJC20 vector (Figure 2.2) was purchased from ATCC. pJC20 vector is a pET derived 
expression vector. It has a T7 RNA polymerase-dependent promoter region and is 
suitable for transformation into BL21 cells which carry the gene for T7 RNA 
polymerase whose expression is controlled by the lacUV5 promoter (IPTG induced). 
The small size of the pJC20 plasmid and the presence of a powerful origin of replication 
makes it an ideal vector system for the cloning of large inserts and the production of 
high plasmid copy number. The plasmid shows a good stability in both XL 1 Blue and 
BL21 E-coli cells. Moreover, protein expression is reported to be well regulated and 
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highly effective in BL21 cells (Rosenberg et ai, 1987; Studier and Moffat, 1986; Studier 
et ai, 1990; Clos and Branda~ 1994). 
2.1.4 Bacterial strains 
XLI Blue and BL21 E-coli cells (Stratagene) were used for plasmid DNA amplification 
and for gene expression respectively. 
2.1.5 Bacterial growth media 
LB solution 
LB-Agar plate 
10 g rl Bactopeptone 
5 g rl Yeast extract 
10 gr1 NaCI 
pH7.5 
2 % agar in LB (w/v) autoclaved and allowed to cool down to 
about 50°. Ampicillin added to a final concentration of 
100 mg I_I. 25 ml poured into each plate and allowed to cool 
further until solidification. 
Plates stored at 4 0c. 
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Multiple Qoning Site 
$ Transcription terminator 
T7 promoter region 
P JC20 vector 
2340 bp 
AmpRgene 
Origin of replication 
Figure 2.2: Schematic representation of the pJC20 vector. The pJC20 
vector has a T7 RNA polymerase-dependent promoter region It has a 
multiple cloning site which includes Bamlll and NdeI restriction sites. It 
also has a powerful origin of replication and an Ampicillin resistant gene. 
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2.2 Molecular biology methods 
All molecular biology procedures were carried out under aseptic conditions. All the 
tubes and pipette tips were autoclaved prior to the start of the experiments. 
2.2.1 Agarose gel electrophoresis 
Plasmid DNA as well as PCR and restriction digest products were visualised by agarose 
gel electrophoresis. 1 % or 1.5 % agarose gels were made in T AE buffer (40 mM TRIS 
pH 8.0, 20 mM glacial acetic acid, 1 mM Na2EDT A) depending on the DNA size to be 
analysed. DNA samples (1- 2 fl.l) were mixed with 2 fl.l of loading buffer and the gel 
was run in TAE buffer at 100 V. The gel was then incubated in ethidium bromide 
solution (0.5 fl.g ml-1) for about 15 minutes and the DNA bands were visualised under 
UV light. 
2.2.2 (3-tropomyosin gene subcloning into pJC 20 vector 
The rat skeletal (3-Tm gene (sequence shown in appendix) cloned into a CGN plasmid 
was kindly donated by David Helfman (Cold-Spring Harbour). The gene was 
sub cloned into a pJC20 expression vector as follows. 
2.2.2.1 Polymerase chain reaction (PCR) 
PCR was used in order to amplifY the gene of interest and to introduce the desired 
restriction sites at both the 5' (NdeI) and 3' (BamHI) ends of the gene. In this case it 
was also used to introduce a dipeptide extension (Ala-Ser) essential for the normal 
functioning of recombinant Tm (see chapter 4). Tm expressed with this N-terminal 
extension will be referred to from now on as Tm (n3) as it has a Met-Ala-Ser codons 
added to its sequence. The PCR reaction mixture was set up in 100 fl.l total volume and 
contained: 10 fl.l of lOx PCR buffer, 200 fl.M dNTPs, 25 mM MgS04, 20 ng of template 
DNA, 0.33 pM of each primer and 2 units of Taq polymerase. A thermal cycler was set 
for the following programme: 
Denaturation at 95°C for 2 minutes (1 cycle) 
Denaturation at 95 °c for 30 seconds (25 cycle) 
Annealing at 50°C for 30 seconds (25 cycle) 
Extension at 72 °c for 40 seconds (25 cycle) 
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The PCR reaction products were separated by size on a 1.5 % agarose gel by loading 
5 III of the reaction mixture and 1 III of loading buffer. The size of DNA bands was 
compared to molecular weight markers A DNA! Hind ill digested and cP X174 
DNAlHae III digested. The band corresponding to the f3-Tm gene (864 base pairs) was 
cut from the gel and the DNA was extracted using gel cleanup kit following the 
manufacturer's instructions. 
2.2.2.2 Restriction digest of the PCR product 
The purified PCR product was digested with NdeI and Bamill restriction enzymes 
(1 U Ilit of DNA) in the manufacturer's supplied buffer at 37°C for 1 hour. The f3-Tm 
fragment was purified using a DNA purification kit. The protocol was carried out as 
instructed by the manufacturer. 
2.2.2.3 Ligation of the 13-Tm gene into pJC20 vector 
The ligation of the cohesive f3-Tm gene ends (0.2 Ilg) into the NdeIl Bamill restricted 
pJC20 vector (0.1 Ilg) was catalysed by 1 unit of the T4 DNA ligase enzyme in the 
manufacturer's supplied buffer at 4 °c overnight in a total volume of 20 Ill. 
2.2.2.4 Production of competent cells 
Competent E.coli cells were prepared on the protocol described by Nishimura et al 
(1990). 50 ml of LB supplemented with 10 mM MgS04 and 0.2 % glucose was 
inoculated with 0.5 ml of a bacterial cell starter culture. The resulting culture was 
incubated at 37°C until its optical density (OD6oOmn) was between 0.6-1.0. The cells 
were then kept on ice for 10 minutes and pelleted down at 1, 500 g for 10 minutes at 4 
°C. The pellet was gently resuspended with 0.5 ml of the pre-chilled supplemented LB 
buffer. 2.5 ml of storage buffer (36 % glycerin, 12 % polyethylene glycol, 
12 mM MgS04 7H20 added to LB and sterilised by filtration) was added and mixed 
well. Aliquots of 100 III were stored at -80°C until use. 
2.2.2.5 Transformation into XLl Blue bacterial cells 
Competent XLI Blue cells (section 2.2.2.4) were transformed with the pJC20 vector 
containing the 13-Tm gene in order to screen for positive clones and amplify the vector. 
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Transformation was performed as follows: 100 JlI of competent XLI Blue bacterial cells 
were thawed on ice. 5 JlI of the ligation mix (section 2.2.2.3) was added to the 
competent cells and the mixture was stirred gently. The cells were incubated on ice for 
30 minutes and then heat shocked at 42°C for 2 minutes. This was followed by a 
2 minute incubation on ice. LB was added to a final volume of 1 ml and the mixture 
was incubated for I hour at 37°C. The cell culture was mixed and 100 J.1l was plated 
onto an ampicillin plate. The plates were incubated at 37°C overnight. 
2.2.2.6 Plasmid DNA amplification and purification 
Single colonies from the transformed XLI Blue plates (section 2.2.2.5) were used to 
inoculate 3 m1 LB supplemented with 100 Jlglml of ampicillin. The cultures were 
incubated with shaking at 37°C overnight. The plasmids from each cell culture were 
purified using DNA mini-prep kit as instructed by the manufacturer. I J.1l of each DNA 
plasmid preparation was run out on an agarose gel to determine concentration. The 
plasmid was then stored at -20°C. 
2.2.2.7 Restriction digest screening for positive clones 
Restriction digests were set up as described in section 2.2.2.2. The presence of insert 
(864 base pairs) was verified by running agarose gel electrophoresis. 
2.2.2.8 DNA sequencing 
(3-Tm DNA sequencing was performed by MWG-Biotech. The (3-Tm fragment cloned 
in the pJC20 vector was sequenced both forward and backward. In that way, the full-
length sequence was confirmed. For that purpose, primers corresponding to the vector 
T7 promoter sequence and the transcription terminator sequence were used. The 
sequences of which are shown below 
T7 sequencing primer: 
5'-GGTITC CTC TAG AAT ATT TTG TIT ACT TTACGAAGGAGATATA-3' 
Transcription terminator sequencing primer: 
5' -CTCAGCTTCCTITCGGGC-3' 
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2.2.3 Recombinant tropomyosin expression and purification 
The following recombinant Tm molecules: rat sk [3-Tm (n3), and the rabbitlhuman sk u-
Tm (n3) both WT and containing cardiomyopathy mutations D175N and E180G 
(cloning performed by Dr Robin Maytum) were expressed as described below. 
2.2.3.1 Transfonnation into BL21 bacterial cells for protein expression 
The E. coli bacterial strain BL21 was used for the [3-Tm protein expression. These cells 
were made competent as described in section 2.2.2.4 and were transformed with 1 ~ 
pJC20 vector as described in section 2.2.2.5. 
2.2.3.2 Small-scale protein expression 
Small-scale protein expressions were carried out in order to identify the BL21 clones 
that express the protein of interest. 
Single colonies were inoculated into 3 m1 of LB containing 100 J.lg/ml of ampicillin. 
The cultres were incubated for about 4 hours (until the optical density OD600 of the 
culture was between 0.6 and 1) at 37°C with shaking. The cells were then induced by 
adding 0.4 mM isopropyl [3-D-thiogalactopyranoside (IPTG). Prior to that, 0.5 ml of 
each cell culture was transferred into a fresh tube and was used as a control sample. 
Both the IPTG-induced and non-induced samples were incubated at 37°C for 3-4 hours. 
Positive clones were identified by running SDS gel electrophoresis of 0.5 ml cultures. 
These were centrifuged and the resulting pellets were resuspended in 50 ~ water and 
10 J.lI sample buffer. 5 J.lI of each sample was run on a 12 % SDS gel. The appearance 
of a large protein band of correct size (33, 000 Da) indicated successful expression of 
the protein of interest. 
2.2.3.3 Large-scale protein expression and purification 
Clones containing the gene of interest were inoculated into 1 1 flask containing LB-Amp 
media (100 mg of Amp) for large-scale protein expression. IPTG was added when the 
OD 600nm of the culture was between 0.6 and l. This was followed by a 3 hour 
incubation at 37°C with continuous shaking. The bacterial cells were then harvested by 
centrifugation at 6, 500 g for 15 minutes. The pellet was resuspended and homogenised 
in lysis buffer (20 mM TRIS, 150 mM NaCI, 1 mM MgCh pH 7.5). Cell free lystates 
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were then produced by sonication (2 minute pulse, 2 minute rest and 2 minute pulse) 
Unlike many other proteins, tropomyosin is a heat-stable protein that is reversibly 
denatured if the temperature is increased up to 80°C. The samples were therefore 
heated up to 80 °C for 10 minutes resulting in the irreversible denaturation of most of 
the bacterial proteins without affecting the structure and function of Tm. The solution 
was then placed on ice and allowed to cool down. Both RNAse and DNase enzymes 
were added (2 units mrl) and incubated for about 1 hour. This was followed by a 
centrifugation step at 12, 000 g for 15 minutes to remove cell debris and precipitated 
proteins. The supernatant was then taken through a pH cut to 4.6 in order to precipitate 
the Tm. The protein was recovered in the pellet by centrifugation at 27, 000 g for 
15 minutes and was resuspended in 5 mM P04 pH 7.0, 100 mM NaCl. The pH of the 
Tm solution was measured and readjusted to 7.0. The final purification of Tm was 
carried out using an ion exchange chromatography column (HiTrap 5 ml Q, Pharmacia 
product). The protein was eluted using a 0.1-1 M NaCl gradient (Figure 2.3). The 
protein-containing fractions were pooled together and pH cut to 4.6. This was followed 
by a centrifugation step at 27, 000 g for 15 minutes to recover the precipitated Tm. The 
Tm was then resuspended and dialysed against storage buffer (10 mM KC1, 10 mM 
MOPS, 1 mM EDTA, 0.2 mM DTT, 1 % sucrose pH 7.5). The resulting purified Tm 
was stored at -20°C. 
Protein concentrations were determined usmg an extinction coefficient (E = 
0.276 mg -1 ml cm-\ and Mwt of 65,679.6 Da for sk a-Tm (n3), 65,677.6 Da for 
ska-Tm D175N (n3), 65,535.4 Da for sk a-Tm E180G (n3) and 65,991.6 Da for 
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Recombinant f3-Tm (n3) 
..... I--__ --.:R:...:.;ecombinant a-Tm (n3) 
Figure 2.3: a) Elutioo profile of recombinant f3-Tm (03). The peaks 
represent the 280nm absorbance of the proteins eluting from the column. As 
most proteins are denatured during the 80°C heating step, the Tm peak is the 
main one obtained during the ion-exchange chromatography step. The salt 
gradient is shown in green b) SDS-gel of a- and f3-Tm (03). The samples 
were run on a 12 % SDS gel. The proteins molecular weights are 33, 000 
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2.2.4 Mass spectrometry 
Electrospray mass spectrometry was used to determine the molecular mass of expressed 
recombinant Tm. The protein samples were prepared by dialysing overnight against 
5mM Tris buffer. The protein samples were then diluted 10 times in 0.1 % formic acid 
and 10% ethanol. The mass spectrometry was performed by Dr Robin Maytum and the 
expected molecular weights were obtained. 
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Chapter 3 Techniques and Analytical Procedures 
This chapter aims at introducing the techniques as well as the analytical methods applied 
in the study presented in this thesis. 
1 Measurement of tropomyosin binding affinity for actin using co-
sedimentation experiments and densitometry analyses 
1.1 Co-sedimentation experiment 
When actin is polymerised (F -actin form), it can be pelleted by centrifugation at 
100, 000 g (Beckman TLA100A). Therefore, any protein that would normally remain 
in the supernatant will pellet when bound to actin. The concentration of bound and free 
protein can be deduced by adding increasing concentrations of the protein of interest to 
a fixed actin concentration, and then checking the content of both the pellets and the 
supernatants on as SDS-PAGE gel. 
On this basis, the binding of different Tms to actin was investigated by co-
sedimentation experiments. These were designed as follows: 0.2, 0.5, 1, 1.5, 2 and 
3 J.1M of Tm were added to a fixed 10 J.1M actin concentration. The appropriate 
experimental buffer (20 mM MOPS pH 7.0, 5 mM MgCh and 100-200 mM KCl) was 
added to reach a total volume of 100 1-11. The samples were well mixed and were then 
incubated at room temperature for at least 1 hour. The samples were then spun at 
100, 000 g for 20 minutes at 20 °C. The supernatants were transferred into fresh tubes 
and the pellets were resuspended with 100 1-11 dH20. 20 Jll and 10 1-11 of sample buffer 
were added to the 100 1-11 pellet and 50 1-11 supernatant samples respectively. 12 1-11 of 
each sample was loaded on a 12.5 % SDS-gel (see chapter 2, section 1.2.1) (Figure 3.1). 
1.2 Densitometry 
The binding constants of Tm to actin were obtained from cooperative binding curves 
generated by combining co-sedimentation experiments with densitometry analyses. The 
stained gels (Coomassie Blue G250) from the co-sedimentation experiment were 
scanned with an Epson 1640 SU scanner and the obtained images were analysed using 
the Image-PC program (Scion Corp. based upon NIH-Image). The density of protein 
bands was measured by comparison to integrated optical densities (the scanner was 
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calibrated using a Kodak neutral density step tablet). A standard curve plotting the 
densities of Tm against known concentrations was used to work out the free Tm 
concentration in the supernatant (Figure 3.2). Both the dissociation binding constant 
(Kso%) and the Hill coefficient (m) parameters were determined by plotting the ratio of 
Tm bound to actin (ratio of the two protein band densities) as a function of free Tm 
concentrations (Figure 3.3). The data was fitted to a Hill equation using Origin 6.0 
software (see appendix, equation 1.1.3). 
Pellet Supernatant 
r_---A ---, r----.... ~-----"' 
actin 
a.-T~ 
Figure 3.1: A co-sedimentation binding gel. 0.2, 0.5, 1, 1.5, 2 and 3 ~M 
(left to right) of recombinant 0.-Tm (n3) were added to 10 fJ.M actin. The 
experimental buffer was 20 mM MOPS, 100 mM KCI, 5 mM MgCh pH 7.0. 
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Figure 3.2: (A) graph representing the distribution of Tm in 
pellet (bound to actin) and supernatant (free) as a function of 
total Tm added to 10 f.1M actin. Saturation of actin occurs at 
stoichiometric concentration of about 1.5 J.1M as one Tm 
molecule binds every seven actins. (B) Tm calibration curve. 
The band density of known Tm concentrations was plotted 
against the corresponding concentrations. This allowed the 
deduction of the bound and free Tm concentrations. 
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[FreeTm] ~ 
Figure 3.3: Binding curve of a-tropomyosin to actin. 
Actin fractional saturation by Tm (ratio of bound Tm band 
density and actin band density) is plotted as a function of 
free Tm (supernatant Tm) concentrations. The 
experimental conditions are detailed in the text. The 
sigmoid curve reflecting the cooperative binding of Tm to 
actin was fitted to a version of the Hill equation Both the 
Hill coefficient m and the midpoint of the sigmoid curve 
Kso% were determined. The data was normalised to 1.0 by 
dividing Tm:actin ratio from densitometry by the Tm:actin 
ratio for saturating stoichiometric binding. 
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2 Kinetic measurements using the stopped-flow technique 
2.1 The stopped-flow machine 
The stopped-flow (SF) spectrophotometry technique enables the monitoring of fast 
reactions that occur at the millisecond time scale. The principle of this technique 
consists in the use of light scattering or fluorescence to measure the association or 
dissociation rates of a given reaction It relies on a rapid mixing method and a suitable 
detection system that allows the reaction to be followed in real time. 
The stopped flow instrument is represented in Figure 3.4. The instrument used for our 
experiments was a Hi-Tech Scientific Ltd (Salisbury, England) SF-51 apparatus. It 
consists of a rapid mixing system made up of two separated compartments in which the 
reactant solutions are placed. The solutions are pushed into the mixing chamber by air-
compressed pressure driven pistons. The system is equipped with Teflon valves that 
control the direction of the flow into the right compartment. Once in the observation 
cell, the solution is excited with UV light produced by a XenonlMercury lamp 
(Hamamatsu 100-W). The desired wavelength is selected for by a monochromator 
(Photon Technology International LP S-20). The observation cell is designed in a way 
that allows the incident light to pass into one surface, and the emitted light, detected by 
a photomultiplier, to be monitored at 90°. A cut-off filter (KV 389 nm) is used in order 
to resolve the fluorescence emission from the scattered excitation light. The back 
syringe acts as a stopping device by hitting a metal block when a fresh solution flows 
into the observation chamber and pushes the old solution out. At this moment, the time 
resolved fluorescence recording is triggered and the obtained curves are visualised and 
analysed by computer using the software provided by Hi-Tech. The rate of the reaction 
is obtained by curve fitting the average of at least three consecutive data sets. The 
system is temperature-controlled by an external water bath and all the experiments 
described were carried out at 20°C. 
Equal volumes of the reactants are mixed each time and therefore half the initial 
concentrations are present in the reaction mixture. All the concentrations in the text 
refer to those in the mixing chamber of the instrument (for a review on SF spectroscopy, 
see Eccleston, 1991). 
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In all our experiments, we monitered the change of Pyrene fluorescence (actin is 
labelled with the pyrene fluorophore (365 nm excitation, 380 nm emission) at Cys 374 
(see chapter 2, section l.2.5). Binding of 81 to actin causes 70% quenching of pyrene 







Figure 3.4: Schematic representation of the stopped-flow apparatus. 
(http://www.hi-techsci.co.uk/scientific/stoppedflow.html 
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2.2 Transient kinetic principles 
In order to understand the data obtained from a SF experiment, one needs to consider the 
kinetics that describe the reaction under investigation The following equations are of 
relevance for the study of binding reactions. 
First order reactions: defines a reaction whose rate or velocity (rate of reactant 
disappearance or rate of product appearance measured in M.s-1) is proportional to the 
first power of the reactant concentration. 
A k >B 
The rate of the reaction is proportional to the concentration of A at time t. 
Rate of reaction = d[BJ<t) / dt = -d[AJ<t)/ dt = k [A](t) 
Integration of the above equation gives the following single exponential: 
[A ](t) = [A]o e -kt, where k is the first order rate constant of the reaction (s -1). 
Second order reactions: occur when two reactants come together to give rise to a 
product. The rate of such a reaction is proportional to the concentration of both 
reactants. 
A+B k )C 
Rate of reaction = d[Clt) / dt = k [Alt) [B](t) 
However, considering the complexity of the analysis of the above equation, second 
order reactions are best studies under pseudo-first order conditions. 
Pseudo-first order reactions: are described when the concentration of one of the 
reactants is in a great excess compared to the other so that it remains effectively 
constant over the course of the reaction. 
A+B k >C 
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Rate of reaction = d[C](t) / dt = k [A](t) [B](t), where k is the second order rate constant. 
Since [A] »> [B] then, [A](t) = [A]o. This gives rise to a new constant termed observed 
rate constant kobs where kobs = k [A]o. 
On integration, the following single exponential equation is obtained 
[B](t) = [B]o e -.koos t. the kobs (S-I) is a linear function of [A]. 
2.3 Experimental conditions 
In all the SF experiments we monitored the binding of S I to pyrene-actin. F or this 
purpose, the concentration of either actin or SI was in IO-fold excess compared to the 
other (10 ~M vs. I~M or 5~M vs. 0.5 ~M syringe concentrations). The experimental 
buffer used was 20mM MOPS, 140 mM KCI, 5mM MgCh pH 7.0. 1 mM DIT was 
added to the buffer when Tn was present in the solution The kobs value of the binding 
reaction shows a linear dependence on the concentration of the reactant which is in 
excess. The buffer's ionic strength will also affect the kobs value. 
2.3.1 Excess actin case: 
A+SI k )A.SI 
[A] »> lSI] 
The rate of the reaction: -d[SIlt) / dt = k [Alt) [SI](t) 
Integration of the above equation predicts an exponential decrease in lSI] 
[SIlt) = [SIlo e(-kobst) where kobs = k [A]o 
Under these conditions, few actin sites will be occupied by S I (one or less S I every one 
actin structural unit). Therefore, the observed rate constant is that of the first S I 
molecule that binds to actin and is dependent on the actin concentration available for S 1 . 
binding (actin sites in the ON state). 
2.3.2 Excess S1 case: 
As described above, when lSI] »> [A], [Alt) = [A]o e(-kobst) where koos = k [SIlo 
Under these conditions, S 1 will occupy all the sites on actin The initial binding of S 1 is 
restricted by the number of actin sites available for binding. So, if a fraction of actin 
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sites is in the OFF state, a lag phase is obtained. As more SI heads bind to actin, the 
filament is turned into the ON state allowing faster S 1 binding. The rate of the fast 
binding follows a single exponential described by the above equation 
2.4 Measurement of the calcium sensitivity of the thin tUament complex 
2.4.1 Calcium-dependence of 81 binding to actin: 
The binding of S 1 to the thin filament is a Ca2+ -dependent reaction In the case of 
excess actin over SI, a 3-fold decrease in kobs value is observed on Ca2+- removal (see 
Figure 3.5). 
This decrease in the SI binding observed rate constant is explained by a 3-fold decrease 
in the fraction of actin sites available for binding. 
Assuming that actin exists between two states ON (that can bind SI) and OFF that cannot 
bind S 1 with the equilibrium between the two defined by KB. 
KB AOFF( )AON 
~ = [AoN] I [AoFF] 
The fraction of actin sites in the ON state is [AoN] I [Ao], where [Ao] = [AoN] + [AoFF] 
Therefore: [AoN] I [Ao] = Ks [AoFF] 1([AoN] + [AoFF]) 
[AoN] I [Ao] = ~ I (~ + 1) 
[AoN] = [Ao] KB I (KB + 1) 
Since S 1 only binds to actin in the ON state. 
AON+SI k )A.SI 
The rate of the reaction -d[SI] I dt = [SI] [AoN] k, where kobs = [AoN] k 
Therefore: kobs = [A]o ~ I (~+ l)k 
The fact that kobs(Ca 2)lkobs(-cl) = 3 is explained by a 3-fold decrease in the fraction of 
actin sites available for SI binding. In other words I<BI (Ks + I) = 0.3, giving I<B a value 
of about 0.42 in the absence of Ca2+. In the presence of Ca2+, the kobs value is similar to 
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that obtained for S 1 binding to actin alone suggesting that all the actin sites are available 
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Figure 3.5: Effect of Ca2+ on the observed rate 
constant of SI binding to actin. Stopped-flow 
transients for S 1 (0.25 11M) binding to Pyrene-actin 
(2.5 11M) in the presence of control protein compl~: 
(1 11M) both in the presence and absence of Ca . 
Fractional fluorescence values (Ffrac) were calculated 
using the formula (F-Ffinal)/(Finitial-Ffinal). 
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2.4.2 The generation of calcium sensitivity curves: 
Measuring the rate of S 1 binding to actin as a function of Ca2+ concentrations or pCa 
(pCa = -log [Ca2+]) gives an indication on the Ca2+ sensitivity of the system It is 
therefore a good assay for looking at the effect of different control protein isoforms as 
well as the effect of mutations that arise in the regulatory proteins on the Ca2+ 
sensitivity of the thin filament. 
Controlling the free Ca2+ concentration is a crucial requirement in this type of 
experiment. This is achieved using Ca2+ chela tors such as EGT A. The pCa solutions 
are obtained by mixing given volumes (ml) of EGTA and CaEGT A as shown in the 
table below. These volumes are calculated usmg a programme 
(http://www.stanford.edu!~cpatton/webmaxclitel15.htm) where all the Ca2+ -binding 
constants are entered (Harrison and Bers, 1987). 
[EGTA] (100 mM) 0 0.05 0.075 0.12 0.2 0.3 0.4 0.6 1.0 1.5 2 
[CaEGTA] (100 mM: 2 l.95 l.925 0.88 l.8 1.7 l.6 1.4 l.0 0.9 0 
pCa(2mM) 4.6 5.0 5.2 5.4 5.6 5.8 6.0 6.2 6.6 7.0 8.9 
Ca2+ -sensitivity curves are obtained by measuring the koos values for S 1 binding to a 
regulated thin filament at different pCa values (Figure 3.6). The kobs values are then 
plotted as a function of pCa as shown in figure 7. The sigmoid curve obtained is fitted 
with a Hill equation (see appen~ equation 1.1.4) and both the midpoint of the curve 
(Kso%) and the Hill coefficient (h) are derived. A shift in the Kso% value is an indication 
of a change in the Ca2+-sensitivity (Figure 3.7). The h value is a measure of the 
cooperativity of the system and is about 1.8 in the case of skeletal Tn and 1.2 in the case 
of cardiac Tn (see chapter 1, section 3). 
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Figure 3.6: Stopped-flow transients for SI binding to pyrene-actin 
in the presence of regulatory proteins. S 1 binding, monitored by 
fluorescence quenching, was recorded at different Ca2+ concentrations 
or pCa (pCa = -log[Ca21). The observed rate of binding (kobs) is Ca2+-
dependent and decreases as Ca2+ concentration is lowered. The raw 
kobs values, obtained from fitting the transients to a single exponential, 
are shown in the above table. Experiment conditions were as follows: 
protein concentrations were 2.5 J.LM Pyrene-actin, 1 flM regulatory 
proteins pushed against 0.25 J.LM S 1. The buffer used was 20 mM 
MOPS, 140 mM KCI, 5 mM MgCh, 1 mM DTI, pH 7.0. Fractional 
fluorescence values (Ffrac) were calculated using the formula 
(F -Ffinal)/(F initial-Frmal). 
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Figure 3.7: Simulation of a Ca2+ sensitivity curve for SI binding 
to pyrene-actin in the presence of regulatory proteins. Ca2+ -
sensitivity curves are obtained by plotting the kobs values (see figure 
3.6 legend) as a function of pCa The sigmoid curve is fitted to a 
version of the Hill equation and both the Kso% (midpoint of the curve) 
and the h (Hill coefficient) values are obtained. A shift in the Kso% is 
indicative of a change in the Ca2+ -sensitivity of the system. The h 
value is a measure of the degree of cooperativity and is defined by the 
slope at the midpoint. The h value used for this simulation was 1.8 
and the Kso% values were 5.2 (green), 5.6 (black) and 6.0 (red). 
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3 Steady-state measurements using fluorescence titration 
experiments 
3.1 Fluorescence titration experiments 
Fluorescence titration experiments were performed in order to define the parameters for 
the binding of S 1 to actin in the presence of different regulatory proteins when the 
system is either fully ON or OFF. Fluorescence titration experiments were carried out 
on a Perkin Elmer Life Sciences 50B spectrofluorimeter at 20°C. Excitation 
wavelength was 365 nm and emission wavelength was measured at 405 run. The slit 
width for both excitation and emission was 15 nm. The SI (10 J-lM stock concentration) 
was titrated from a 100 fll Hamilton glass syringe by a syringe pump (Harvard 
Apparatus Syringe Infusion Pump 22) at a rate of 12 fll min-I into a constantly stirred 
cuvette. The latter contained 2 mI of 50 nM phalloidin- stabilised pyrene-actin and 
2 flM excess of Tm When titrations were performed in the presence of both Tn and Tm 
proteins, the concentration of each was reduced to 0.2 J.1M as the whole regulatory 
protein complex has a much higher affinity for actin as compared to Tm alone (Wenger 
and Walsh, 1981; Heald and Hitchcock-DeGregori, 1988). The experimental buffer 
used was 20 mM MOPS pH 7.0, 5 mM MgCh, 200 mM KCI (1 mM DTT was added to 
the buffer when Tn was present in the mixture). Binding of SI to actin causes 70% 
quenching of the pyrene fluorescence. Therefore, the change in fluorescence gives a 
measure of the proportion of actin bound to S 1. The fluorescence recording was 
triggered using a contact switch attached to the syringe drive-plate and connected to the 
TTL trigger input of the fluorimeter. The titrations were carried out for a period of 
250 S-1 and data points were collected every 0.5 S-I. The software Scientist was used for 
the plotting and fitting of the obtained fluorescence curves. These were fitted to the 
three-state model equation or to a two-state version of that equation when only Tm is 
bound to actin (see appendix, equations 1.2.2 and 1.2.3). 
Fitting data is achieved by a systematic fitting procedure where the parameters are 
defined and only few of them are allowed to vary (KT, Kl). The best fit is that with the 
lowest standard deviation value from the fit as the n value is varied from 5 to 12. 
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3.2 Steady-state kinetics 
3.2.1 Equilibrium binding reactions 
S 1 binding to actin can be represented by the following reaction 
Kd 
A+Sl< )A.Sl 
The dissociation constant of the reaction K<t = [SI](A]/[A.81], where [SI], [A] and 
[A.Sl] are concentrations of reactants and product at equilibrium. 
K<t = llKass (Kas is the equilibrium association constant) and has units of concentration 
(M). 
Since K<t/[SI] = [A]/[A.Sl], then K<t represents the equilibrium SI concentration at 
which the concentration of free actin equals that of actinS 1 complex i.e. when 50 % of 
actin is bound to S 1. 
Since [A]o = [A] + [A.Sl] and [SI]o = [SI] + [A.Sl] 
Then K<t = ([A]o -[A.Sl])([SI]o-[A.Sl]) / [A.Sl], and the following quadratic equation 
can be derived 
[A.Slf - [ASl] ([A]o + [SI]o + K<t) + [A]o [SI]o = 0 
For the equation: 
ar+ bx+ c= 0 
In this case, x or [A. S 1], is the concentration of actin. S 1 complex at equilibrium. 
x= 
([A]o + [SI]o + Krl)± ~([A]o + [SI]o + KrlY - 4 [A]o[S 1]0 
2 
a the fractional saturation is the fraction of actin that binds to S1. a = [ASl]/[A]o 
Therefore, 
([ A]o + [S 1]0 + Krl) ± ~([A]o + [S 1]0 + Krl Y - 4 [A]o[S 1]0 
a= 2[A]0 
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a is proportional to the quenching of pyrene fluorescence as S 1 binding to actin causes 
fluorescence change (see Figure 3.8). 
Therefore (l = Bound actin/total actin = (Fo-F)/(Fo-Foo) 
([A]o + [SIlo + Kd) ± ~([A]o + [S 1]0 + Kd) 2 - 4[A]o[Sl]o 
F=Fo (Fo-Foo) 
2[A]o 
3.2.2 Experimental conditions 
The concentration of actin (50 nM) was in the range of the Ka for S 1 binding to actin. 
This allowed the observation of hyperbolic binding curves from which the different 
binding isotherms were derived (see append~ equation 1.2.1). The titration of a total of 
250 nM SI (5 times the actin concentration) should saturate the actin filament. 
The system was shown to be in equilibrium as stopping the S 1 titration was followed by 
no further fluorescence quenching (Maytum et ai, 1999). 
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Figure 3.8: A simulation of the change in pyrene fluorescence 
(F) as a function of SI concentrations. The quenching of 
pyrene fluorescence is proportional to the formation of the 
actin.S! complex. The fractional saturation ([A.Sl]/[A]o) is 
therefore proportional to the fluorescence quenching and can be 
represented as (Fo-F)/(Fo-F<XJ)' 
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4 Measurement of protein thermal stability using Differential 
Scanning Calorimetry 
Differerential Scanning Calorimetry (DSC) is a very useful technique for investigating 
the thermal unfolding of protein domains or sub domains either isolated or in complex 
with other proteins (Freire, 1995; Privalov and Privalov, 2000). In this work, we used 
DSC to look at the effect of cardiomyopathy mutations expressed in tropomyosin on the 
stability of the protein both in the presence and absence of actin. 
4.1 Experimental conditions 
Tropomyosin was dialysed into the following experimental buffer 20 mM Hepes, 
pH 7.3, 100 roM KCI, 2.5 mM MgClz. Measurements were performed both in the 
presence and absence of 1 mM f3-mercaptoethanol as the state of oxidation/reduction 
affects Tm thermal stability. Phalloidin-stabilised actin was used each time as it shifted 
the actin melting transition by 20 °C above the Tm melting transition In all cases, actin 
concentration was 46.7 J.1M but Tm concentrations varied depending on the experiment. 
The DSC apparatus used was a differential adiabatic scanning microcalorimeter DASM-
4M (Institute of Biological Instrumentation, Pushchino, Russia) with scanning 
performed at a constant pressure of 152 kPa and a heating rate of I°C minute-I. The 
traces obtained are analysed and plotted using Origin software package. 
The reversibility of Tm unfolding was assessed by heating up to 65 °C to achieve full 
denaturation, then cooling the sample down and scanning again. The protein unfolding 
is said to be reversible if similar transitions are reproduced (similar melting temperatures 
and amplitudes). Performing two heating scans also allows the reduction of Tm 
disulfide bonds. The first heating scan will result in the denaturation of the two Tm 
chains, facilitating the accessibility of the reducing agent (f3-mercaptoethanol in this 
case) to the cysteine residues which allows the protein to be fully reduced. 
4.2 The DSC technique 
Protein unfolding is a heat driven reaction, the heat energy input of the system increases 
when the specific protein melting temperature is reached. DSC is therefore a useful 
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method, not only for providing an insight into protein melting temperatures, but also 
information concerning thermodynamic changes associated with such a process. 
DSC is a calorimetric method that allows the measurement of the heat capacity (Cp) of 
the system of interest. In other words, it allows the investigation of the change in the 
amount of heat energy (f.l W) as a function of temperature eC). Hence the name 
scanning microcalorimeter as, it continuously heats the calorimetric cell at a constant 
rate and measures the heat capacity over a range of temperatures. Scanning calorimeters 
are differential instruments as they measure the difference in heat capacity between two 
identical cells which only differ in their protein content. One of the cells is loaded with 
the protein-containing solution whereas the other one contains the buffer in which the 
protein is found. The difference between the two heat capacities should correspond to 
the protein's heat capacity. This is achieved by sustaining the same temperature in both 
cells and monitoring the difference in power produced by the electrical heater. The 
difference between the power output of the two cells is recorded over a range of 
temperatures. 
The cells are filled with liquid through two capillruy inlets and they are thermally 
isolated from the surroundings to avoid heat loss by thermal shells providing adiabatic 
conditions. Once the cells are filled with the liquid, a small constant pressure is applied 
in order to exclude the presence of any bubbles in the cell which might interfere with the 
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1 Introduction 
1.1 N-tenninal acetylation of tropomyosin 
Most proteins expressed in eukaryotic cells undergo a number of co- and post-
translational modifications, one of which is acetylation of the amino terminal residue 
(Kendall et aI, 1990). The full biological significance of such a process is still an open 
question but it is known that acetylation affects different proteins in different ways. In 
some cases, the loss of an acetyl group decreases the thermal stability of the protein, 
whereas in other cases it decreases the half-life of proteins by increasing their 
susceptibility to proteolytic degradation (Polevoda and Sherman, 2000). 
Acetylation of the N-terminal methionine of tropomyosin is fundamental for the normal 
function of the protein. Tropomyosin expressed in bacteria and which does not undergo 
acetylation is characterised by impaired head to tail polymerisation, weaker actin 
binding and deficient inhibition of acto-myosin ATPase activity (Heald and Hitchcock-
DeGregori, 1988). However, the expression of Tm with a fusion peptide upstream of 
the N-terminal methionine residue was reported to restore the native-like properties of 
the protein Monteiro et al (1994) showed that Tm expressed with the dipeptide Ala-Ser 
fused to its N-terminal end had similar actin binding affinities, head to tail 
polymerisation, inhibition of acto-myosin ATPase and Ca2+ regulation properties as 
those of native, tissue purified Tm. Therefore, it was concluded that the Ala-Ser 
extension was a good substitute for the acetyl group as it restored all the functional 
properties of the protein. 
A likely explanation for this finding can be drawn from the fact that the initiation 
methionine carries no net charge when blocked by acetylation and has a positive charge 
on its amino group when unacetylated. Since methionine occupies position a of the 
heptad, it is involved in making hydrophobic interactions which contribute to the 
formation of the hydrophobic core of the coiled-coil tropomyosin. The presence of two 
protonated amino groups at positions a and a' of the coiled-coil is likely to result in 
repulsive forces which could disrupt the local structure and result in molecule 
dysfunction. The presence of the fusion peptide neutralises that charge by forming the 
amide bond that would normally arise from acetylation A crystal structure of a 
recombinant 81 residue N-domain fragment of Tm revealed a slight opening at the 
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unacetylated N-terminal end which has been shown to be fully helical in the native 
acetylated protein (Brown et aI, 2000). This rmding is consistent with the crucial role 
of acetylation for the normal functioning ofTm 
The ability to produce a modified recombinant Tm with native-like properties is a 
valuable tool as it would permit the expression of different Tm isoforms and introduce 
desired changes potentially useful for the investigation of structure/function relationship 
in Tm. In addition, it would allow the expression of Tm cardiomyopathy-causing 
mutations and examine the effect these have on the function of the molecule. 
Considering the subtle changes in regulation that would arise from small changes in the 
system, it is important to exclude the likelihood that the behaviour noticed IS a 
consequence of differences between recombinant and native protein. 
In order to validate the use of recombinant proteins, we expressed rabbit skeletal u-Tm 
with the Ala-Ser extension at the N-terminal end of the protein in E-coli (referred to in 
the text as recombinant aa Tm (n3), (see chapter 2, section 2.2.2.1). We also purified 
native a-Tm from rabbit skeletal muscle and we carried out a number of measurements 
to compare the behaviour of the two molecules. In this chapter, we determined the 
parameters described in the 3-state model of regulation (chapter 1, section 3.1) in each 
case using both transient kinetic and equilibrium measurements (described in chapter 3, 
sections 2 and 3). We also investigated the thermal stability of the two proteins using 
the DSC technique (chapter 3, section 4). 
The results presented here will show that the recombinant protein is very similar to the 
native one and no significant differences in behaviour could be detected using our 
assays. 
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1.2 Striated tropomyosin isofonns 
Skeletal Tm can be fractioned into two major isoforms, u and 13, which were identified 
when running a preparation of rabbit skeletal Tm on acrylamide gel electrophoresis 
(Cummins and Perry, 1973). Sequence analysis revealed that the two isoforms had the 
same number of amino acids (284). Most of the amino acid differences (25 out of 39) 
are located at the C-terminal part of the protein where the troponin complex binds (see 
amino acid sequence comparison in Figure 4.1) (Male et ai, 1980). Most of the residue 
substitutions between the two isoforms are chemically similar and should not introduce 
major changes in the protein coiled coil structure. Investigating the frequency of 
residue substitution suggested that residues at position a, d, e and g which are crucial for 
the formation and the stabilisation of the coiled coil structure are more conserved than 
those responsible for making interactions with the solvent and other proteins of the thin 
filament (residues b, c, and/). In fact, only one charge substitution out of the total two 
that occur in the 13-Tm happens at position e of the heptad (serine residue in (1-Tm 
replaced by glutamic acid in 13-Tm at position 229). Introducing a negative charge at 
that position is therefore likely to change the local structure of the 13-Tm. Another 
important difference between the two Tm components is the number of Cys groups 
present in each isoform. In a-Tm one Cys residue is found at position 190, whereas two 
such residues are found in p-Tm at position 36 and 190. 
The significance of having two major Tm isoforms has not been established but the 
differential tissue expression of the two components suggests a relationship between 
muscle function and the type of Tm associated with it. It has been reported that the 
ratio of a and 13 Tm varies from one muscle type to another and within the same muscle 
type during development (Amphlett et ai, 1976; Bronson and Schachat, 1982; 
Muthuchamy et ai, 1993). In general, the ratio of u to 13 chains is greater than 1 in fast-
contracting muscles and is close to 1 in slow-contracting muscles (Cummins and Perry, 
1974; Heeley et ai, 1983). Since there is evidence for preferential heterodimer over 
homodimer formation (Lehrer and Qian, 1990), this suggests that fast-contracting 
muscles are likely to contain both au homodimers and up heterodimers whereas the 
slow-contracting muscles are more likely to have mostly ap heterodimers. The 1313 
homodimer is believed to be less stable than the al3 heterodimer and is therefore not 
expected to exist in very large amounts in the muscle cell. 
90 
Chapter 4 Bacterially expressed striated tropomyosin isoforms 
In the cardiac muscle, 0.-Tm, which is identical in its sequence to the skeletal 0.-Tm 
(Lewis and Smillie, 1980), is the predominantly expressed isoform However, while 
completely absent in the heart of small mammals, 13-Tm is present in small amounts (up 
to 20 %) in the slower-beating hearts of bigger mammals. 
Transgenic mice lines have been produced where 13-Tm was over-expressed. These 
mice showed severe cardiac abnormalities that were lethal (Muthuchamy et ai, 1995; 
Muthuchamy et ai, 1998) and were reported to have a significant increase in the Ca2+ 
sensitivity of the cardiac muscle (Palmiter et ai, 1996). 
In this work, the functional differences between the two Tm isoforms were investigated 
in order to gain an insight into the biological significance of having two different Tm 
components. F or this purpose, we expressed the 13-Tm protein with an Ala-Ser 
extension at its N-terminal end (referred to in the text as recombinant 1313 Tm (n3), (see 
chapter 2, section 2.2.2.1)) and we used a number of in vitro assays to compare the 
behaviour of recombinant aa and 1313 Tm. We looked at the binding affinities of the 
two proteins to actin, the ci+ sensitivities in the presence of either cardiac or skeletal 
Tn complex, the thermal stability of the two isoforms in the presence and absence of 
actin and the effect of f3-mercaptoethanol on each. 
The results obtained demonstrated that the 1313 Tm dimer causes an increase in the Ca
2
+ 
sensitivity of the thin filament when associated with cardiac Tn complex. Also, the 
1313 Tm was found to be considerably less stable than the aa Tm dimer. This explains 
why the 13-Tm chain is predominantly found as a heterodimer and mainly in the skeletal 
muscle. 
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Figure 4.1: Sequence comparison between human a and fl Tm ch~s. 
Line 1 and 2 correspond to the amino acid sequence of a and J3 Tm chains 
repectively. The differences in amino acids are highli~ted in black and 
are mostly found at the C-terminaI part of the protem where the .Tn 
complex binds. In line 3 the heptad position of the non-conserved ammo 
acids are indicated. The binding location for both TnT fragments are 
shown. TnT2 is the globular domain of TnT which binds to TnI and 
Tne. TnTl is the TnT tail which binds mainly to Tm and extends to the 
overlap region between two neighbouring Tm. 
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2 Results 
2.1 Assessment of tropomyosin binding to actin 
We analysed the binding of both native and recombinant 0.0. Tm to F-actin using co-
sedimentation assays (see chapter 3, section 1). The ability ofTm to bind and saturate 
actin is reflected by its ability to co-sediment with F -actin during ultra-centrifugation 
and to saturate the F -actin filament at a 1:7 ratio of Tm:actin respectively. Qualitative 
analysis of the protein bands from both pellets and supernatants showed that the 
recombinant 0.0. Tm (n3) was as efficient as the native uu Tm in binding actin with 
saturation achieved at Tm concentrations of about 1.5 J.1M when using 10 J.1M of actin 
(see Figure 3.2 and 3.3). This not only confirmed the previous observations that the 
Ala-Ser (AS) extension restored the ability of the unacetylated Tm to bind actin 
(Monteiro et ai, 1994) but it also indicated that the Tm concentration was accurately 
estimated and that all Tm is properly folded and able to bind actin. 
Quantitative analyses were also carried out in the case of recombinant (l(l and f3f3 
Tm (n3) to compare their binding affinities to actin. Densitometry of the gel bands 
allowed the determination of Tm binding affinities to F-actin as described in chapter 3, 
section 1. The sigmoid binding curves (Figure 3.3), which reflect the cooperative 
nature of the binding, were fitted to a Hill equation Both the midpoint of the curve 
(Kso%) and the Hill coefficient (m) were determined and are shown in table 4.1. Our 
results indicated that no affmity difference exists between the two homodimers 
regardless of their oxidised/reduced state. The measurements were carried out both in 
the presence and absence of f3-mercaptoethanol (ME) (Tm was heated to 65°C in the 
presence of 1 roM ME and the resulting Tm was then assayed for actin binding). The 
effect of reduction was investigated as the thermal stability of Tm is found to be 
sensitive to the oxidation state of the protein (section 2.6 of this chapter). This is 
because a Tm has one Cys residue at position 190 while the f3 Tm has two residues at 
position 36 and 190. 
The affinity values for the two Tm homodimers binding to actin at 100 mM and 
200 roM KCI concentrations are shown in table 4.2. The binding affinities of 
recombinant 0.0. Tm (03) to actin were of the order of 0.2 J.1M and 0.6 J.1M at 100 mM 
and 200 roM salt concentrations respectively. This is comparable to the published 
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0.5 .... M obtained at 150 mM salt concentration The reported data for native au Tm 
binding is also within the same range (Monteiro et aI, 1994). Like with the aa Tm, the 
affinity of the (3(3 Tm at 200 mM KCI also decreased by a factor of 3. Therefore. the 
relative affinities remained the same. 
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au Tm (n3) 
1313 Tm (03) 
Bacteriallyexpressed striated tropomyosin isoforms 
Kso% ± SD (J.LM) 
+ME -ME 
0.16 ± 0.02 
0.27 ± 0.05 




1.3 ± 0.20 2.05 ± 0.66 
1.3 + 0.13 1.6 +0.4 
Table 4.1: Parameters for aa and 1313 Tm (n3) binding to actin. The Tm 
binding curves to actin were generated as explained in chapter 3, section 1 both in 
the presence and absence of 1 mM J3-mercaptoethanol (ME). The buffer 
conditions were 20 mM MOPS, 100 mM KCI, 5 mM MgCh at pH 7.0. The 
parameters obtained from fitting the binding curves to a Hill equation are Kso% 
(the midpoint of the curve) which gives a measure of the binding affinity and m 
(the Hill coefficient). The SD values were obtained using data from three 
independent measurements (N=3). 
100 mM KO 200 mM KCI 
K50"10 + SD (~ m±SD K5O"10 ± SD (~ m±SD 
au Tm (n3) 0.21 + 0.02 2.05 + 0.66 0.58 ±ND 3.35 ±ND 
13(3 Tm (n3) 0.24 + 0.04 1.6 + 0.4 0.60 ±ND 2.80±ND 
Table 4.2: Salt concentration effect on Tm binding aiTmity for actin. A 
three-fold decrease in the affinity of Tm for actin is reported on increasing the 
salt concentration of the buffer from 100 to 200 mM KCI in the case of both 
au and f3f3 Tm (n3). The measurements were carried out in the absence of 
ME. ND stands for not determined. 
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2.2 Assessment of normal tropomyosin function 
The ability of Tm to regulate the binding of 81 to actin was assessed by stopped-flow 
measurements of the rate of 81 binding to a reconstituted thin filament both in the 
presence and absence of Ca2+ (in the presence of either 2 mM CaCb or 2 mM EGT A 
respectively; see chapter 3, section 2.4). The thin filament was reconstituted by mixing 
5 J.1M pyrene-actin, 2 J.1M Tm and 2 J.1M Tn (either phosphorylated human cardiac Tn or 
tissue purified skeletal Tn) to ensure saturation of the filament. Figure 4.2 shows the 
fluorescence transients obtained in the case where pyrene-actin is in a large excess over 
81 (10:1 ratio of actin: 81; see chapter 3, section 2.3.1). 81 binding to actin causes 
quenching of the fluorescence of the pyrene label attached to actin The curves obtained 
were fitted to a single exponential (chapter 3, section 2.2). The superimposed raw and 
fitted traces indicated that pseudo-first order conditions were met. The observed rate 
constant (l<obs) of the reaction (81 binding to actin) was derived from curve fitting and 
the kobs values obtained with different Tm are presented in table 4.3. As previously 
reported, ci+ removal from the system causes a decrease in the rate of 81 binding to 
pyrene-actin. A 3-fold decrease was measured in the presence of skeletal control 
protein complex and a 2 to 2.5-fold decrease was recorded in the presence of cardiac 
control protein complex (control proteins are the tissue purified Tm.Tn complex) 
(McKillop and Geeves, 1993; Head et aI, 1995; Reiffert et aI, 1999). The values 
presented in table 4.3 are comparable to the results obtained with the control protein 
complex and are similar for both native 0.0. Tm and recombinant a.aJ(3(3 Tm (n3). This 
suggests the following: 1) the reconstitution of the different regulatory protein 
components is successful in giving rise to a fully functional regulatory complex, 
2) similarly to the native protein, recombinant Tm binds both skeletal and cardiac Tn 
proteins to form aTm. Tn complex able to function as a mediator of the ci+ -dependent 
regulation of the acto-myosin interaction 
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2.3 Characterisation of the blocked state: 
The observed rate constant for S 1 binding to an excess of actin was determined in the 
presence of native 0.0. Tm, recombinant uu Tm (n3) or recombinant ~~ Tm (n3). S 1 
binds to actin filament both in the presence and absence of Tm with the same rate, 
suggesting that there is no detectable blocked state in the presence ofTm (McKillop and 
Geeves, 1991) (chapter 3, section 2.4.1). It was therefore important to determine if any 
blocked state would be induced by the presence of the Ala-Ser extension in the 
recombinant protein or by switching isoforms. Our results (Figure 4.3) showed that SI 
binds to the actin in the presence and absence ofTm with the same rate (about 5 sec-I) 
regardless of what Tm was associated with actin, suggesting the absence of a blocked 
state. 
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Figure 4.2: Stopped-flow transients for SI binding to a 
reconstituted thin fUament in the presence and absence of 
Ca2+. The thin filament was reconstituted with 2.5 J.1M pyrene-
actin, 1 J.1M Tm and 1 J.1M Tn The thin filament complex was 
pushed against 0.25 J.1M S l. Buffer conditions were 20 mM 
MOPS, 140 mM KCI, 5 mM MgCh, pH 7.0, 1 mM DTT. The 
curves represented in this graph are those of recombinant 
a.a. Tm (n3) in the presence of sk Tn. Fitting these curves to a 
single exponential gave the following kobs rates of 4.35 and 
1.15 S-1 for (+) and (-) Ca2+ respectively representing a 2.9 fold 
decrease. When cardiac Tn was used kobs values were 3.20 and 
1.25 S-1 representing a 2.5 fold decrease in the rate. The results 
for the native a.a. Tm protein were very similar. The results 
with reconstituted thin filament were also very similar to those 
obtained with tissue purified control protein complex. 
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!cobs KB 
skTn cTn 
+Ca2+ _CaLi +CaZ+ _CaZ+ skTn cTn 
Native a.a. Tm 4.50 1.20 3.40 l.25 0.35 0.55 
a.a.Tm (n3) 4.35 1.15 3.20 l.25 0.35 0.66 
66 Tm (n3) 4.55 1.10 3.35 1.15 0.33 0.55 
SkTm 4.50 1.35 2.85 1.10 0.42 0.60 
Table 4.3: KB measurements of Sl binding to regulated actin filaments. The Ks 
measurements were carried out in the presence of different Tm isofonns (nn (both 
native and recombinant), recombinant ~~ Tm (n3) or mixed nn and n~ (skTm» and 
either tissue purified rabbit skeletal or recombinant human Tn. The Ks value was 
calculated using the equation kobs (-Ca2+)lkobs (+Ca2j=KsI(l+Ks) (Chapter 3, section 
2.4.1). The experimental conditions were as described in Figure 2 legend. In the 
presence of tissue purified control protein com~lex (sk Tm Tn complex) the koos 
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native 0.0. Tm 
0.0. Tm (n3) 
(3@ Tm (n3) 
Time (s) 
5.35 ± 0.09 
5.30 ± 0.38 
5.30 + 0.44 
Figure 4.3: Stopped-flow transients for SI binding to actin 
either in the presence of native 0.0., recombinant au Tm (n3) 
or recombinant (3(3 Tm (n3). 2.5 J.LM pyrene-actin and 1 J.1M Tm 
were pushed against 0.25 f.lM S 1. The buffer conditions were 
20 mM MOPS, 140 mM KCI, 5 mM MgCh, pH 7.0. The curves 
were fitted to a single exponential. Both the raw (continuous) and 
fitted (dashed) curves are shown. In the table are shown the 
observed rate constants (kobs) obtained from curve fitting. These 
are averages of 3 independent measurements. The rate of S 1 
binding to actin in the absence ofTm was also about 5 S·l . 
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2.4 Determination the three-state model parameters: 
The parameters that describe the three-state model of regulation (chapter!. section 3.1) 
were determined for each Tm in order to determine whether the affinity of S 1 for actin 
(Kl value), the position of Tm on actin at equilibrium (KT value) as well as the 
cooperative unit size (n value) are affected by 1) the N-terminal extension of the 
recombinant Tm (by comparing native 0.0. Tm with recombinant 0.0. Tm (n3)), 2) the 
presence of a (3 component (by comparing pure 0.0. with mixed 0.0. 0.(3 (sk Tm which 
had a ratio of 3: 1 of a to (3 chains corresponding to a 1: 1 ratio of au and up Tm)). 
Figure 4.4 shows the raw data of a titration curve for the binding of SI to actin in the 
presence of recombinant 0.0. Tm (n3). The titration of very low actin concentrations 
(50 nM) with s 1 required the use of phalloidin to stabilise the actin in the filamentous 
form (F-actin). The use of phalloidin does not affect the affinity ofSl for actin (Criddle 
et aI, 1985). As shown in the figure 4.4, working at 50 nM actin provided a high 
enough concentration to obtain a reasonable fluorescence signal with relatively low 
levels of noise. The initial fluorescence value (Fo) was about 350 fluorescence units 
with normally about 5 % variations. The Fro value obtained from the fit is 112 and 
corresponds to 68 % fluorescence quenching. Since binding of S 1 to pyrene-actin 
results in 70% fluorescence quenching, this is consistent with there being no substantial 
background fluorescence in the buffer. 
The affinity of Tm for actin under our experimental conditions (200 mM KCI 
concentration) was determined by co-sedimentation experiments to be at about 0.6 JlM 
(Table 4.2). Consequently, the presence of a large excess of 2 JlM Tm in the cuvette 
ensures actin filament saturation. The SI binding curves in the presence ofTm are of a 
sigmoid nature reflecting the cooperative binding of S 1 to the filament. The S I-actin 
binding curves were fitted to a 2-state version of the 3-state model equation (see 
appendix, equation 1.2.3). This is because no blocked state was detectable in the 
stopped-flow measurements when only Tm is bound to actin (see previous section). 
The filament is in equilibrium between closed and open states (less than 10 % blocked 
state) and therefore the Ks value is excluded from the equation. Considering the 
complexity of the equation and the number of parameter escribe it, the fitting can 
~EN'" 
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only be carried out by fixing few parameters with either known or independently 
determined values (total actin concentratiOl\ K2, Fo and n) and systematically varying 
the other parameters (Kl, KT and F~). For instance, the K2 value (the equilibrium 
constant for the isomerisation from weakly to strongly bound acto-S 1 complex) was 
previously determined to have a value of200 in the absence of nucleotide (Coates et ai, 
1985). Fits were repeated for a range of n values (n varied from 6-12 and was fixed 
each time). The best fit was the one that offered the lowest deviation from the raw data 
(Table 4.4) (Maytum et aI, 1999). 
Figure 4.5 represents the binding curve of S 1 to actin when bound to either recombinant 
pure 0.0. Tm (n3), native pure au Tm or to native sk Tm (mixed 0.0. and o.J3 dimers). 8 
curves were analysed in each case. The best fit parameters for each curve were 
averaged and are shown in Figure 4.5 table. In all cases, the best fit was obtained for an 
n value of 7 -8. The Kl, KT values for both native and recombinant 0.0. Tm were very 
similar ranging between 145-150xl03 M-1 and 0.075-0.08 respectively. In the presence 
of sk T~ SI was found to bind with a significantly higher affinity (Kl is 185xl03 M-1 
for sk Tm and 150 x 103 M-1 for 0.0. Tm) as revealed with a statistical analysis using the 
student T -test at p=O. 05. The KT value was however not affected by the presence of the 
J3 component of Tm on actin. 
These results suggest that the type of isoform that makes up the Tm dimer does not 
affect the equilibrium position of Tm on actin but does increase the binding affinity of 
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Figure 4.4: Raw titration data for SI binding to pyrene-
actin in the presence of recombinant aa Tm (n3). S 1 was 
continuously titrated into a stirred cuvette that contained 50 nM 
pyrene-actin and an excess of 2 J.LM Tm. S 1 binding was 
monitored by fluorescence quenching. The measurements were 
carried out at 20°C and the buffer was 20 mM MOPS, pH 7.0, 
200 mM KCI, 5 mM MgCh. 
n 6 7 8 9 10 11 12 
SD 0.92 0.66 0.51 0.52 0.60 0.85 1.2 
KT 0.17 0.125 0.09 0.68 0.05 0.04 0.028 
KI (x103) 165 158 153 150 148 140 135 
Table 4.4: Fitting of SI titration curves over a range of n 
values. The fitting of S 1 titration curves is achieved by varying 
the n value from 6 to 12. The best fit parameters are those obtained 
with the lowest standard deviation (SD) value (highlighted in bold). 
The data shown in the table is that of a curve obtained in the 
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native aaTm 
100 
145 ± 25 
150 ± 20 
185 + 20 
150 200 
[S1] nM 
200 0.075 ± 0.02 
200 0.08 ± 0.03 






Figure 4.5: SI binding curve to actin in the preseoce of either 
native aa Tm, recombinant 0.0. Tm (03) or sk Tm (mixed 0.0. and 
ap Tm). The curves were fitted to a 2-state version of the McKillop 
and Geeves 3-state model equation The raw (continuous) and fitted 
(dashed) data are superimposed. F or ease of comparison, the data was 
normalised to 1.0 (F-Foo)/(Fo-FaJ. The parameters obtained from 
curve fitting are represented in the table. Kl and K2 are the 
equilibrium constants for weak and strong 81 binding to actin 
respectively (81 affinity for actin is KIK2). KT is the equilibrium 
constant for the transition between closed and open states of the 
filament. n is the cooperative unit size (the number of actins that 
switch between the two states of the filament) . The K1, KT and n 
values represented are averages calculated from analysing 8 curves 
(N=8). 
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2.5 Measurement of the calcium sensitivity of the system 
The rate of S 1 binding to actin is a Ca2+ -dependent reaction as it is proportional to the 
number of actin sites available for S 1 binding which in its turn is dependent on whether 
TnC is Ca
2
+-bound or free (chapter 3, section 2.4). Sl binding to pyrene-actin at 
different Ca
2
+ concentrations (pCa) is therefore a good assay for investigating the Ca2+ 
sensitivity of the system under different conditions (Figure 3.7). 
Figure 4.6 and 4.7 represent Ca2+-sensitivity curves for SI binding to pyrene-actin in the 
presence of recombinant 0.0. Tm (n3) or recombinant J3J3 Tm (n3) bound to either sk Tn 
or cTn. The sigmoid curves were fitted to a Hill equation and both the midpoint of the 
curve Kso% (which reveals the Ca2+ concentration at which filament switching from the 
ON to OFF state takes place) and the Hill coefficient h are represented in the figure 
tables. The data obtained is of good quality as the data points have low scatter from the 
fitted curve. Also, the standard error (SE) obtained from the fit is within the same range 
for each parameter in each set of experiment. The differences between the two Tm 
homodimers were observed in terms of a shift in the Ca2+ -sensitivity curve midpoints. 
Interestingly, a 0.23 pCa shift (curve midpoint shift from pCa 5.57 to pCa 5.80) 
corresponding to 1.10 flM shift in Ca2+ concentration from 2.69 JlM to 1.58 JlM, was 
observed in the case of J3J3 Tm but only when bound to cTn complex. No difference in 
Ca2+ -sensitivity was observed between the two isoforms in the presence of skTn 
Unlike skTnC which has two functional Ca2+ -binding sites, cTnC has only one. This is 
reflected by the h value of 1.0 in the presence of cardiac Tn complex and the much 
higher value of 1.7 in the presence of skTn. Therefore, this result is compatible with 
each Tn complex operating independently. 
This experiment was repeated with proteins from different preparations and with the 
same pCa solutions to minimise the error that could potentially arise from variations in 
Ca2+ concentrations. The results were reproducible as the same pCa shift is reported 
each time. 
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P(3 Tm (n3) 
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Figure 4.6: Cal + -sensitivity measurements for SI binding to 
pyrene-actin in the presence of either aa Tm (n3) or (3(3 Tm 
(03) and sk Tn. The Ca2+-sensitivity curves were obtained by 
plotting the kobs values for S 1 binding to pyrene-actin as a function 
of pC a (see chapter 3, figures 6 and 7). The curves were fitted to a 
Hill equation to determine both the midpoint of the curve (Kso%) 
and the Hill coefficient (h). Parameters obtained from curve 
fitting are shown in the table above. The standard error (SE) was 
obtained from fitting the data shown in this graph. 
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0.0. Tm (n3) l.15 ± 0.09 5.57 ± 0.08 2.69 
@@ Tm(n3) l.20 + 0.10 5.80 + 0.07 l.58 
Figure 4.7: Ca2+ -sensitivity measurements for 81 binding to 
pyrene-actin in the presence of either 0.0. Tm (03) or 1313 Tm 
(03) and cTo. The data was obtained and analysed as explained in 
Figure 6. The presence of 1313 Tm (n3) caused a 0.3 pCa shift in the 
midppoint of the curve. The midpoint values of the curves are also 
shown in Ca2+ concentration 
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2.6 Protein thennal unfolding using DSC: 
The thermal stability of native 0.0., recombinant 0.0. Tm (n3) and recombinant 
J3J3 Tm (n3) was assessed both in the presence and absence of actin. The effect of 
disulphide bridge reduction by J3-mercaptoethanol (ME) was also investigated. 
The 0.-Tm chain contains one Cys residue at position 190 (C-domain of the protein), the 
J3-Tm chain on the other hand has two Cys residues, at positions 190 and 36 (C- and N-
domains respectively) (see Figure 4.1 for sequence). In all cases, these Cys residues 
occupy position a of the heptad, and since the two Tm chains are parallel and in register, 
they can be cross-linked by the formation of a disulphide bond under oxidising 
conditions. That would potentially give rise to a single cross-linked 0.0. Tm dimer or 
either a single or a double cross-linked J3J3 Tm dimer. 
As previously demonstrated by Williams and Swenson (1981) the unfolding of the C-
domain part of an Tm is sensitive to the oxidation state of Cys 190. This was verified 
by using strong oxidising agents, chemically blocking the SH-groups of Cys 190 
(equivalent to the reduced state of the protein) and producing N- and C-domain 
fragments of Tm. All these modifications showed that when the SH-groups are 
blocked, two melting transitions are obtained. However, when Tm is oxidised only the 
high temperature transition is seen The use of the N- and C-domain fragments 
confirmed that the presence of a disulphide bond at the C-domain of Tm stabilises the 
protein and causes a shift of the low temperature transition into the high temperature 
transition. Therefore, under oxidising conditions, the N- and C-domain transitions 
overlap. The low-temperature transition was assigned to the melting of the C-domain 
with reduced Cys 190, whereas the high-temperature transition was assigned to the 
melting of both the C-domain with oxidised thiol groups and the N-domain ofTm. 
Figure 4.8 shows the melting profile of recombinant 0.0. Tm (n3) in the absence of ME. 
Two separate melting transitions were observed during the first heating with maxima at 
42°C and 54 °C. During the second heating, the low temperature peak completely 
disappeared and only the 54°C peak was observed. In the presence of 1 roM ME 
(Figure 4.9) two melting transitions were also observed during the first and second 
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heating. However, the size of the two peaks was altered. A reduction in the size of the 
higher temperature peak (maximum at 52°C) and an increase in the size of the lower 
temperature peak (maximum at 42 °C) were recorded. This finding is in good 
agreement with the explanation proposed by Williams and Swenson (1981). The low-
temperature peak corresponds to the melting of the C-domain of the protein with 
Cys 190 reduced. The second high-temperature peak is composed of two overlapping 
transitions: the melting transition of the protein N-domain and that of the C-dornain 
with cross-linked thiols of Cys 190. Therefore, when Tm becomes reduced after the 
first heating in the presence of ME, there is a shift of the higher temperature peak to the 
lower-temperature peak. This explains the increase in the size of the first peak and the 
reduction in the size of the second peak. This was further confirmed by measuring the 
thermal unfolding of C190S Tm mutant, which mimics the reduced state of the protein 
(data not shown). 
In the presence of phalloidin-stabilised actin, three heating steps were performed. First, 
the sample was heated up to 65°C to reversibly denature Tm and allow the reduction of 
Cys 190 residues. In this case, actin remains intact as its melting transition is at 80°C. 
After cooling to 5°C, the sample was heated again to 90°C resulting in the irreversible 
denaturation of actin. The third heating was to 65 °C and should give results similar to 
that of reduced free Tm. 
Figure 4.10 describes the DSC profile of recombinant ua Tm (03) in complex with F-
actin. A new sharp transition with maximum at about 47°C was observed. During the 
third heating and after irreversible denaturation of actin, only the peaks corresponding 
to the thermal unfolding of free Tm (42°C and 52°C) were observed. This indicated 
that the new transition at 47°C obtained in the presence of actin reflects the thermal 
denaturation of actin-bound Tm. As explained above, the reduction in the size of the 
most thermostable peak in the second heating is due to the reduction of Cys 190 groups. 
Comparing the size of peaks of the fully reduced free Tm (third heating) with those 
from the second heating (i.e. in the presence of actin) suggests that only the first thermal 
transition (the one corresponding to the melting of reduced C-domain of Tm) IS 
sensitive to the presence of actin 
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The thermal unfolding of native uu Tm obtained from rabbit skeletal muscle was very 
similar to that of recombinant uu Tm (03) both in the presence and absence of actin. 
The comparison was made in terms of maximum temperatures of the melting transitions 
and the response to reduction by ME. 
Figure 4.11 shows the thermal unfolding of recombinant ~~ Tm (03) both in the 
presence and absence of 1 mM ME. Tm samples will have a mixture of oxidised and 
reduced molecules, as the state of the Tm molecule will vary depending on the sample 
history. Because ~-Tm has two Cys groups located both at the C- and N-domains, a 
mixture of single/double cross-linked or fully reduced molecules can arise. The first 
heating, which will either reduce or oxidise Tm depending on conditions (presence or 
absence of ME), will give different melting profiles for different samples. Therefore, 
for ease of interpretation only the second heating is shown. In the case of ~~ Tm, two 
melting transitions were obtained at 37 °C and 52 °C. The size of the lower temperature 
peak was bigger in the presence of ME, and the size of the higher temperature peak 
bigger in the absence of ME. 
Figure 4.12 represents the thermal unfolding of ~J3 Tm (03) in complex with F-actin in 
the presence of 1 mM ME. As with uu Tm, a new sharp transition, corresponding to 
the melting of actin-bound Till, was observed but in this case at about 41 0c. 
Interestingly, the third heating, which corresponds to the melting of reduced free Tm, 
had only one transition at 37 °C. The high temperature transition at 52 °C completely 
disappeared. 
By analogy with the au Till, the high temperature peak at 52 °C should correspond to 
the melting of the more stable oxidised domains, whereas the low temperature transition 
should correspond to the melting of reduced domains. Since the higher temperature 
peak completely disappeared after the third heating with actin (Figure 4.12), it 
suggested that 1) ~J3 Tm unfolds as a single transition at 37 °C when fully reduced, 2) 
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Figure 4.8: DSC profile of aa Tm (03) io the abseoce 
of ME. 20 fJM Tm present in 20 mM Hepes, 100 mM 
KCI, 2.5 mM MgCh, pH 7.3 was scarmed twice at a 
constant heating rate of 1 °C min-I. The first heating 
(black line) shows the presence of two melting 
transitions with maxima at 42°C and 54 °C. The second 
heating (red line), shows the complete disappearance of 
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Figure 4.9: DSC melting profile of recombinant aaTm 
(03) in the preseoce of ME. Experimental conditions used 
were the same as desribed in Figure 4.8 legend except for 
the presence of 1 mM ME. Tm concentrarion used was 
30 J.1M. The first scan (black) shows the presence of two 
melting transitions with peaks at 42°C and 52 °C. The 
second scan (red), shows an increase in the size of the first 

















20 30 40 50 60 70 
Temperature (0C) 
Figure 4.10: DSC melting profile of recombinant au Tm 
(n3) in complex with F-actin. The complex was obtained by 
mixing 30 f.1M Tm with 46. 7 ~M phalloidin-stabilised actin. 
Experimental conditions used were the same as desribed in 
Figure 4.8 legend except for the presence of 1 mM ME. The 
mixture was first heated to 65°C (black), then to 90 °C (red) 
and finally to 65°C (green). The actin melting transition with 
maximum at 80 °C is not shown. In the presence of actin, a 
new sharp peak at 47°C appeared. The peaks were at 42°C, 
47°C and 52°C. 
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Figure 4.11: DSC melting profile of PP Tm (n3) both in the 
presence and absence of ME. 30 JlM of f3f3 Tm (n3) was 
scanned twice up to 65°C both in the absence (black) and 
presence (red) of 1 mM ME. The buffer conditions were as 
described in Figure 4.8 legend. In both cases only the second 
heating is considered for ease of analysis (see text) Two main 
melting transitions were observed with values for maximum 
melting temperatures at 37°C and 52 °C. 
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Figure 4.12: DSC melting profile for recombinant f3f3 Tm 
(03) in the preseoce of actin. The complex was obtained by 
mixing 15 J.LM f3f3 Tm (n3) with 46.7 f.1M phalloidin-stabilised 
actin. Experimental conditions used were the same as desribed 
in Figure 4.8 legend except for the presence of 1 roM ME. 
Three heating scans were performed, the first to 65°C (black), 
the second to 90 °C (red) and the third to 65°C (green). 
Maximum melting temperatures are 36 °C, 41°C and 53 °C. 
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3 Discussion 
Comparing the regulatory and thermal properties of native and recombinant au Tm 
using a wide range of techniques revealed the similar behaviour of these two proteins. 
The binding affinities for actin and the ability to mediate the Ca2+ -dependent regulation 
of muscle contraction were comparable in both cases. The affinity of Sl binding to 
actin in the presence of either protein was indistinguishable and so were the equilibrium 
constants (Ks and K T), which describe the position of Tm on actin. The DSC melting 
profiles for both proteins were identical in terms of maximum melting temperatures and 
the ability to unfold reversibly and so was the response to ME. 
It can therefore be concluded that the expression of an Ala-Ser (AS) extension is 
efficient in substituting for the lacking acetyl group without interfering with the normal 
function of the protein. This is in good agreement with the conclusions published in the 
Monteiro et al paper (1994). 
The data obtained from comparing the regulatory properties of a and f3 Tm isoforms 
clearly suggests that significant differences in the properties of the thin filament would 
arise by switching between aa and f3f3 Tm. The f3f3 Tm, if existent in the cell, is found 
in very small amounts. The f3 Tm chain is found mainly associated with the a Tm chain 
as a heterodimer, mostly in slow contracting muscles and in slower beating hearts of big 
mammals (Cummins and Perry, 1974; Heely et aI, 1983). This is not surprising as the 
thermal unfolding profiles obtained with DSC noticeably suggest that f3f3 Tm is 
thermally less stable than the aa Tm. f3f3 Tm protein is unstable at 37°C, the normal 
temperature of the body. Though, binding to actin stabilises the protein by shifting the 
maximum melting temperatures by SoC to 41-42 °c, it is still a temperature that the 
muscle can reach during exercise. Tn complex is reported to provide additional stability 
to Tm (Kremneva et aI, 2003). However, prior to control protein assembly and binding 
to actin, the f3f3 Tm will be unstable in the cytoplasm especially if the cellular 
environment is reducing (Hwang et aI, 1992). In the future, it will be important to study 
the thermal unfolding of the physiologically more relevant af3 Tm heterodimer as it is 
abundant in the skeletal muscle. The aJ3 heterodimer production and characterisation 
was not possible due to time limitations. 
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In the presence of actin, the thermal stability of Tm is increased, notably that of the low 
temperature melting transition (5°C shift is observed for both aa and ~~ Tm). The 
high temperature melting transition is unaffected by the presence of actin. The 
temperature at which Tm dissociates from actin under condition similar to those of the 
DSC second heating was investigated by Kremneva and Levitsky (Bach Institute of 
Biochemistry, Moscow). The results obtained showed that aa Tm dissociates from 
actin at 46.4 °C whereas ~J3 Tm dissociates at 40.5 °C (data not published). This 
finding explains why only the low temperature transition is sensitive to the presence of 
actin, as the N-domain and the cross-linked C-domain unfold at a temperature higher 
than that of Tm dissociation from actin. The sharp character of the actin-induced 
transition can be explained by the cooperative dissociation of Tm from actin being 
simultaneously followed by unfolding of the reduced C-domain. The low temperature 
transition was still observed in the presence of actin because Tm was in large excess. It 
therefore represents the melting of reduced C-domain of non-actin bound Tm. 
The DSC experiments performed on the two Tm homodimers were very useful in giving 
an insight into the thermal stability properties of the two proteins. However, an 
appropriate comparison of the melting profiles was made difficult by the fact that the 
measurements are sensitive to the oxidised/reduced states of the starting protein 
samples. To facilitate the analysis, future experiments should be conducted with 
homogeneous samples. This can be achieved by either fully reducing (heating up to 
650C in the presence of strong reducing agents like DIT) or fully oxidising Tm 
samples prior to the start of the experiments. 
The distribution between the three states of the thin filament is not affected by the type 
of Tm isoform bound to actin Both KB (measured in the presence of either skTn or 
cTn) and KT values were very similar for both aa and ~~ Tm dimers. The Ks value 
was however larger when Tm was bound to cTn (Table 4.3). This would suggest that 
the proportion of actin sites not available for S 1 binding is smaller in the cardiac system 
when the muscle is relaxed as compared to the skeletal system. Therefore the cardiac 
system is less off than the skeletal system, which is consistent with its function as it 
constantly beats and hence does not relax for a long period of time. 
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The equilibrium measurements revealed that the presence of the ~ component in T~ as 
opposed to pure 0,0, Tm, resulted in a significant increase in the binding affinity of S 1 
for actin. It has already been established that the affinity of S 1 for actin was enhanced 
in the presence of Tm (Maytum et ai, 1999; Tobacman and Butters, 2000). Two 
different explanations were put forward by these two groups. Tobacman and Butters 
speculated that a conformational change in actin induced by Tm movement, promotes 
the S I-actin interaction. Maytum et al on the other hand, speculated that electrostatic 
interactions between S 1 and Tm would favour S 1 interaction with actin. Both these 
hypotheses can be accounted for by the difference in amino acid sequence between the 
a and ~ Tm chains. 
The constants for the S 1 binding reaction to actin in the presence of Tm were defined by 
both kinetic and equilibrium measurements. The binding rate constant, measured with 
stopped-flow, is unchanged (kobs is about 5 sec-l) in the case of both aa and ~~ Tm 
However, the overall affinity of SI binding to actin (Kl value) is higher in the presence 
of the ~ component of Tm. This indicates that the two different Tm isoforms affect the 
dissociation rate constant of S 1 for actin. This could be confirmed by measuring the 
ATP-induced dissociation of S 1 from an actin filament both in the presence and absence 
ofTm in the stopped-flow machine. 
Earlier studies (Palmiter et ai, 1996) demonstrated that a to ~ Tm isoform switching in 
the mice heart altered the Ca2+ -induced activation of the thin filament. An increase in 
Ca2+ sensitivity of the thin filament results in activation of muscle contraction occurring 
at lower free Ca2+ concentrations. The Ca2+ sensitivity measurements carried out with 
isolated proteins in solution reinforce the idea of a change in ci+ sensitivity as a result 
of a change in Tm isoforms. We report an increase in Ca
2
+ sensitivity in the presence of 
the ~~ Tm. Interestingly, this finding is only valid when Tm is in association with 
cardiac Tn complex. This shows that the presence of ~~ Tm in the cardiac muscle 
would render the thin filament more sensitive to Ca2+ i.e. contraction would still happen 
at C~+ concentrations at which the filament should normally be turned off. 
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A change in the Ca2+ sensitivity of muscle can be linked to either a change in the 
affinity of Ca2+ for TnC, or to an alteration in the inhibitory action of Tn! (due to 
changes in the nature of interaction between Tn. Tm and actin). Binding of Ca2+ to TnC 
has been reported to decrease the affinity of the Tm. Tn complex to actin. This effect 
has been reported to be more significant in the skeletal system as compared to its 
cardiac counterpart (Rosenfeld and Taylor, 1985; Dahiya et aI, 1994). This is consistent 
with the results presented in this chapter. The midpoint of the Ca2+ sensitivity curve 
obtained with the reconstituted skeletal complex (a.a. Tm in complex with skTn) is at 
pCa 6.0 (corresponding to a midpoint ci+ concentration of 1 fJM) whereas that 
obtained with the cardiac complex (aa Tm in complex with cTn) is at pCa 5.6 
(corresponding to a midpoint Ca2+ concentration of 2.5 J.1M). This suggests that more 
Ca2+ has to be removed from the system for the skeletal muscle to be turned into the 
OFF state. This could be linked to the greater effect Ca2+ has on Tn. Tm and actin 
interactions in the skeletal muscle. Therefore, the nature of interactions between the 
thin filament regulatory proteins could influence the Ca2+ -dependent filament switching 
from ON to OFF states. 
The Ca2+ sensitivity curve for J3J3Tm is identical to that of a.a. Tm when both bound to 
skTn but shifted when bound to cTn. This could be attributed to cTn interacting 
differently with different Tm isoforms. TnT subunit of Tn is an important player in the 
Ca2+ -mediated regulation of muscle contraction (Potter et aI, 1995). TnT is responsible 
for holding the whole Tn-Tm complex together. Tm binding to TnT happens mainly 
through the TnT1 region of the protein but it is the TnT2 region that interacts with the 
TnI-TnC components of Tn. Most of the sequence differences between the 20 different 
TnT isoforms occur at the N-terminal part of the protein (TnTI region) (Perry, 1998 for 
review). This hypervariable region of TnT is therefore likely to provide fimctional 
modulations, which could account for the differences that arise between the different 
muscle systems. It would therefore be interesting to compare the binding properties of 
f 2+ cTnT to both aa and J3J3 Tm, in the presence and absence 0 Ca . 
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1 Introduction 
Familial Hypertrophic Cardiomyopathy (FHC) is a genetic disorder caused by mutations 
in sarcomeric proteins. So far, four of these mutations (A63V, K70T, D175N and 
E 180G) have been found to arise in the a-Tm gene making up 5 % of all reported 
mutations (Thierfelder et ai, 1994; Nakajima-Tanigushi et ai, 1995; Watkins et ai, 
1995). The two mutations D 17 5N and E 180G have been of a particular interest over the 
last few years probably due to their location in the TnT binding region of Tm, more 
precisely the Ca2+-sensitive TnT region Residues 175 and 180 of the a-Tm chain are 
found at positions g and e of the heptad respectively. They could therefore be involved 
in either intra- or inter-chain salt bridge formation In both cases, the mutation leads to 
the substitution of a charged residue with a non-charged one, and in the case ofE180G, 
it results in the introduction of a small residue (glycine) also known as a helix breaker. 
Consequently, considering the nature of the changes and the position at which they 
occur, both within the helix heptad and relative to the location of the Tn binding site, it 
is not surprising that these two mutations have been reported to alter the normal 
function of the thin filament (Golistina et ai, 1997; Coviello et ai, 1997; Bottinelli, 
1998; Bing et aI, 1997; Bing et ai, 2000). Studies on transgenic mouse lines that encode 
these FHC mutations showed that while D 17 5N mutation causes mild hypertrophy 
(Muthuchamy et ai, 1999), E180G mutation leads to severe cardiac dysfunction and 
death in mice (prabhakar et ai, 2001). This suggests that the E180G mutation is more 
disruptive than the D 17 5N mutation. These two FHC mutations are also in the vicinity 
of Cys 190 whose state of oxidation has been demonstrated to be crucial for determining 
the stability ofTm (see chapter 4, section 2.6). 
In this study, the effects of the two FHC mutations DI75N and EI80G on I) the ability 
of Tm to bind actin, 2) the thermal stability of Tm both in the presence and absence of 
actin, and 3) the Ca2+ -sensitivity of the system were investigated. Both WT and FHC 
mutant aa Tm were overexpressed in E.coli (chapter 2, section 2.2.3) with the N-
terminal extension (Ala-Ser referred to as the n3 extension) that mimics the N-terminal 
acetylation (Monteiro et ai, 1994) (also see chapter 4). The results obtained showed that 
both D175N and E180G decrease the affinity of Tm for actin and cause an increase in 
the Ca2+ -sensitivity of the thin filament but with a more significant effect from E 180G 
mutation Also, the actin-induced stabilisation of E180G Tm, as measured with DSC, 
1?0 
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was found to be significantly less than for WT and D 17 5N Tm. This could therefore 
explain why the E180G mutation has more dramatic consequences on the heart's 
function 
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2 Results 
2.1 Effect ofFHC mutations on tropomyosin binding to actin 
The binding of recombinant aa. Tm (n3) carrying the FHC mutations DI75N and 
E 180G was investigated using co-sedimentation assays (chapter 3, section 1) both in the 
presence and absence of ME. This is because reduction of Cys 190 residues is found to 
have an effect on Tm thermal stability and could potentially affect Tm ability to bind 
actin 
Figure 5.1 shows plots of the cooperative binding curves of different Tms to actin. The 
binding parameters i.e. the Tm concentration at which half of actin filaments are 
saturated (K50%) and the Hill coefficient m, were obtained by fitting the curves to a Hill 
equation. The parameter values are shown in Figure 5.1 table. The K50% values 
obtained were 0.18 f.lM for WTaa Tm (n3), 0.51 f.lM foraaD175N Tm (n3) and 
0.68 f.lM for aa E180G Tm (n3). The relative affinities remained the same when 
measured at 200 mM KCI concentration as the three affinities decreased by a factor of 3 
(data not shown). This indicates that both mutations cause a decrease in the affinity of 
Tm binding to actin with a greater effect in the case ofEI80G mutation. The m value, 
which reflects the cooperative nature of the binding, is also affected by the two FHC 
mutations. The m value appears to be inversely proportional to the affinity of Tm for 
actin and is increased from l.5-2 in the case ofWT aa Tm (n3) to 2.5-3 and 3.5-4 in the 
case of aa DI75N Tm (n3) and aa. E180G Tm (n3) respectively. A change in the m 
value indicates a change in the cooperativity of the Tm binding to actin 
In order to investigate the effect of Tm reduction on the binding to actin, a sample of 
each of the three Tm was heated to 65°C in the presence of 1 mM ME. The resulting 
Tm was then assayed for actin binding as detailed in chapter 3, section 1. No detectable 
change on the affinity for actin was apparent in the case of each Tm (see Figure 5.1 
table). 
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[Free Tm] J.tM 
Kso% (~) m 
aa Tm (n3) -ME 0.18 1.98 
+ME 0.14 1.40 
aa DI75N Tm (n3) -ME 0.51 2.98 
+ME 0.44 2.53 
a.a E180G Tm (n3) -ME 0.68 3.95 
+ME 0.59 3.31 
Figure 5.1: Binding curves of tropomyosin to actin. The binding ofWT 
recombinant aa Tm (n3) (black) and its FHC mutants aa DI75N Tm (n3) 
(red) and a.a EI80G Tm (n3) (green) to actin was investigated using co-
sedimentation assays. The experiment details are outlined in chapter3, 
section I. The curves are fitted to a Hill equation and the values obtained for 
both the Kso% (the concentration of free Tm at which half actin is saturated) 
and m (the Hill coefficient) are shown in the table. 
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2.2 Effect of FHC mutations on tropomyosin thennal stability 
The two FHC mutations D175N and E180G result in the substitution of residues which 
could be involved in stabilising the coiled coil structure. These two residues are also 
possibly involved in interacting with actin and Tn. Therefore, the stability of Tm and 
the Tmactin complex in the presence of such mutations could be significantly affected. 
We applied the DSC technique (chapter 3, section 4) in order to investigate the thermal 
unfolding properties of these proteins when free and bound to actin 
Figure 5.2 shows the DSC curves obtained for a.a D175N Tm (n3) and 
0.0. E180G Tm (n3) in the absence of ME. Only the second heating is shown (when the 
protein is believed to be fully oxidised), as the first heating was variable depending on 
the sample history. In the absence of ME, both proteins showed a melting proftle 
similar to that obtained with WT a.a Tm (03) (Figure 4.8), except for the presence of a 
small thermal transition at 35°C for 0.0. D175N Tm (n3) and 26°C for 
a.a E180G Tm (03). Since these low-temperature transitions were not observed in the 
WT protein, they could therefore be assigned to the melting of the mutation-containing 
region ofTm. The E180G mutation therefore appears to have more destabilising effect 
compared to D 17 5N mutation. 
Figure 5.3 shows the thermal melting obtained from the second heating of 
0.0. D175N Tm (03) in the presence of ME. As with the WT 0.0. Tm (n3) (Figure 4.9), 
two melting transitions were obtained. The first peak at 42°C corresponds to the 
melting of the C-domain of Tm with reduced Cys 190, the second peak at 52°C is 
attributed to the melting of the N-domain part of Tm as well as the C-domain part with 
oxidised thiol groups (see chapter 4, section 2.6). The small transition at 35°C can still 
be seen as a shoulder to the 42 °c peak. Interestingly, the 0.0. E180G Tm (n3) under the 
same conditions showed a very small transition at 38°C combined with the loss of the 
low temperature transition at 26 °c (Figure 5.4). 
These results suggest that the E180G mutation, unlike the D175N, significantly affects 
the stability of the reduced C-domain ofTm and its ability to undergo reduction 
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In the presence of actin three heating scans were performed on the same sample. 
During the first heating (shown in black) the sample was heated to 65°C in order to 
reversibly unfold Tm and reduce its Cys groups. Actin remains intact in this case (actin 
melting transition happens at 80°C and is not affected by the presence of Tm). After 
cooling the sample to 5°C, it was heated again to 90°C achieving the irreversible 
denaturation of actin. This allows the observation of the actin-induced transition under 
the conditions where Tm is reduced (see chapter 4, section 2.6). The third heating 
(shown in green) was to 65°C and aimed at confirming the reversibility of Tm melting. 
DSC experiments with Tm.actin complexes were performed in the presence of ME. 
The melting profile ofWT uu Tm (03) in complex with actin (Figure 4.10) showed the 
appearance of a new peak at 47°C. This new peak was attributed to the melting of 
reduced C-domain of actin-bound Tm as it was not present in the third heating. 
Figure 5.5 represents the DSC melting of uu D175N Tm (03) when bound to actin. As 
with WT uu Tm (03) (Figure 4.10) a new sharp peak appeared at 47°C. As previously 
explained (chapter 4 discussion), Tm thermal denaturation only occurs upon 
dissociation from actin. Like with the WT uu Tm (03), ua D175N Tm (03) dissociates 
from actin at 46.5 °C (Kremneva and Levitsky, data not published). The 42°C 
transition (in this case only seen in third heating), which in the presence of actin 
represents the melting of reduced C-domain of unbound Tm, was completely absent in 
both first and second heating. This is because actin was almost saturated with Tm 
(actin:Tm ratio of 1 :6). As Tm becomes reduced in the second heating, a reduction in 
the size of the 52°C peak is accompanied by an increase in the size of the 42°C peak 
(chapter 4, section 2.6) under the conditions where Tm is in large excess. However, 
under the conditions where actin is not fully saturated by Tm, an increase in the size of 
the actin-induced peak at 47°C was expectedly observed during the second heating. 
This is consistent with the assumption that the actin-induced transition at 47°C 
originates from the melting transition of reduced C-domain. Overall, 0.0. D175N Tm 
(n3) is indistinguishable from the WT protein. 
The uu El80G Tm (03) melting profile (Figure 5.6) showed significant differences to 
the WT au Tm (03) when bound to actin. The profile obtained from the first heating 
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was similar to that obtained in the absence of actin and ME (Figure 5.2) except for the 
complete disappearance of the small 26 °C transition and the appearance of a peak at 
38 °C. This peak could therefore be assigned to the stabilisation by actin of the region 
of Tm where the mutation is located. During the second heating, a sharp new transition 
was observed at 42 °C. This transition was lost after the irreversible unfolding of actin 
(third heating). Also during the second heating a decrease in the size of the most 
thermostable transition was observed due to the reduction of Cys 190 residues. The 
profile from the third heating was similar to that obtained with free reduced aa E180G 
Tm (n3) (Figure 5.4). 
Thus, DSC results show that significant differences exist between ua E180G Tm (n3) 
and WT 0.0. Tm (03), 0.0. D175N Tm (03) in the ability to undergo the actin-induced 
changes of the thermal unfolding of Tm. 
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Figure 5.2: DSC meltiog prorlle of aa D175N Tm (03) 
and aa E180G Tm (03) in the absence of ME. 20 JlM 
Tm was present in 20 mM Hepes, 100 mM KCL 
2.5 mM MgCh, pH 7.3. The thermal unfolding of 
aa D175N (n3) is shown in black. Two separate melting 
transitions with maxima at 35°C and 53 °C were 
observed. The thermal unfolding of an EISOG (n3), 
shown in red, also showed two melting transitions but 
with maxima at 25°C and 52.7 °C. Both mutants showed 
melting profiles similar to that observed with wr protein 
(Figure 4.S) except for the appearance of the small low-
temperature transitions. 
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Figure 5.3: DSC melting profile of 0.0. D175N Tm (03) 
in the presence of ME. The thermal unfolding of reduced 
aa D175N (n3) (20 J.1M) was similar to that of the WT aa 
Tm (n3) in the presence of ME (Figure 4.9) with 
transitions at 42 °e and 52 °e. The small transition at 
35 0 e could also be seen. Buffer conditions were the 
same as described in Figure 5.2 legend except for the 
presence of 1 mM ME. 
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Figure 5.4: DSC melting profile of an E180G (n3) in 
the presence of ME. The thermal unfolding of reduced 
aa E180G (n3) (20 ~M) had Two separate melting 
transitions at 38°C and 52 °C. Buffer conditions were the 
same as described in Figure 5.2 legend except for the 
presence of 1 mM ME. 
129 
ChapterS 















25 30 35 40 45 50 55 60 65 70 
Temperature tC) 
Figure 5.5: DSC melting profIle of au D175N Tm (n3) in 
complex with F-actin. 7.5 JlM 0.0. D175N Tm (03) was 
mixed with 46.7 J.1M phalloidin-stabilised actin. Actin 
unfolds as a single transition with maximum at 80°C (not 
shown). The first heating (black) to 65 °C had two transitions 
at 47°C and 54 0c. The second heating to 90°C (red) 
displayed the same maximum melting temperatures of the two 
transitions. The third heating (green) had two peaks at 42 °C 
and 52°C. The 0.0. D175N Tm (03) meting profile in the 
presence of actin is identical to that of the WT protein 
(Figure 4.10). Buffer conditions were the same as described 
in Figure 5.2 except for the presence of 1 mM ME. 
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Figure 5.6: DSe melting profile of aa E180G Tm (03) 
io complex with F-actin. 7.5!JM of aa E180G Tm (n3) 
was mixed with 46.7 !JM phalloidin-stabilised actin (actin 
melting transition at 80°C is not shown). The first heating 
to 65 °C (black) had two transitions at 38°C and 52 °C 
similar to the profile obtained in Figure 5.4. The second 
heating to 90°C (red) is characterised by the appearance of 
a sharp transition at 42 °C and the disappearance of the low-
temperature transition. The third heating (green) is that of 
reduced free Tm. Buffer conditions were the same as 
described in Figure 5.2 legend except for the presence of 
1 mMME. 
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2.3 EtTect of FHC mutations on the calcium sensitivity of the system 
The two FHC mutations D 17 SN and E 180G are located in the Tm region which 
interacts with the TnT2 part of TnT (the TnT region that binds to TnI and TnC 
proteins). The presence of mutations in this region could affect the Ca2+ -mediated 
regulation of the thin filament. This was investigated by measuring the Ca2+ sensitivity 
of the rate of S 1 binding to actin (chapter 3, section 2.4) in the presence of either WT or 
mutated 0.0. Tm (n3) in complex with Tn. Since the same a-Tm gene is expressed in 
cardiac and skeletal muscles, both cTn and skTn were examined. 
Figure S. 7 shows the ci+ sensitivity curves obtained for WT and FHC mutant 
0.0. Tm (n3) in the presence of phosphorylated cTn. This is shown in comparison with 
the Ca2+ sensitivity measurements obtained with (3(3 Tm (n3), whose overexpression in 
the heart was reported to be lethal (Muthuchamy et aI, 1998). Both D 17 SN and E 180G 
mutations caused a shift in the midpoint of the Ca2+ sensitivity curve with a bigger 
effect reported in the case of E180G mutation. The Ca2+ sensitivity curve midpoint shift 
from 2.69 J.1M (WT 0.0. Tm (n3)) to 2.18 J.1M and 1.99 J.1M in the case ofaa D17SN Tm 
(n3) and 0.0. E180G Tm (n3) respectively, is consistent with an increase in the Ca2+ 
sensitivity of the thin filament. In other words, the presence of these two FHC 
mutations results in the thin filament remaining in the ON state at Ca2+ concentrations at 
which the WT system would normally be turned OFF. A greater shift was observed 
with (3(3 Tm (n3) (from 2.69 J.1M to I.S4 J.1M). The h value in this case is as expected 
around 1.0 as the cTnC protein has only one functional Ca2+-binding site. The results 
described above were reproducible when measurements were repeated with proteins 
from different preparations. 
Figure 5.8 shows the Ca2+ sensitivity measurements obtained with WT aa Tm (03) and 
FHC mutations D17SN and E180G in the presence of skTn. A very small increase in 
the Ca2+ sensitivity, which was relatively greater in the case of E180G mutation, was 
reported. Interestingly, the h value did differ between WT and mutant Tms. The 
cooperativity measured in this case is believed to occur between the Ca
2
+ -binding sites 
on TnC. In the presence of sk Tn complex, the h value is normally around or higher 
than 1.S, as there are two functional Ca2+ binding sites in sk Tne. The h value in the 
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case of the two mutants in the presence of sk Tn is similar to that obtained with cTn 
(compare values in Figure tables 5.7 and 5.8). This suggests that the presence of either 
of the two FHC mutations in skeletal muscle does not affect the Ca2+ sensitivity of the 
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0.0. D175N Tm (n3) 
a.a E180G Tm (n3) 
f3f3 Tm (n3) 
4 5 
h±SE 
l.15 ± 0.09 
l.21 ± 0.09 
l.16 ± 0.04 
l.20 ± 0.10 
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.... . ' 
6 7 8 9 
pCa 
Kso% ± SE Midpoint [Ca
2l Shift in [Ca2l 
~~~ ~~M~ 
5.57 ± 0.08 2.69 
5.66 ± 0.07 2.18 O.Sl 
5.70 ± 0.03 1.99 0.70 
5.81 ± 0.07 l.54 1.1S 
Figure 5.7: Ca1+ seositivity measurements for SI binding to pyrene-actin in the 
presence of either WT 0.0. Tm (03), 0.0. D175N Tm (n3) or 0.0. E180G Tm (n3) in 
complex with cTn. The Ca2+ -sensitivity curves were obtained by plotting the kobs values 
for S 1 binding to pyrene-actin as a function of pCa (Figures 3.6 and 3.7). The curves were 
fitted to a Hill equation to determine both the midpoint of the curve (K50%) and the Hill 
coefficient (h). Parameters obtained from curve fitting are shown in the table above. The 
standard error (SE) was obtained from fitting the data shown in this graph. WT 
0.0. Tm (n3), 0.0. D175N Tm (n3) and 0.0. E180G Tm (n3) curves are shown in black, blue 
and red respectively. Both FHC mutants expressed in Tm caused a shift of 0.09 pCa 
(0.0. D17SN Tm (n3» and 0.13 pCa (0.0. E180G Tm (n3» from the midpoint of the WT 
protein complex (pCa 5.57). This corresponds to a midpoint Ca
2
+ concentration increase of 
O.SO f..1M and 0.70 f..1M from the 2.69 f..1M obtained with 0.0. Tm (n3). Ca2+-sensitivity 
measurements for SI binding to pyrene-actin in the presence off3f3 Tm (n3) is shown in 
green. A shift of 1.15 f..1M in the midpoint Ca2+ concentration was observed. 
134 
ChapterS Study of FHC mutations expressed in tropomyosin 
• • • 














3 4 5 6 7 8 9 
pea 
h±SE Kso% ± SE Midpoint [Ca
2j Shift in [Ca2j 
(J.1M) (J.1M) 
aa Tm(n3) 1.47 ± 0.09 6.05 ± 0.03 0.89 
aa D175N Tm (nJ) 1.22 ± 0.07 6.08 ± 0.04 0.83 0.06 
aa E180G Tm (nJ) 1.19+0.10 6.15 + 0.07 0.70 0.19 
Figure 5.8: Ca1+ sensitivity measurements for SI binding to pyrene-actin in 
the presence of either WT aa Tm (nJ), aa D175N Tm (n3) or au E180G Tm 
(n3) in complex with skTn. The experimental details are outlined in Figure 5.7. 
The curves for WTaa Tm (n3), aa D175N Tm (n3) and aa E180G Tm (n3) are 
shown in black, blue and red respectively. The midpoint of the curve (Kso%) and 
the Hill coefficient h are shown in the table. The standard error (SE) was obtained 
from fitting the data shown in this graph. 
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3 Discussion 
Both D175N and E180G mutations occur in residues that have been highly conserved 
during evolution (Thierfelder et aI, 1994). However, D175N causes cardiac 
hypertrophy with milder effects on the life expectancy of patients compared to E 180G 
(Coviello et aI, 1997). This was verified by producing transgenic mouse lines 
expressing each of the FHC mutations. The D 17 5N mutation was found to cause mild 
hypertrophy (Muthuchamy et aI, 1999) whereas E 180G mutation caused severe cardiac 
abnormalities and ultimately led to death (Prabhakar et aI, 2001). This is most likely 
due to the dramatic changes (change in both charge and side chain size) E 180G 
mutation introduces into the helix structure of Tm The results presented in this chapter 
show that the E 180G mutation has a greater effect on both the overall stability of Tm 
and its ability to bind actin as compared to D 17 5N and WT Tm. 
Tm ends sequences were found to be crucial for its normal binding to actin, (Cho et aI, 
1990; Cho and Hitchcock-DeGregori, 1991, Urbancikova and Hitchcock-DeGregori, 
1994). However, single point mutations introduced at a distance from the Tm ends are 
found to have a major effect on the ability of Tm to bind actin. Both D 17 5N and 
E 180G mutations significantly decrease the affinity of Tm for actin, a bigger effect is 
observed with E180G (The affinity was reduced by a factor of2.8 in the case ofD175N 
mutation and by a factor of3.8 in the case ofE180G). These results contrast with those 
published by Golistina et al (1994) who reported a small decrease in the affInity in the 
presence ofD175N and a significant loss of actin affinity in the presence ofE180G (2-3 
fold decrease). However, those measurements were carried out with bacterially 
expressed Tm which lacked the N-terminal Ala-Ser extension (see chapter 4, section 
1.1). Bing et al (1997) also reported a considerable decrease in the E180G Tm affinity 
for actin as compared with WT but saw no significant change in the affinity of D 17 5N 
Tm. However, as the salt concentration under which the experiments were performed 
was low, the binding affinities were very tight and hence not well defined. 
The Hill coefficient m, which reflects the cooperative nature of Tm binding to actin, is 
also altered in the presence of the two FHC mutations. In systems where ligand binding 
to a multi-subunit protein occurs in a cooperative manner, the m value reflects the 
number of protein sites available for ligand binding. However, this rule cannot apply to 
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the more complex binding of Tm (long filamentous protein) to the multi-subunit actin 
protein (one Tm binds seven actin monomers). The physical meaning of m in this 
particular case can only be described if the binding of Tm to actin is fitted to a 
mathematical model that would describe all the possible states of such a complex 
reaction. F or instance, the Tm can either polymerise in solution and then bind actin or 
undertake the head to tail polymerisation on the surface of actin. It is however likely 
that an equilibrium between a combination of all these states exists, with distribution 
between states dependent on experimental conditions. 
Although a loss in the affinity of Tm for actin is caused by the two FHC mutations, the 
affinity between Tm ends should be unaffected. In other words, the mutant Tms should 
undergo normal head to tail polymerisation but with much weaker binding to actin. The 
WT Tm which has a high affinity for actin (0.2 ~ is likely to bind actin and 
polymerise into a long filament concomitantly. In the case of Tm carrying the FHC 
mutations, the equilibrium for Tm polymerisation could be favoured over the 
equilibrium for binding actin resulting in Tm binding to actin as a longer filament rather 
than shorter ones. Alternatively, the presence of a mutation in Tm could introduce a 
twist in the molecule when bound to actin. This could affect the conformation of Tm 
ends, preventing the normal head to tail polymerisation process to take place on the 
surface of actin In both situations, the m values would be inversely proportional to the 
binding affinity values. 
Both D175N and E180G FHC mutations destabilise the local structure of Tm as 
revealed by the DSC measurements when Tm is oxidised. Yet again a bigger effect is 
observed in the case of E 180G mutation This is in good agreement with Golistina et al 
(1997) conclusions of partial unwinding of the coiled coil in the region of the mutations 
as revealed by an increase in ratio of labelling of Cys 190 with pyrene. Even though 
both D175N and E180G mutations are in the proximity of Cys190, the response to 
reduction by ME was different. While unfolding of reduced 017 5N was similar to that 
of WT Trn, reduced E180G unfolding suggested that this mutation destabilises the C-
domain of Trn, which in this case unfolds at 38°C instead of 42 °c. In the presence of 
actin, 017 5N Tm melting profile is indistinguishable from that of WT Tm. The WT 
Tm has a relatively unstable C-domain as it starts unfolding at about 37°C, the resting 
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1998). This is also consistent with the fact that FHC is not a severe disease condition as 
it is lethal only in adulthood. 
An increase in Ca2+ sensitivity of the heart can be linked to an increase in relaxation 
time and hence a decrease in the recovery time between two heart beats. The 
hypertrophy is therefore believed to be a compensatory mechanism for the 
hypercontractile state of the heart (Bonne et aI, 1998). 
When the mutant Tms were associated with skTn, the Ca2+ sensitivity of the system did 
not appear to be affected as seen with the cTn. However, the Hill coefficient value was 
lower than expected and similar to that obtained with cTn. The cooperativity measured 
in this case is thought to be that of the Ca2+ -binding sites of TnC as it is around 1.0 in 
the case of cardiac Tn (one Ca2+ -binding site) and less than 2.0 in the case of skeletal Tn 
(Ca2+-binding sites). The MWC model of cooperativity (see chapter 3, section 3.2.3.1) 
is defined by three parameters: the equilibrium constant between the low- and the bigh-
affinity state for ligand binding, the equilibrium constant for ligand binding to each state 
and the ratio between the two binding affinities (Figure 3.9). Alterations in any of these 
parameters will result in variations in the nature of cooperative system. 
139 
CHAPTER 6 
STUDY OF FHC MUTATIONS 
EXPRESSED IN TROPONIN 
Chapter 6 
Study of FHe mutations expressed in troponin 
1 Introduction 
A number of FHC-associated mutations in the cardiac Tn complex proteins have been 
described in the literature. Kimura et al (1997) reported the presence of six of these 
mutations in the cardiac TnI gene interestingly all located at the C-domain of the protein 
(RI45G, R145Q, R162W, S 199N, G203S and K206Q). SO far, only one mutation 
(L29E) in the cardiac TnC gene has been associated with the FHC disease (Hoffmann ef 
ai, 2001). Residue 29 in TnC is located in the surface loop that links the two Ca2+-
binding sites of the regulatory domain of TnC (Figure 1.14). Residues 203 and 206 in 
TnI are located at the C-terminal end of the protein. This is the regulatory domain of 
TnI which interacts with actin. Tm complex in a Ca2+ -dependent manner. 
The cardiac Tn! protein contains a 31-amino acid extension at the N-terminal part of the 
protein which does not exist in the skeletal counterparts (Wilkinson and Grand, 1978). 
In this extension, two adjacent serine residues at position 22 and 23 in the human 
sequence become phosphorylated by c-AMP dependent protein kinase PKA (Mittmann 
et ai, 1990) in response to f3-adrenergic stimulation of the heart (England, 1975; Solaro 
et aI, 1976). The phosphoserines are dephosphorylated by the action of protein 
phosphates 2A (PP2A) (Mumby et ai, 1987; Mittmann et ai, 1992). 
The effect of phosphorylation on the Ca2+ sensitivity of the system has been investigated 
in a number of ways. Ca2+ -activated force measurements in skinned muscle (Zhang et 
ai, 1995a) as well as myofibrillar Ca2+ -activated ATPase activity (Bailin, 1979) showed 
that phosphorylation of TnI resulted in a decrease in the pCa value at which half-
maximal force and ATPase is achieved. This was consistent with results obtained from 
reconstituting skinned cardiac muscle with human recombinant TnI containing either a 
Ser-Ala or a Ser-Asp mutation at positions 22 and 23 to mimic the dephosphorylated and 
bisphosphorylated states of TnI respectively (Dohet et aI, 1995). Measurements of the 
C~+ -dependent binding of S 1 to actin carried out with isolated proteins in solution also 
gave the same results (Reiffert et aI, 1996). All these results suggest that TnI 
phosphorylation decreases the Ca2+ sensitivity of the system i.e. switching of the 
filament from the ON to the OFF state occurs at higher Ca2+ concentrations. This could 
be linked to the finding that Tn phosphorylation resulted in reduced Ca2+ affinity for 
TnC (Robertson et ai, 1982; Zhang et aI, 1995b). 
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It was not clear how the phosphorylation of the N-terminal end of TnI influenced the 
Ca2+ binding properties at the N-terminal end of TnC. NMR studies conducted by 
Jaquet et al (1998) suggested that when Tn! is monophosphorylated on either Serine 
residue, the phosphorylation region of Tn! does not interact with TnC, TnT or Tn! 
structures. In the bisphosphorylated form, the NMR measurements obtained were used 
to postulate a likely interaction with the N-domain of TnC explaining the influence on 
the Ca2+ binding properties. Later on, Schmidtmann et al (2002) suggested that TnI in 
the bisphosphorylated form interacted rather with TnT and TnI and not TnC. 
Ward and co-workers (2002) put forward another model to explain the molecular 
mechanisms by which the phosphorylation signal could be transmitted, by identifying 
the structural regions in the TnI N-domain required for such a process to happen. Their 
results indicated that deletion of residues 16-29 of the cardiac specific N-terminal 
extension had the same effect as phosphorylation. They therefore concluded that 
residues 16-29 when unphosphorylated bind to TnC and stabilise the open state of the 
protein (the Ca2+-bound state). This action is reversed when the sequence is 
phosphorylated or deleted. 
In this work, the two mutations in TnI (G203S and K206Q) and the mutation in Tne 
(L29E) have been investigated in terms of their effects on 1) the Ca
2
+ sensitivity of the 
system 2) the binding properties of SI to actin and 3) the switching between the three 
states of the thin filament. Also, the effect of TnI phosphorylation on the Ca
2
+ 
sensitivity of the system was examined. The results obtained show that all the mutations 
were indistinguishable from WT except for the K206Q mutation in Tn! which was found 
to affect the Ca2+ sensitivity of the system but only when Tn! is phosphorylated. 
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2 Troponin protein preparation 
In this study, human cardiac Tn proteins (hcTn) were used. The proteins were cloned, 
expressed, purified and reconstituted by Anja Schmidtamnn (University of Boch~ 
Germany). The protein subunits were reconstituted by mixing a 1: 1: 1 ratio of hcTnI, 
hcTnC and hcTnT. Phosphorylation of the two Ser residues in the N-terminal arm of 
TnI was achieved using the recombinant catalytic subunit of Protein Kinase A. Tnl 
bisphosphorylation was checked by Isoelectric Focusing. The details of these 
preparations are outlined in Lohmann et al (2001) and Schmidtarnnn et al (2002). 
Dephosphorylation of Tnl was achieved by incubating the 2 IJ.M phosphorylated Tn 
complex with 2 JlM Tm and 5 IJ.M actin in the experimental buffer for 30 min at room 
temperature to allow the reconstitution of the thin filament complex. Protein 
Phosphatase 2A (PP2A) was used in the presence of 0.7 mM MnCh. The solution was 
then incubated for 5 hours at room temperature. The protein solution was dialysed 
overnight against the experimental buffer. 
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3 Results 
3.1 Effect of FHC mutations on the calcium sensitivity of the system 
Measurements of the Ca2+ sensitivity of the system for WT hcTn as well as hcTn 
expressed with the three different FHC mutations in its components was carried out in 
order to look at the effect these mutations might have on the Ca2+ -dependent regulation 
of the filament. 
Figure 6.1 shows the Ca2+ -dependence of the observed rate constant for S 1 binding to 
pyrene-actin. The sigmoid curves were fitted to a Hill equation and both the midpoint of 
the curve (Kso%) and the Hill coefficient (h) were determined and are shown in the table. 
The results obtained showed that the Ca2+ sensitivity properties of the thin filament in 
the presence of either L29E mutation in TnC or G203S mutation in TnI are 
indistinguishable from the WT system. However, a 0.28 pCa shift from the 5.80 pCa 
midpoint obtained with the WT complex was observed in the case of K206E. This 
corresponds to a shift in the Ca2+ concentration midpoint from 1.58 ~M to 0.83 ~M. 
This result indicated that K206E caused an increase in the Ca2+ sensitivity of the thin 
filament. 
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4 5 6 7 8 9 
pCa 
h±SE KsO"f., ± SE Midpoint [Ca2+] Shift in [Ca2+] 
(~) (~) 
WTTn 1.10 + 0.08 5.80 + 0.08 1.58 
TnCL29E 1.16 + 0.08 5.84 + 0.06 1.45 0.13 
Tn! G203S 1.20 ± 0.10 5.86 + 0.07 1.38 0.20 
Tn! K206Q 1.08 ± 0.10 6.08 + 0.10 0.83 0.75 
Figure 6.1: Ca1+-sensitivity measurements for SI binding to pyrene-actin in 
the presence of phosphorylated human cardiac Tn (hcTn) complex. The 
binding of S1 (0.25 flM) to pyrene-actin (2.5 flM) was monitored at different 
pCa values in the presence of skTm (1 J.LM) and phosphorylated hcTn (1 J.LM). 
Three FHC mutations were analysed, L29E in TnC (red), G203S in TnI (green) 
and K206Q in Tn! (blue). The trace for the WT complex is shown in black. The 
measurements were carried out at 20 °c in 20 mM MOPS, 140 mM KCI, 5 mM 
MgCh, 1 mM Drr at pH 7.0. The curves were fitted with a Hill equation. Both 
the midpoint of the curve (KSO%) and the Hill coefficient (h) are shown in the 
table. The standard error (SE) on the data is obtained from fitting the dataset 
shown in the graph. A 0.28 pCa shift from the 5.80 pCa midpoint obtained with 
WT protein was observed in the case of K206E mutation expressed in TnI. This 
corresponds to a 0.75 flM shift in the Ca2+ concentration midpoint of the curve 
from 1.58 J.LM to 0.83 J.LM. 
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3.2 Effect of troponio dephosphorylation 00 the calcium sensitivity of the system 
The dephosphorylation of Tn is cataIysed by protein phosphatase PP2A in the presence 
of MnCh. To investigate the effect of dephosphorylation on the Ca2+ sensitivity of the 
system, it was first necessary to find out if the presence of the cation Mn2+ has any effect 
on the Ca
2
+ sensitivity curves as it can compete with Ca2+ for the TnC binding sites. 
Figure 6.2 shows the control experiments carried out in order to test that any effect seen 
as a result of dephosphorylation is independent of the presence of MnCh. Investigating 
the effect of MnCh was achieved by comparing the midpoint of the Ca2+ sensitivity 
curve in the presence and absence of MnCh (0.7 mM) when hcTn is phosphorylated. 
Clearly, a shift to the right was caused by the presence of Mn2+ ions. However, it might 
not be accurate to describe this observation as a shift as Mn2+ can compete with Ca2+ for 
EGT A, altering the free Ca
2
+ concentration of the pCa solution It was therefore essential 
to remove the MnCh from the buffer after dephosphorylation by means of dialysis, the 
efficiency of which was also checked. Figure 6.2 shows that phosphorylated hcTn to 
which 0.7 mM MnCh was added and then removed by dialysis behaved like the 
untreated phosphorylated hcTn complex. This suggested that dialysis was effective. All 
the parameters that describe the Ca2+ sensitivity curves are shown in the table. 
Figure 6.3 shows the effect dephosphorylation has on the Ca2+ sensitivity of the system. 
In order to make the results comparable, the measurements for both phosphorylated and 
dephosphorylated complexes were carried out at the same time using the same proteins 
and pCa solutions. Figure 6.3A shows the Ca2+ sensitivity measurements for the 
phosphorylated complexes. The results are comparable to Figure 1 results and as before, 
only K206E mutation in TnI shows a shift in the midpoint of the ci+ sensitivity curve. 
However, the size of the shift is bigger than what was previously found (0.6 pCa shift as 
compared to 0.28 pCa shift). Figure 6.3B shows the Ca2+ sensitivity curves for the 
dephosphorylated complexes. In this case all the three mutation-containing complexes 
were indistinguishable from the WT system. These findings are very interesting as they 
suggest that the effect of an FHC mutation expressed in the C-domain of TnI on the Ca2+ 
sensitivity of the thin filament depends on the phosphorylation state of the TnI N-
domain. These results also showed that while WT, L29E mutation in TnC and G203S 
mutation in TnI caused the expected increase in the Ca2+ sensitivity (shift in the curve 
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midpoint from 5.7 to 5.85), K206E mutation in TnI caused a decrease in Ca2+ sensitivity 
(shift in the curve midpoint from 6.27 to 5.83). As a consequence, dephosphorylated Tn 
carrying the K206E mutation in TnI has the same Ca2+ -sensitivity as the WT protein 
complex. 
3.3 Effect of FOC mutations on the KB value 
Ks defines the equilibrium constant between the blocked and closed states of the thin 
filament and is defined by the ratio of the observed rate constant for S 1 binding to 
pyrene-actin in the presence and absence of Ca2+ (kobs (+Ca2+)lkobs (_Ca2+) = Ksl1+Ks) 
(see chapter 3, section 2.4.1). The calculated l<B values for WT system and in the case 
of each mutation are shown in table 6.2. The Ks, with a value of 0.6, is unchanged in 
each case and is comparable to previously published values (ReifIert et ai, 1996). This 
result suggests that the presence of the FHC mutations under investigation in the Tn 
complex does not influence the extent by which the filament is switched OFF when C~+ 
is removed. 
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Kso% ± error h± error 
Phosphorylated WT hcTn + MnCh+dialysis 5.8 + 0.05 l.13 + 0.06 
Phosphorylated WT hcTn + MnCh 6.58 2.21 
Phosphorylated WT hcTn 5.8 ± 0.08 l.10 ± 0.08 
Figure 6.2: Effect of MnCh on the Ca2+ sensitivity measurements. The 
experimental conditions and the details of the fitting are described in Figure 6.1 
legend. Phosphorylated WT hcTn from which MnCh (0.7 mM) was removed 
by means of dialysis is shown in black. Phosphorylated WT cTn with no added 
MnCh is shown in blue. The effect of MnCh on the Ca2+ sensitivity curve is 
shown in green. 
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Figure 6.3: Effects of Tn dephosphorylation on the Cal + sensitivity of the 
system. The measurement were carried out in the presence of phosphorylated 
(A) and dephosphorylated (B) hcTn both WT and in the presence of different 
FHC mutations. Both the experimental conditions and the fitting procedures 
are detailed in Figure 6.1 legend. In both graphs WT is shown in black, Toe 
L29E mutation in red, TnI G203S mutation in green and TnI K206Q 
mutation in blue. The fitting parameters are shown in Table 6.1 . 
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WT L29E G203S K206Q 
Phosphorylated Tn Kso%±SE 5.68 ± 0.03 5.67 + 0.04 5.70 + 0.05 6.27 + 0.05 
h ±SE 1.25 + 0.05 1.26 + 0.06 1.21 + 0.08 1.30 + 0.09 
Dephosphorylated Tn Kso%±SE 5.84 ± 0.03 5.85 ± 0.06 5.84 + 0.06 5.83 + 0.07 
h ±SE 1.15 + 0.04 1.17+0.08 1.10 + 0.06 1.22 + 5.83 
Table 6.1: Parameters obtained from fitting Ca2+ sensitivity curves. The curves for 
both phosphorylated and dephosphorylated hcTn complex shown in Figure 6.3 are fitted 
to a Hill equation. Both the curve midpoint (Kso%) and the Hill coefficient (h) are 
shown. The standard error (SE) on the data was obtained from fitting the datasets 
shown in the graphs. 
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3.4 Effect of FHC mutations on SI binding to actin 
Titration of pyrene-actin with S 1 in the presence of skTm and hcTn and its mutants both 
in the presence and absence of Ca2+ was used in order to define the three-state model 
parameters (chapter 1, section3.1). 
Figure 6.4 shows the binding curve of S 1 to actin in the presence of WT hcTn. As 
previously reported (Maytum et aI, 1999; Maytum et aI, 2003) both binding curves have 
a sigmoid character, which reflects the cooperative binding of S 1 to actin when bound to 
regulatory proteins. However, the sigmoidicity is more prominent when Ca2+ is absent 
as more S 1 is needed to bind actin before the filament is turned into the ON state. Curve 
fitting of the data gives values for the parameters as shown in table 6.2. As expected, 
the KT value shows a 5-fold decrease from 0.11 to 0.022 on ci+ removal as it has been 
shown to be Ca2+ -dependent (Maytum et aI, 1999). The value for Kl, which in 
combination with K2 (KIK2) defines the overall affinity of S 1 for actin, is about 80-
100 M-1. The K2 is fixed at the independently determined value of 200 for nucleotide-
free S 1 (Coates et aI, 1985). Values for the apparent cooperative unit size (n) are similar 
in the presence and absence of Ca2+. In both cases, n varies between 7 and 8. This 
result is inconsistent with the published data of Maytum et al (1999, 2003) where n is 
reported to be around 7 in the absence of Ca2+ and larger than lOin the presence of Ca
2
+. 
The I<B equilibrium constant between blocked and closed states is determined with 
stopped-flow measurements of the rate of S 1 binding to actin in the presence and 
absence ofCa2+ as described in section 3.3. 
When the experiment was repeated with the Tn complex containing the FHC mutations, 
there was no noticeable difference with the WT system, suggesting that these FHC 
mutations do not interfere with the switching between the different regulatory states, or 
with the binding properties of S 1 to actin. 
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Figure 6.4: Effed of FHC mutations on the binding of SI to actin. Sl 
was continuously titrated into a stirred cuvette that contained 50 nM 
phalloidin- stabilised pyrene-actin and 0.2 ~ of both skTm and 
phosphorylated hcTn in the presence and absence of Ca2+. The curves shown 
in the graph were obtained with WT hcTn S 1 binding was monitored by 
fluorescence quenching of the pyrene label. The measurements were carried 
out at 20°C and the buffer was 20 mM MOPS, 200 roM KCI, 5 mM MgCh, 
1 mM DTT at pH 7.0. The curves were fitted using the three-state model 
equation. The raw (continuous) and fitted (dashed) data are superimposed. 
The parameters that define these curves are shown in Table 6.2. 
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Ca:l+ KT+SD n Kl+SD Ks 
WT + (N-4) 0.11+ 0.04 7-8 86+ 13 > 10 
- (N-4) 0.022 + 0.01 7-8 100 + 10 0.6 
TnCL29E + (N'-3) 0.13 ± 0.08 7-8 80 +7 > 10 
- (N=2) 0.022 + 0.01 7-8 96+6 0.6 
Tnl G203S + (N=2) 0.095 + 0.04 7-8 83 +4 > 10 
- (N=2) 0.028 ± 0.002 7-8 105 + 12 0.6 
TnlK206Q + (N=2) 0.10 ± 0.02 7-8 90+ 10 > 10 
- (N=2) 0.026 + 0.03 7-8 93 + 10 0.6 
Table 6.2: Parameters obtained from titration curve fitting of Figure 6.4 data. 
The three-state model parameters were determined for both the WT and the three FHe 
mutations expressed in the hcTn components. KB and KT are the equilibrium constants 
between the blocked - closed and closed-open states of the filament respectively. Kl is 
the equilibrium constant for the weak binding of S 1 to actin and n in the cooperative 
unit size of actin that switches between states. Ks values were obtained independently 
from stopped-flow experiments. The number of curves analysed is indicated between 
brackets. 
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4 Discussion 
The C-domain of TnI is where the inhibitory activity of TnI is localised. In the cardiac 
isoform sequence, residues 150-159 interact with TnC N-domain when Ca2+-saturated. 
This interaction drives the detachment of two regions of Tn!, which in the absence of 
Ca
2
+ bind to actin and inhibit the acto-myosin ATPase activity. The two FHC mutations 
expressed in TnI (G203S and K206Q) are located in a region of Tn! C-domain that is 
believed not to have a direct contact with Tn but which can bind actin and relocate along 
side the inhibitory regions of TnI in a Ca2+ -dependent manner (Takeda et ai, 2003). The 
two mutations though found in close proximity in TnI were reported to result in slightly 
different phenotypes. Patients with K206Q developed the characteristic hypertrophy, 
whereas those with G203S exhibited a hypertrophy only at the apex of the heart (Kimura 
et ai, 1997). The result obtained in this study showed that while the Tn complex with 
G203S mutation in TnI behaved like WT, Tn complex containing K206Q caused an 
increase in the ci+ -sensitivity of the thin filament. This result is in agreement with 
published data by Takahashi-Yanaga et al (2001). The authors replaced endogenous TnI 
with expressed human TnI carrying the FHC mutations into porcine myofibrils and 
reported a large increase in Ca2+ sensitivity with K206Q mutation and not a significant 
difference between WT and G203 S mutation The FHC mutation expressed in TnC 
(L29E) also did not have any effect on the Ca2+ -sensitivity of the thin filament. The 
mutated residue is located in the surface loop that joins the Ca2+ -binding sites I and II 
located at the N-domain of TnC. 
Assessing the effect of these FHC mutations on the three-state model parameters 
revealed that the occupancy of the three states is not affected by these mutations as 
revealed by the unchanged KB and KT values. Also the binding affinity of S 1 for actin is 
unaffected both in the presence and absence of Ca2+. The cooperative unit size n, which 
refers to the number of actin monomers that switch between two states at a time, is no 
bigger than the structural unit size both in the presence and absence of Ca
2
+. This result 
contrasts with the previously published values of Maytum et al (1999) and Maytum et al 
(2003). In both papers, the n value is reported to be around 7 in the absence of Ca
2
+ and 
larger the lOin the presence of Ca2+. The published results were similar for skeletal and 
cardiac Tn. This was explained by the pinning effect of Tn!, which binds strongly to 
every seven actins in the absence of ci+. The significant increase of n value from 7 to 
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~ lOon Ca
2
+ addition was attributed to the increased stiffuess of the Tm overlap region 
by the TnTl portion of TnT (Figure 1.19). The KB, KT and Kl values presented in this 
chapter are very similar to those published by Maytum et aI, and since the same 
experimental and fitting procedure was applied, it is possible that the difference in n 
values is due to the use of different Tn isoforms. Maytum et al (2003) used bovine 
cardiac Tn complex and not human cardiac Tn The explanation put forward by 
Maytum et al could therefore only be true for some TnT isoforms and not others. Over 
20 TnT isoforms are produced by alternative splicing, the differences between them 
arise mainly at the N-terminal hypervariable region (Perry, 1998). The different TnT 
isoforms most certainly provide different regulatory properties required for the function 
of the muscle they are associated with. 
Overall, both L29E mutation in TnC and G203S mutation in TnI, though reported to 
cause hypertrophic cardiomyopathy, do not seem to alter the normal function of the 
system based on our in vitro assays. Either the methods used were not sensitive enough 
for detecting the alterations caused by the mutations (changes could be very subtle and 
not readily detectable) or the mutations affect other properties of the filament that were 
not assessed in this study (actin activated myosin ATPase, binding to Tm and actin). 
As previously published (Zhang et ai, 1995a; Zhang et ai, 1995b; Dohet et aI, 1995; 
Reiffert et ai, 1996), phosphorylation of TnI decreases the Ca2+ sensitivity of the thin 
filament. The results presented in this chapter are consistent with the published work. 
K206Q mutation in TnI increases the Ca2+ sensitivity of the thin filament when TnI is 
phosphorylated but shows no difference to the WT system on Tn dephosphorylation. In 
other words, the alteration in the properties of the thin filament caused by this mutation 
is only detectable when TnI is phosphorylated. In the WT protein residue 206 will carry 
a positive charge. Though residue 206 is located at the C-domain of Tn! and the site of 
phosphorylation is at the N-domain, the possibility of an interaction between the 
negatively charged phosphate groups and the positively charged lysine group at position 
206 cannot be ruled out. The absence of this interaction might affect the switching 
between the ON and OFF states of the filament. In other words, the disruption of a 
possible interaction between the N- and C-domains of TnI by charge change at a single 
residue position could affect the equilibrium switching between C-Tn! attachment and 
detachment from actin 
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K206Q mutation, unlike the WT protein complex, causes a decrease in Ca2+ sensitivity 
upon dephosphorylation. How a single point mutation in the C-domain of TnC reverses 
the effect of dephosphorylation is not clear. Ward et al (2002) proposed that the 
dephosphorylated N-domain of TnI stabilises the Ca2+ -bound state of TnC. Clearly the 
opposite happens in the presence of K206Q mutation. The results obtained with the 
K206Q FHC mutation demonstrate that a residue positioned at the C-domain of TnI can 
influence the nature of interaction between the N-domain of TnI and TnC but also the 
phosphorylated state of the N-domain of TnI seems to influence the nature of 
interactions between the C-domain ofTnI and actin 
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Chapter 7 
Summary and General Discussion 
In striated muscle such as skeletal and cardiac, the regulation of the acto.myosin 
interaction, which ultimately leads to muscle contraction, is primarily dependent on the 
reversible binding of Ca
2
+ to the thin filament and is mediated by the regulatory protein 
complex of Tm.Tn. The three-state model of regulation described by McKillop and 
Geeves (1993) is a widely accepted model of muscle regulation. In this model~ the 
filament is described to be in equilibrium between three myosin-binding states or as 
shown by structural data between three equilibrium Tm positions on actin (Vibert et aI, 
1997). The position of Tm is influenced by both the allosteric changes triggered as a 
result of Ca
2
+ binding to TnC and the binding of myosin heads to actin. The three 
biochemical states are referred to as blocked, closed and open states. In the blocked 
state, Tm occupies both the weak and strong myosin-binding sites on actin preventing 
the formation of a stereo-specific acto. myosin complex. In the closed state, Tm 
position only prevents the strong binding of myosin and a weakly bound acto.myosin 
complex forms. In the open state, Tm is further displaced to allow the rigor myosin 
binding and the formation of ATPase active acto.myosin complex. The three-state 
model of regulation describes the equilibrium constants for the occupancy of the 
different states of the filament as well as the affinity of myosin head binding to actin 
All our results were analysed and discussed in terms of the three-state model of 
regulation. Both equilibrium and kinetic measurements are required to define the 
model parameters. The kinetic measurements are carried out with the stopped flow 
machine and allow the measurements of the rate of 81 biding to thin filaments 
reconstituted with the desired proteins. These allowed the determination of the 
equilibrium constant between the blocked and closed states of the filament either in the 
presence or absence of C~+ or as a function of pCa (-log[Ca2+]). The equilibrium 
measurements are obtained by the continuous titration of 81 into a cuvette containing 
reconstituted thin filaments under varying conditions. Both types of experiments probe 
the pyrene fluorescence signal as binding of 81 to pyrene-Iabelled actin causes 
fluorescence quenching. 
The ability to express recombinant Tm in bacteria is a valuable tool as it allows 1) the 
overexpression of different Tm isoforms and the investigation of their regulatory 
properties, 2) the production of Tm expressing FHC mutations and the examination of 
their effect on the regulatory function ofTm. However, the crucial requirement was to 
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produce recombinant Tm with native-like properties. Bacterially expressed Tm lacks 
the N-terminal acetyl group, reported to be essential for the normal function of the 
protein (Heald and Hitchcock-DeGregori, 1988). Expression of Tm with and Ala-Ser 
extension at the N-terminal was reported to restore the normal function of Tm as 
revealed by a number of assays (Monteiro et ai, 1994). We further investigated this 
claim by applying a wide range of techniques, which included actin-binding assays, 
stopped-flow and fluorescence titration experiments as well as DSC measurements. In 
all cases, native tissue-purified and recombinant Tm with the Ala-Ser extension were 
indistinguishable. Therefore, the Ala-SeT extension expressed at the N-terminus of Tm 
is a good mimic of the acetyl group. 
On this basis, a and f3 TIll, the two major Tm isoforms in striated muscle were 
overexpressed in E. coli allowing the regulatory properties of each to be characterised. 
f3 Tm, which is expressed in very small amount in slow-beating hearts of mammals, 
causes a significant increase in the Ca2+ sensitivity of the thin filament when associated 
with cardiac Tn proteins. This was reflected by a shift in the Ca2+ concentration at 
which the filament is turned into the OFF state. This finding is consistent with fibre 
force measurement obtained with transgenic mice where f3 Tm was overexpressed in 
the heart (Muthuchamy et ai, 1998). Determination of the three-state model parameters 
showed that while the occupancy of the different states is not changed by the type of 
Tm isoform associated with actin, the affinity of S 1 binding to actin is enhanced in the 
presence of f3Tm. Finally, DSC measurements clearly indicate that f3 Tm is thermally 
less stable than a Tm both in solution and when in complex with actin A structural 
domain of f3 Tm is 50% unfolded at normal body temperature. Though the presence 
of actin increases its stability by shifting the maximum melting temperature to 42 °C, J3 
Tm will still be susceptible to denaturation in the case of disease. This could explain 
the low level of f3 Tm expression in the cardiac muscle and the reason why J3 Tm is 
mostly found associated with a Tm as a heterodimer. This also points to the 
importance of producing the aJ3 heterodimer as it will provide a better understanding of 
the in vivo system. The heterodimer can be produced by mixing a 1: 1 concentration of 
the homodimers heated up to 65 °C in the presence of 20 roM DTT. The mixture 
should be allowed to cool down to 35 °C on a water bath to allow chain exchange. 
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DTT can then be removed by means of gel filtration and the heterodimer can be 
oxidised by Cu2+-catalysed K3Fe(CN)6. 
The three state model of regulation was also used as a working model for investigating 
the effects of FHC mutations expressed in Tm and Tn proteins. The selected mutations 
in Tm were E180G and D175N, both of which rendered the thin filament more Ca2+_ 
sensitive. A more dramatic effect was seen with E180G mutation previously reported 
to cause more serious cardiac dysfunction as compared to D175N. This result was 
consistent with published fibre measurements. 
The ability to reproduce in vivo results with our in vitro assays offers the possibility of 
studying FHC mutations using a simple system. The use of purified proteins means 
that the observations could be more easily interpreted as the possibility of an effect 
from other factors such as the presence of different protein isoforms and different levels 
of phosphorylation is eliminated. However, not all FHC mutations affect the Ca2+ 
sensitivity of the thin filament and it is important to investigate their potential effect on 
the stability, binding to the other thin filament proteins as well as the ATPase activity. 
Point mutations were also introduced in Tn proteins; these were K206Q, G203S in TnI 
and L29E in Tne. Only K206Q caused alterations of the Ca2+ - dependent regulation of 
the thin filament. An increase in the Ca2+ sensitivity was however observed only when 
TnI was phosphorylated. Phosphorylation of cardiac TnI modulates the Ca2+ -sensitivity 
of the thin filament by decreasing the affinity of Ca2+ for TnC. This was true for WT, 
G203S and L29E Tn complexes. The opposite effect was observed with K206Q 
mutation. It was therefore concluded that the phosphorylation state of the N-domain of 
TnI influences the function of the TnI C-domain, which binds actin in a Ca2+ -dependent 
manner and that the interaction of the N-domain of TnI with TnC C-domain can be 
disrupted and reversed by a single point mutation in TnI C-domain 
Equilibrium measurements of S 1 binding to actin in the presence of phosphorylated Tn 
complex showed no effect of the FHC mutations expressed in Tn on the three-state 
model parameters. The measurements were carried out under the conditions where the 
filament was either fully ON (presence of Ca2j or fully OFF (absence of Ca2+). 
However, since the graded response to Ca2+ was different from WT in the case of 
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K206Q mutation, it would be interesting to see if the equilibrium parameters are 
changed within the range of pCa values where a difference in the Ca2+ sensitivity was 
observed. Also, it will be important to investigate the effect of dephosphorylation on 
these parameters. 
In summary, different FHC mutation expressed in both Tm and Tn as well the ~ Tm 
isoform render the thin filament more Ca2+ sensitive. The Ca2+ sensitivity assays are a 
measure of the Ca2+ dependency of the I<B equilibrium constant between the blocked 
and closed states. I<B is also the equilibrium for the Ca2+ -dependent binding of Tn! to 
either actin or TnC. In the absence of Ca2+, Tn! is strongly bound to actin and weakly 
bound to TnC whereas in the presence of Ca2+ Tn! is strongly bound to TnC and 
weakly bound to actin (Grabarek et aI, 1983). 
C 2+ Blocked A.TnI+TnC (Tn! binds actin strongly) - a 
1 KB 1 
+Ca2+ Closed A+ TnI.TnC (Tnl binds TnC strongly) 
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The above model can therefore explain the effect of mutations and isoform being due to 
an alteration in the equilibrium binding of TnI to actin and the ability of TnI to stabilise 
the high Ca2+ affinity state of ToC explaining the pCa shift. 
This model could also account for the differences measured between the cardiac and the 
skeletal systems, which suggest that the cardiac system is less turned off than the 
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skeletal one. The TnI.ActinffnI. TnC equilibrium should be adjusted in order for the 
cardiac muscle to fulfil its function of constant beating. The structural differences in 
Tm and Tn proteins between the cardiac and skeletal muscles are specific adaptations 
which fine-tune the differing needs of each system 
DSC was also used to investigate the effect of E180G and D175N mutations on the 
thermal stability of Tm. Both mutations significantly destabilised Tm when free in 
solution but when bound to actin the D175N was indistinguishable from WT. This was 
consistent with the observation that E180G mutation was more disruptive than D175N 
mutation. A decrease in the thermostability of Tm could have implications on the 
ability of the muscle cell to synthesise fully folded and functional Tm molecules but 
also to maintain the normal assembly of the sarcomere. Such severe consequences are 
however not expected to arise in the in vivo system in view of the late onset of the 
disease. In future experiments, it will therefore be interesting to examine the effect of 
Tn proteins on the stability of the mutated Tm. 
In order to complete the work presented in this thesis and in addition to the production 
and characterisation of the (l~ heterodimer, it will be necessary in the future to carry 
out the S1 fluorescence titration experiments 1) in the presence of the ~~ Tm in order to 
confirm the increased affinity of S 1 for actin, 2) in the presence of dephosphorylated 




1.1 Equations generated using Origin 6.0 Software 
1.1.1 Linear equation 
Equation 
y= axx+ b 
Parameter definition 
a: slope of the line 
b: intercept with y axis 
Equation expressed in Origin format 
Parameter names: a, b 
Indept variable: x 
Dept variable: y 
Defllrition:y=a*x+b 
1.1.2 Single exponential 
Equation 
y=-axexp( -xx b )+c 
Parameter definition 
a: amplitude of the single exponential 
b: observed rate constant of the reaction 
c: end point of the curve 
Equation expressed in Origin format 
Parameter names: Amp, k, Vinf 
Indept variable: x 
Dept variable: y 
Defllrition: y=-Amp*exp(-x*k)+Vinf 





b: the x value corresponding to the midpoint of the curve 
c: the Hill coefficient 
Equation expressed in Origin format 
Parameter names: Amp,k,n 
Indept variable: x 
Dept variable: y 
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Defmition: y= Amp*X"n/(k''n+X'''n) 




a: maximum value for y 
b: the amplitude 
c: the Hill coefficient 
d: the x value corresponding to the midpoint of the curve 
Equation expressed in Origin format 
Parameter names: Amp, h, k, Vmax 
Indept variable: x 
Dept variable: y 
Definition: y=Vrnax-Amp*«(l O"'xY-h)l«(l Ol\kY'h+(l O"'xY'h) 
1.2 Equations generated using Scientist Software 
1.2.1 Hyperbolic equation 
Equation 
f = ([SI]+kd+[Ao])-~([SI]+kd+[Ao])2 -4[Ao][SI] 
2[Ao] 
Equation expressed in Scientist format 
Independent Variable(s): sl 
Dependent Variable(s): fl 
Parameter(s): fO, aO, kd,fl 
f=«sl +kd+aO)-«sl +kd+aO)1\2-4*sl *aOY'.5)/(2*aO) 
f=(fO-fl)/(fO-fl ) 
Parameter definition 
f: fraction of actin with S 1 bound 
fl: fluorescence value 
sl: SI concentration 
Appendix 
f(): starting fluorescence value 
aO: starting actin concentration 
kd: dissociation constant or S 1 value for half the maximum fluorescence value 
fl: fluorescence infinity value 
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1.2.2 Three-state model equation 
f = KI[SI]p n- 1 {KT(l + K2)n + I} 
(KTpn + Qn + 1/KB)(l + K2)n-l 
P= I+Kl[SI](l+K2) 
Q= I+Kl[SI] 











1.2.3 Two-state version of the three-state model equation 
f = KI[Sl]pn-1{KT(l+K2t +1} 
(KTpn + Qn)(l + K2t-1 
P= I+Kl[SI](l+K2) 
Q= I+Kl[Sl] 
Equation expressed in Scientist fonnat 
IndVars: sl 










f: fraction of actin with S 1 bOWld 
fl: fluorescence value 
kl: equilibrium constant for the weak S 1 binding to actin 
k2: equilibrium constant for the isomerisation step from weakly to strongly 
bound acto.S1 complex 
Kb: equilibrium for the blocked to closed transition 
kt: equilibrium for the closed to open transition 
n: the cooperative unit size 
as: starting actin concentration 
fO: initial fluorescence value 
fi: fluorescence infinity value 
164 
Appendix 
2 Protein gels 
-
S 1 heavy chain 
116 KDa 
S 1 light chain 
Appendix 
Rabbit S1 preparation fWl on 15% SDS-gel. From left to right 0.5, 1 and 1.5 f.1g of 
S 1 were loaded 
actin .--




Tm, actin and regulatory protein (Tm, TnT, TnI and TnC) preparations from rabbit 
skeletal muscle run on a 12% SDS-gel. 
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3 Hardware 
Centrifuges 54I5C, Eppendorf, USA 
J2-2I, Beckman, USA 
Ultracentrifuges Optima MAX, Beckman, USA 
Columns Resource 
L8-70M, Beckman, USA 
Q 6ml, Pharmacia 
DEAE-Sephacel 
HiTrap 5 ml Q, Pharmacia product 
Appendix 








Mini Protean n, Biorad, USA 
Hydurs 300, Orion Research, USA 
Gilson, USA 
ABI04, Mettler, Switzerland 
PB302, Mettler, Switzerland 
Cary 50 Bio, Varian, Germany 
Varian, Germany 
JA 20, Beckman, USA 
JA 10, Beckman, USA 
TLA 110, Beckman, USA. 
TLA 100.1, Beckman, USA 
Ti 60, Beckman, USA 
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4 Skeletal rat fi Tm sequence 
atggacgccatcaagaagaagatgcagatgctgaaactggacaaggagaatgccatcgac 
M D A I KKK M Q M L K L D KEN A I D 
cgcgcagagcaggccgaagccgacaagaagcaagctgaagaccgatgcaagcagctggag 
RAE Q A E A D K K Q A E D R C K Q L E 
gaagagcagcaggccctccagaagaaactgaaggggacagaggatgaggtggaaaagtat 
E E Q Q A L Q K K L K GTE D EVE K Y 
tccgagtctgtgaaggatgcccaggagaaactggagcaggccgagaagaaggccaccgat 
S E S V K D A Q E K L E Q A E K KAT D 
gctgaagcagatgtggcttctctgaatcgacgcattcagctcgtagaggaggagttggat 
A E A D V A S L N R R I Q L VEE E L D 
cgggcacaggagcgcctggctacagccttgcaaaagctggaggaggctgagaaagccgct 
R A Q E R L A TAL Q K LEE A E K A A 
gatgagagcgagagaggaatgaaggtcattgagaaccgggccatgaaggatgaggagaag 
DES ERG M K V lEN RAM K DEE K 
atggagctgcaggagatgcagctgaaagaagccaagcacatcgctgaggactcagaccgc 
MEL Q E M Q L K E A K H I A E D S D R 
aaatacgaggaggtggccaggaagctggtgatcctggaaggagagctggagcgctctgaa 
K Y E E V ARK L V I LEG E L E R S E 
gagagagccgaggtggctgagagtaaatgtggggacctagaggaggagctgaaaattgtt 
ERA E V A E S KeG D LEE ELK I V 
accaacaacttgaaatctctggaagcccaagcggacaagtattccaccaaagaggacaaa 
T N N L K S LEA Q A D K Y S T KED K 
tacgaagaagagatcaaacttctggaggagaagctgaaggaggctgagacccgagcagag 
Y E EEl K L LEE K L K E A E T RAE 
tttgctgaaagatctgtggcaaagttggagaaaaccatcgatgacctggaagatgaagtc 
F A E R S V A K L E K TID D LED E V 
tatgcacagaagatgaagtacaaggccatcagcgaggagctggacaacgcgctcaatgac 




5 List of abbreviations, symbols and units 
Ala Alanine 
}lnnp }lnnpicillUn 




























Ethylene glycol bis (b-aminorthyl ether)- N,N,N' ,N'-
tetraacetate) 
Essential Light Chain 
Familial Hypertrophy Cardiomyopathy 


























Myosin Heavy Chain 
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Appendix 
MOPS 4-morpholinopropanesufonic acid 
Mwt Molecular weight 
N Aspargine 
NMR Nuclear Magnetic Resonance 
N-terminal Aminoterminal 
Pi Inorganic Phospahte 
Pyrene N-(l-pyrenyl)iodoacetamide 
Q Glutamine 




S1 Myosin Subfragment 1 
S2 Myosin Subfragment 2 
SDS Sodium Deodecyl 
SkTn Skeletal Tn 
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